Trading Analysis Report: BABA¶

Analysis date: 2026-10-08
Rating: Underweight
Generated: 2026-10-09 07:48:22
TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-opus-5-5
Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

I. Analyst Team Reports¶

Market Analyst¶

Current Price: 105.70 USD Price As Of: 2026-10-08

BABA (Alibaba Group Holding Limited, NYQ): technical report¶

1. Indicators used and why¶

BABA has been falling for a year. After a sharp bounce in summer, it keeps making lower highs and lower lows. I picked eight indicators that each answer a different question:

Category	Indicator	Why it fits now
Trend (medium)	`close_50_sma`	Shows the direction of the swing since July, and where the first big resistance sits
Trend (long)	`close_200_sma`	Tells us whether this is a bear market or just a pullback
Trend / stops	`supertrend`	Weekly, monthly and daily trend direction, plus the price at which each would flip
Momentum	`macd` (with `macdh` history)	Shows whether selling pressure is speeding up or slowing down, and tracks crossovers
Momentum	`rsi`	Overbought/oversold reading and divergence. I left out StochRSI because it repeats RSI.
Volatility	`atr`	Stop placement and position sizing
Volume	`obv`	Checks whether volume agrees with the new price lows
Exhaustion	`td_9`	Whether the decline is close to a statistical "exhaustion" point on each timeframe

The verified snapshot also gave the 10-day EMA and Bollinger Bands, which I use below. Every indicator value from the separate calls matched the snapshot exactly (50 SMA 116.38, 200 SMA 129.37, RSI 39.09, MACD −2.11, ATR 3.11), so there are no discrepancies to flag.

2. The big picture: a long-term downtrend¶

One year: BABA closed at 187.62 on 2025-10-02 and at 105.70 on 2026-10-08, down about 43.7%.
The 2026 low: an intraday low of 91.99 on 2026-06-26 (close 94.81).
The summer rally: price ran from that 91.99 low to an intraday high of 132.57 on 2026-08-10. A second push reached 130.62 on 2026-08-20.
The turning point: on 2026-08-21 the stock fell from 130.53 to 119.34 (−8.6%) on 32.55M shares, one of the heaviest volume days since July. It hasn't recovered since.
Lower highs: 130.62 (Aug 20), then 120.40 (Sep 22), then 111.40 (Oct 5).
Lower lows: 109.67 (Sep 3), 106.64 (Sep 16), 105.00 (Oct 2), and 104.75 (Oct 8).
How much of the rally is gone: the stock has given back about 66% of the 91.99 → 132.57 rally. That puts it below the 61.8% retracement level (about 107.49). The next retracement level, 78.6%, is about 100.67. These levels are my own arithmetic from the tool prices, not tested support.

Bottom line: the summer rally was a bounce inside a bear market, and that bounce has now mostly unwound.

3. Trend: moving averages and SuperTrend¶

The averages are stacked in full bearish order. Price sits below every one of them, and each shorter average sits below the longer one:

Measure	Value	Price vs. it
Close	105.70	—
10-day EMA	108.23	price below
20-day SMA (Bollinger middle)	109.51	price below
50-day SMA	116.38	price 9.2% below
200-day SMA	129.37	price 18.3% below

The 50 SMA has turned down. It peaked at 118.13 on 2026-09-22 and has fallen every day since, to 116.38.
The 50 SMA will probably keep falling. Its 50-day window now starts at 2026-07-30. The next prices to drop out of it are the early-August closes of 122–129, well above today's price. Unless BABA rallies hard, the average will keep sliding, so that resistance will move lower over time.
The 200 SMA is falling steadily: from 138.85 on 2026-08-10 to 129.37 now, about 9.5 points in two months.
The 50 SMA is about 13 points below the 200 SMA. That gap is a long-term bearish signal, and nothing suggests it will close soon.

SuperTrend is down on all three timeframes:

Timeframe	Direction	Flip level (stop)	Price vs. stop
Weekly (main)	DOWN	131.16	−19.41%
Monthly (backdrop)	DOWN	176.16	−40.00%
Daily (timing)	DOWN	114.44	−7.63%

No timeframe disagrees, so there's no conflict to weigh.
The only level within reach is the daily flip at 114.44, about 2.8 ATRs above price. A daily close above it would be the first sign the short-term trend is turning.
The weekly flip at 131.16 sits right next to the 200 SMA (129.37) and the August highs. That band is where a real trend change would have to happen.

4. Momentum: MACD and RSI¶

MACD: a new sell crossover, but a weak one¶

Today's reading: MACD −2.11 versus its signal line at −2.10. The gap between them (the histogram) flipped from +0.100 on Oct 7 to −0.015 on Oct 8, so the bearish crossover happened today.
The crossovers keep failing. There have been four since mid-September, all below the zero line:
Sep 21: bullish, lasted until Sep 29
Sep 30: bearish
Oct 5: bullish, lasted only 3 sessions
Oct 8: bearish
Each rally is weaker than the last. The largest positive histogram reading was +0.67 on Sep 22, then only +0.17 on Oct 6.
The selling bursts are also shrinking. The histogram's lows went from −1.38 on Sep 9 to −0.21 on Oct 2, and now −0.015.
What this means: momentum is squeezing toward neutral. The stock is grinding lower rather than collapsing. Crossover signals near the signal line are unreliable here. A MACD move above zero would matter much more.

RSI 39.09: weak, but not oversold¶

RSI has stayed between 33.73 (Sep 16) and 53.71 (Sep 22). It never reached 30 (oversold), so there's been no panic selling.
Bounces stall around 48–54 (48.18 on Oct 5, 53.71 on Sep 22). That's typical of a bear market, where 50 acts as a ceiling.

A possible sign of slowing selling (bullish divergence)¶

RSI and MACD are both rising while price makes slightly lower closes:

Date	Close	RSI	MACD
2026-09-16	107.27	33.73	−3.29
2026-10-02	105.85	35.63	−2.39
2026-10-08	105.70	39.09	−2.11

This is a classic bullish divergence: selling pressure is weakening even as price edges down. But it hasn't been confirmed. The price lows are only about 1.5% apart, and the next section shows volume points the other way.

5. Volatility: ATR and Bollinger Bands¶

ATR is 3.11, about 2.94% of price per day. It fell from 4.50 on 2026-08-24 to a low of 2.82 on 2026-10-02 and is now rising again (3.01 on Oct 5, 3.11 on Oct 8). Volatility tends to pick up when price tests lows, which can come before a breakdown.
Oct 8 had a wide range of 4.64 points (high 109.39, low 104.75), about 1.5 times the ATR.
Bollinger Bands: upper 115.24, middle 109.51, lower 103.78.
Price sits about 17% of the way up from the lower band toward the upper band.
The bands span about 10.5% of the middle value, so they are not unusually tight.
The lower band at 103.78 is only 1.92 points (0.6 ATR) below price.

For sizing: a 1-ATR move is about $3.11 and a 2-ATR stop is about $6.22. Size positions so a 2-ATR adverse move stays within your per-trade risk limit.

6. Volume: OBV and the Oct 8 session¶

OBV (running buy/sell volume) is at its lowest point of the whole 60-day window, which disagrees with the bullish RSI/MACD divergence.

OBV peaked at +92.8M on 2026-08-20. It was +64.4M on Sep 22, +5.6M on Oct 2, and is now −10.45M.
OBV lost about 75M from Sep 22 to Oct 8, in 12 sessions.
Between Sep 16 and today, price fell only about 1.5% but OBV dropped from +18.1M to −10.45M. Volume is concentrated on down days.
The Sep 18–22 rally added about 38M to OBV, and all of it has been given back.

The Oct 8 session looks like distribution:

It opened at 108.25, above the prior close of 107.00.
It rose to 109.39, just under the 20-day average (109.51), where sellers took over.
It closed at 105.70 (−1.2%), in the bottom 20% of the day's range.
Volume was 11.56M, the highest since Sep 23 (12.22M). Most sessions since late September traded 5.8–7.9M.

This has happened before. On Sep 22 the stock opened at 120.15 and closed at 116.31, then fell 4.7% the next day. Rallies that open with a gap up are being sold.

One bullish footnote: the Oct 8 low (104.75) dipped below the Oct 2 low (105.00), and the close finished back above that low. If the next session closes strongly higher, that dip could prove to be a failed breakdown. Until that happens, the volume says sellers are in control.

7. Exhaustion: TD Sequential setup counts¶

Timeframe	Count	What it means
Weekly (main)	+7 (buy setup, 7 of 9)	The weekly downtrend is getting close to a statistical exhaustion signal
Monthly	−1 (sell setup, 1 of 9)	Too early to matter (October so far closes above June's 95.98)
Daily	+2 (buy setup, 2 of 9)	A new daily down-count has just started

I checked the weekly count against the weekly closes, and it matches:

Weekly bar	Week ending	Close	vs. close 4 weeks earlier (week ending)
1	Aug 28	118.90	122.25 (Jul 31)
2	Sep 4	113.24	128.41 (Aug 7)
3	Sep 11	109.30	123.81 (Aug 14)
4	Sep 18	113.24	119.34 (Aug 21)
5	Sep 25	109.74	118.90 (Aug 28)
6	Oct 2	105.85	113.24 (Sep 4)
7	Oct 9 (partial week)	105.70 so far	109.30 (Sep 11)

Count 7 holds if Friday Oct 9 closes below 109.30.
Count 8 needs the week ending Oct 16 to close below 113.24.
Count 9 needs the week ending Oct 23 to close below 109.74.
So a completed weekly 9 could appear as soon as the week of Oct 19–23. These thresholds are my own math using the standard rule (each close below the close four bars earlier). The tool reported only the count.

A 9 means the downtrend is mature, which is a reason to watch for a reversal. It is not a buy signal by itself. The weekly count matters more than the daily or monthly ones.

8. Key price levels¶

Level	Price	Where it comes from
Major resistance	129.37–131.16	200 SMA and weekly SuperTrend flip, near the Aug 20 high of 130.62
Swing high (lower high)	120.40	2026-09-22 high
Resistance	116.38	50 SMA (falling)
Resistance	115.24	Upper Bollinger Band
Trend-flip trigger	114.44	Daily SuperTrend
Most recent lower high	111.40	2026-10-05 high
Near resistance	108.23–109.51	10 EMA and 20 SMA; the Oct 8 high stopped at 109.39
Current price	105.70	2026-10-08 close
Near support	104.75–105.00	Oct 8 and Oct 2 lows (after the Oct 2 low, price rallied to 111.40 on Oct 5)
Volatility floor	103.78	Lower Bollinger Band
Unfilled gap	99.74–105.65	Gap between the Jul 7 high and the Jul 8 low; price is now at its top edge
Major support	91.99–94.81	2026 low (Jun 26 intraday low and close)

9. Scenarios and what to watch¶

Most likely: the downtrend continues (bearish)¶

Evidence: - All SuperTrend timeframes are down. - The moving averages are in full bearish order. - A fresh MACD sell crossover formed below zero. - RSI is below 50. - OBV is at a new low. - Gap-up opens on Sep 22 and Oct 8 were sold.

Trigger: a daily close below 103.78 (lower Bollinger Band), and especially below 104.75, confirms a breakdown into the July gap.

Targets: 101–100 first (78.6% retracement and the bottom of the gap at 99.74). Then the 2026 low zone around 95–92 if selling speeds up.

Approach: rallies toward 108.2–109.5 are lower-risk spots to sell or short. A second option is 111.4, where the Oct 5 high was.

Invalidation: a daily close above 111.40 breaks the pattern of lower highs. Stops belong above that or above the daily flip at 114.44.

Alternative: a short-term bounce from exhaustion (counter-trend)¶

Evidence: - RSI and MACD are rising while price makes lower closes (Sep 16 → Oct 2 → Oct 8). - The weekly TD count is at 7 of 9. - Price sits near the lower Bollinger Band and at the top of the July gap. - MACD momentum is squeezing toward neutral.

What needs to happen first: 1. A close back above 108.23 and 109.51. 2. The MACD histogram turning positive again. 3. OBV starting to rise, which hasn't happened yet.

Bigger confirmation: a close above 111.40, then above 114.44, which would flip the daily SuperTrend.

Upside target: 115–116.4 (upper Bollinger Band and 50 SMA). This is a counter-trend trade, not a trend change. The weekly and monthly trends stay down below about 131.

Risk: a stop about 1 ATR under the low, near 102.6–103.7. Keep the position small, because higher timeframes argue against it.

Timing to watch¶

Friday Oct 9 weekly close: whether TD count 7 holds (close below 109.30).
Weeks ending Oct 16 and Oct 23: a possible weekly 8 and 9. A completed 9 near the 100–95 zone, with RSI and MACD still rising, would be a better long setup than buying now.

10. Overall assessment¶

The trend is clearly down on every timeframe. That's the dominant fact.
The bounce case is real but weak. Momentum divergence and the weekly 7-of-9 count suggest the selling is losing steam. Volume (OBV) and the Oct 8 reversal on heavy volume both contradict that.
Better long timing: wait for either (a) price to win back the 20-day average and a 111.40 high, or (b) a weekly TD 9 to complete.
For trend-followers: selling rallies into 108–111, with risk defined above 111.4–114.4, fits the evidence best.

Summary table¶

Area	Reading	What it means
Price	105.70 (2026-10-08); lowest close since 2026-07-07 (98.14)	Stock is pressing on recent lows
1-year trend	187.62 (2025-10-02) → 105.70, about −43.7%	Long-term bear market
Moving averages	Price < 10 EMA (108.23) < 20 SMA (109.51) < 50 SMA (116.38) < 200 SMA (129.37)	Fully bearish; 50 and 200 SMA both falling
SuperTrend	Weekly DOWN (131.16), Monthly DOWN (176.16), Daily DOWN (114.44)	All timeframes agree; 114.44 is the first flip trigger
MACD	−2.11 vs. signal −2.10; histogram turned negative today (+0.100 → −0.015)	New sell crossover below zero; crossovers keep failing
RSI	39.09; range 33.73–53.71	Weak but not oversold; 50 acts as a ceiling
Divergence	Closes 107.27 → 105.85 → 105.70 while RSI rose 33.7 → 39.1 and MACD rose −3.29 → −2.11	Selling may be slowing; not yet confirmed
ATR	3.11 (about 2.94%); rising from a 2.82 low	Volatility picking up; 2-ATR stop ≈ $6.22
Bollinger Bands	Upper 115.24 / middle 109.51 / lower 103.78; price near lower band	Lower band is 0.6 ATR away
OBV	−10.45M, lowest in 60 days (from +64.4M on Sep 22)	Volume confirms the decline; argues against the divergence
Oct 8 session	Opened higher, high 109.39, closed 105.70 on 11.56M shares	Rejected at the 20-day average on heavy volume; looks like selling
TD-9	Weekly +7, Monthly −1, Daily +2	Weekly exhaustion is close; a 9 is possible by the week of Oct 19–23
Resistance	108.23–109.51 / 111.40 / 114.44 / 116.38 / 129.4–131.2	Areas to sell rallies; trend-flip triggers
Support	104.75–105.00 / 103.78 / 99.74–105.65 gap / 91.99–94.81	Breakdown targets
Main scenario	Downtrend continues below 111.40	Sell rallies at 108–111, stop above 111.4–114.4
Alternative	Counter-trend bounce if price reclaims 109.51, then 111.40	Upside to 115–116; small size; stop near 102.6–103.7

Sentiment Analyst¶

Overall Sentiment: Mildly Bullish (Score: 5.6/10) Confidence: Low

BABA Sentiment Report (2026-10-01 to 2026-10-08)¶

Data coverage caveat: Only two of the three sources returned data. Reddit was skipped because it is disabled by the sentiment_include_reddit config, so there is no community read from r/wallstreetbets, r/stocks or r/investing. StockTwits returned just 8 messages, and only 2 carry a stance tag. The news feed has 19 headlines with no article bodies, so the read below rests on headline framing alone. Confidence is therefore low.

1. Source-by-source breakdown¶

News (Yahoo Finance, 19 headlines)¶

The headlines sort into three groups.

About 9 headlines are directly about BABA.

Constructive: - Jefferies keeps a 'buy' rating and sees Alibaba cloud revenue growth above 50% in FY2028 (Proactive). This is the most concrete institutional datapoint in the window. - "Alibaba Stocks Jump 4% as AI Cloud Growth Reclaims the Narrative" (GuruFocus) shows a sharp positive session within the week, explicitly tied to AI cloud. - "Alibaba's New Chip Is 3X Better Than Its Predecessor" (Barchart) supports an in-house AI silicon story, framed against Chinese AI chips that "could flood the market." - Joe Tsai: open-source AI is Europe's best path to tech independence (Quartz). This is strategic positioning for the Qwen open-source ecosystem in non-Chinese markets. - "Alibaba Plunges 16.2% in 6 Months: 3 Key Reasons to Hold" (Zacks). The framing is defensive but still constructive: hold, not sell.

Cautionary: - "Why Alibaba (BABA) Dipped More Than Broader Market Today" (Zacks) shows at least one session of underperformance. - "After Lawsuit And Defense List Shock Is It A Bargain Or Priced In" (Simply Wall St.) points to two discrete negative events: a lawsuit and a defense-list designation. The headline alone does not give details such as which list, which lawsuit, or the timing. The piece is framed as a valuation question, which suggests the market treats these as overhangs rather than thesis-breakers. - The 16.2% six-month decline confirms BABA is in a drawdown, not a momentum regime.

Neutral or mixed: - Motley Fool, "Alibaba vs. Uber: Which Is a Better Buy in 2026?" is a comparison piece with no visible direction. - Hirundo releases a "Westernized Qwen", cutting censored or CCP-aligned answers from 89.8% to 2.8%. This cuts both ways. Third parties call Qwen "the leading Chinese AI model" and are building on it, which is an adoption signal. But it also spotlights censorship baggage that could limit Western enterprise uptake.

About 7 headlines cover the peer group or macro context. - Competitors are raising capital for AI: Tencent is weighing a $5B offshore bond for AI, Moonshot faces a "$50 billion test," and Kuaishou's Kling AI is targeting a Hong Kong IPO of at least $1B. Hong Kong AI fundraising hit a record summer. This confirms investors are still funding Chinese AI, which supports the sector, but also signals rising competitive intensity and capital spending. - US-China security scrutiny: Webull fell after a House panel flagged its China ties as a security risk. BABA is not named, but this is the same regulatory current behind the defense-list headline. - Michael Burry on stocks most at risk in tax-loss harvesting season (Stocktwits). The headline does not say whether BABA is on the list. Still, a stock down 16% over six months is a plausible tax-loss-selling candidate into Q4, so this is a seasonal risk to note rather than a confirmed one. - Virtual Machine market report lists Alibaba alongside Microsoft, Amazon and Google as a hyperscale player. This is minor peer-group validation.

About 3 headlines are irrelevant: the Swiss recommerce market, Bloom's $3.6M raise (using "Alibaba" as a metaphor), and confidential computing.

Net news read: The tone tilts constructive. The AI cloud and chip narrative dominates the BABA-specific flow, backed by a named sell-side rating. That is offset by real but loosely described overhangs: the lawsuit, the defense list, and a 16% drawdown.

StockTwits (8 messages)¶

Tag counts: 2 Bullish (25%), 0 Bearish (0%), 6 unlabeled.

Bullish-tagged messages: - @Laststock007 wrote: "the market went down 345 point and this went down $1.30 today... this stock will be at 120+ next week! 🚀." This argues for relative resilience, but the target is speculative and the tone exuberant. - @pocketmoney posted only "$BABA 🙄." The tag is bullish but the content says nothing, and the eye-roll may be ironic.

Most substantive unlabeled post: - @VolumeSpreadAnalysis reports price $105.7 on above-average volume, citing as catalysts "stronger cloud division growth and renewed optimism around stimulus measures." It gives resistance at $110.5 and support at $101.2, and frames a bull case on a high-volume break above $110.5. - These levels are user-generated and unverified. Notably, the stimulus catalyst does not appear in any news headline in this dataset.

Other unlabeled posts: - @Diamond666: "China number 1 in" (truncated). Bullish-leaning. - @RTG0528: "sell and buy btc and eth and our problems will be solved." Bearish or dismissive. - @inthegrove: "way of the road bubs." Ambiguous. - @Laststock007 posted two near-identical replies to @Alpaca88, accusing them of spending too much time "hating" BABA. This tells us an active bear exists in the thread, even though no Bearish-tagged post appears in the sample. The 0% bearish figure likely understates real bearish presence.

Concentration risk: One user, @Laststock007, wrote 3 of the 8 messages (37.5%), including one of the two bullish tags. With so few posts, the tag ratio mostly reflects one or two individuals, not a crowd.

Net StockTwits read: Mildly bullish in tone, focused on relative strength versus the market and the cloud catalyst, with some visible bull-versus-bear friction. Statistically it is very weak.

Reddit¶

Unavailable: disabled by config. No read is possible for r/wallstreetbets, r/stocks or r/investing.

2. Cross-source divergences and alignments¶

Alignments: - AI cloud growth is the shared thesis. Jefferies' above-50% cloud forecast and the "AI Cloud Growth Reclaims the Narrative" headline line up directly with @VolumeSpreadAnalysis citing "stronger cloud division growth." Retail is repeating the institutional narrative rather than inventing its own. - Both sources show a recovery attempt from a drawdown, not a trend. The news cites a 16.2% six-month decline; StockTwits places the price around $105.7, still below its own cited resistance at $110.5.

Divergences: - Relative performance conflicts. Zacks reports BABA dipped more than the broader market on one day. @Laststock007 claims BABA held up better (down $1.30 versus a 345-point index drop). These are probably different sessions, but they show day-to-day relative strength is unstable. - Risk awareness differs. News explicitly raises the lawsuit, the defense-list designation, and US-China security scrutiny. None of the 8 StockTwits posts mentions any of these. Retail appears to be looking past the regulatory overhang, or simply not engaging with it. - Stimulus appears only on StockTwits. It is cited there as a catalyst but has no corroborating headline in this dataset, so treat it as unverified retail framing.

3. Dominant narrative themes¶

AI cloud re-rating. This is the most frequent BABA-specific theme across both sources: the Jefferies cloud call, the +4% move, chip progress, Qwen ecosystem adoption, and Tsai's open-source positioning in Europe.
Drawdown and valuation debate. "Plunges 16.2%... Reasons to Hold" and "Bargain or Priced In" frame BABA as a value-recovery debate.
US-China regulatory and geopolitical overhang. The defense-list designation, the lawsuit, the Webull House-panel precedent, and the censorship framing in the Hirundo/Qwen story all fit here.
Chinese AI capital-raising boom. Tencent's bond, Kling's IPO, Moonshot, and record Hong Kong AI fundraising support the sector bid but mean more competitors are better funded.

4. Catalysts and risks surfaced by the data¶

Potential upside catalysts: - Continued evidence of cloud acceleration, which would validate Jefferies' FY2028 view. - AI chip rollout (the 3X-improved chip). - Qwen's international adoption, including Western fine-tunes like Hirundo's and the European open-source pitch. - A technical break above $110.5 on volume, per one StockTwits user (unverified). - Stimulus optimism, which is mentioned only by retail.

Risks: - Lawsuit and defense-list designation. Specifics are not available in the data, so the magnitude cannot be assessed. - Escalating US congressional scrutiny of China-linked companies (the Webull precedent). - Possible tax-loss harvesting pressure into Q4, given the 16% six-month loss. Whether Burry named BABA is not confirmed. - Intensifying, well-funded domestic AI competition (Tencent, Moonshot, Kuaishou/Kling). - Reputational and adoption friction from censorship concerns around Qwen. - Day-to-day underperformance versus the market (the Zacks dip article).

Scheduled events: No earnings date or other scheduled event appears in the provided data.

5. Summary table of key sentiment signals¶

Signal	Direction	Source	Supporting evidence
Jefferies 'buy', cloud growth above 50% in FY2028	Bullish	News (Proactive)	Named sell-side rating and growth forecast
"Stocks Jump 4% as AI Cloud Growth Reclaims the Narrative"	Bullish	News (GuruFocus)	Sharp up-session tied to the AI cloud thesis
New AI chip 3X better than predecessor	Bullish	News (Barchart)	In-house silicon progress
Joe Tsai's open-source AI pitch for Europe	Mildly Bullish	News (Quartz)	Strategic international positioning for Qwen
"Plunges 16.2% in 6 Months: 3 Reasons to Hold"	Mixed	News (Zacks)	Confirms drawdown; framing is hold, not sell
Lawsuit and defense-list "shock"	Bearish	News (Simply Wall St.)	Two regulatory/legal overhangs; details unavailable
Dipped more than broader market	Mildly Bearish	News (Zacks)	Relative underperformance in at least one session
Webull flagged by House panel over China ties	Bearish (sector)	News (Barron's)	Rising US scrutiny of China-linked firms
Burry tax-loss harvesting risk list	Mildly Bearish (unconfirmed)	News (Stocktwits)	Seasonal risk for losers; BABA inclusion not verified
"Westernized Qwen" by Hirundo	Mixed	News (Business Wire)	Adoption signal, but highlights the censorship issue
Peer AI fundraising (Tencent, Kling, Moonshot, HK record)	Mixed	News (Quartz/Investing.com/GuruFocus)	Sector bid, but more competition
2 Bullish / 0 Bearish tags out of 8 messages	Mildly Bullish (weak)	StockTwits	Tiny sample; one user wrote 3 of 8 posts
Price $105.7, above-average volume, S $101.2 / R $110.5	Mildly Bullish	StockTwits (@VolumeSpreadAnalysis)	Cloud and stimulus cited; levels unverified
"Down $1.30 while market fell 345 points"	Mildly Bullish	StockTwits (@Laststock007)	Relative-resilience claim; exuberant 120+ target
Bull-versus-bear argument; "sell and buy btc"	Mildly Bearish	StockTwits	Active bears present but untagged
Reddit	Unavailable	Reddit	Disabled by config

Bottom line¶

Sentiment on BABA leans mildly bullish, driven by a coherent AI cloud and chip narrative that both institutional headlines and the few retail posts repeat. That lean is held back by: - unquantified legal and defense-list overhangs; - broader US-China scrutiny; - a 16% six-month drawdown that keeps the stock in recovery mode.

The retail signal is too thin (8 posts, 2 tags, concentrated in one user) and Reddit is absent, so this read deserves low weight on its own. Treat it as a soft overlay to fundamentals and technicals, not as a directional call.

News Analyst¶

BABA (Alibaba Group Holding Limited): News and Macro Report¶

As of: 2026-10-08 | Exchange: NYQ | Sector: Consumer Cyclical / Internet Retail (in practice, AI and cloud now drive the story)

1. Summary¶

BABA is caught between two forces:

Supporting the stock: the AI and cloud story is getting stronger. Jefferies kept its Buy rating and expects cloud revenue growth above 50% in FY2028. Alibaba released a new AI chip it calls 3x faster than the previous one. Its Qwen models are spreading internationally.
Working against it: a new US Defense Department list designation plus a lawsuit, the highest 10-year Treasury yield since 2002, a surprise Fed rate hike in September, and an oil shock driven by Iran tensions.

The stock is down 16.2% over six months (Zacks) and recently fell more than the broader market. Tax-loss selling season and the November 3 US midterms are coming up, so near-term risk leans to the downside even though the long-term AI case is improving.

2. Company News (BABA)¶

A. Regulatory and political risk: the main negative¶

"Alibaba… After Lawsuit and Defense List Shock: Is It a Bargain or Priced In?" (Simply Wall St.). This headline says BABA was hit by a US Defense Department list action and a lawsuit at the same time.
My inference: this is most likely the Section 1260H list of "Chinese military companies." That list mainly restricts Defense Department purchasing and does not by itself ban US investors from owning the stock.
The bigger risk is escalation to the Treasury's investment-ban list (the OFAC NS-CMIC list). That could force some US institutions to sell and cause index-exclusion worries. The trading agent should confirm which list is involved; I only have the headline.
"Webull Stock Plummets as House Panel Flags China Ties as Security Risk" (Barron's). Congress is applying more pressure to China-linked companies. With midterms on Nov 3, more China-hawkish headlines are likely in the next four weeks.
Hirundo's "Westernized Qwen." A company cut censored or Communist Party–aligned answers in Qwen from 89.8% to 2.8%. This shows Western developers are using Qwen, but it also reminds Western enterprise buyers of censorship and compliance risk.

B. AI and cloud: the main positive¶

Jefferies keeps its Buy rating and expects cloud revenue growth above 50% in FY2028 (Proactive). That would be faster growth than today, not slower.
"Alibaba Stocks Jump 4% as AI Cloud Growth Reclaims the Narrative" (GuruFocus). Buyers are still stepping in on AI news.
New AI chip "3X better than its predecessor" (Barchart: "Chinese AI chips could flood the market"). Alibaba's in-house chips reduce its exposure to US export controls on Nvidia hardware and support cloud margins over time.
Joe Tsai: open-source AI is Europe's best path to tech independence (Quartz). Alibaba is pitching Qwen as a neutral open-source option for Europe, which could broaden its customer base beyond China.

C. China AI funding cycle: background and comparisons¶

Tencent is considering a $5B offshore bond to fund AI. Rivals are borrowing to spend on AI, which suggests heavy industry-wide spending and pressure on BABA's free cash flow (Alibaba has a large multi-year AI spending plan already announced).
Kuaishou's Kling AI is targeting a Hong Kong IPO of at least $1B, and Hong Kong fundraising had a record summer driven by AI deals (Bloomberg). This supports valuations of China AI assets. It also means more new AI shares competing for the same China-tech investment money.
"Moonshot Faces Massive $50 Billion Test" (GuruFocus). Alibaba has been reported as a Moonshot investor, so a successful raise at that valuation would support the implied value of Alibaba's AI stakes.

D. Sentiment and positioning¶

"Alibaba Plunges 16.2% in 6 Months: 3 Key Reasons to Hold" (Zacks), and "Why Alibaba Dipped More Than Broader Market Today" (Zacks). BABA is lagging the market.
Michael Burry's list of stocks most at risk from tax-loss selling (Stocktwits) showed up in the BABA news feed. I can't confirm BABA is on the list, but a stock down 16% in six months is a natural candidate for selling from October through December.
"Alibaba vs. Uber: Which is a better buy in 2026?" (Motley Fool). This is retail-investor framing with no new information.

3. Macro Backdrop (FRED data)¶

Rates: a rising-yield shock driven by the Fed and long-term bonds¶

Indicator	Latest	Change	Takeaway
Fed Funds Effective (daily)	3.88% (Oct 7)	+25bp on Sep 17 (from 3.63)	The Fed hiked, reversing course after its late-2025 cuts (4.09% to 3.64%)
10Y Treasury	5.28% (Oct 7); peak 5.31% Oct 5	+72bp since Jul 10 (4.56%)	Highest since 2002 (Yahoo Finance)
10Y real yield (TIPS)	2.92%	+60bp since Jul 10	~83% of the 10Y rise comes from real yields, not inflation expectations
10Y breakeven inflation	2.35%	+11bp	Inflation expectations are steady, so this is about higher real rates and a higher premium for holding long bonds
2Y Treasury	4.77%	+52bp since Aug 10; peak 4.92% Sep 28	The market has priced in tighter Fed policy
2s10s spread	+0.47%	Low of +0.20 on Sep 21, now +0.47	Since late September, long-term yields have risen while short-term yields stayed flat (10Y +32bp, 2Y about +1bp)

What this means for BABA: a 2.9% real yield is very bad for long-duration growth stocks and for money flowing into emerging markets. It raises the discount rate on BABA's AI story at the same time as company-specific risk is rising. Yahoo's "Chart of the Day" noted that rapid bond-yield moves have preceded nearly every major financial blowup, so the risk of sudden de-risking is high.

Inflation and jobs¶

CPI: +0.40% month over month in August (334.131). Since November 2025 it has risen 2.79%, about 3.7% annualized. There was a big jump in March to May (+0.87% in March alone).
Core PCE: +0.25% in August. About 3.1% annualized since October 2025. That is above the Fed's target, which explains the hike.
Unemployment: 4.2% in September, up slightly from 4.1% in July and August. The job market is cooling, but not enough to bring rate cuts back.

Oil and geopolitics¶

Brent: $125.44 (Oct 6). That is up 69% since Jul 10 ($74.34), with spikes to $130.80 (Sep 15) and $135.51 (Oct 2).
WTI: $96.24. The ~$29 gap between Brent and WTI points to a disruption in seaborne or Middle East supply.
Headline: "Oil falls to $103 as Trump says US will not attack Iran before the midterm elections." Brent likely dropped after the Oct 6 print. That lowers the near-term risk of a major escalation, but only until Nov 3.
What this means for BABA: China is the world's largest crude importer. An oil shock hurts its trade balance, squeezes consumers, and raises shipping and delivery costs for Alibaba's logistics arm (Cainiao) and its overseas marketplace (AliExpress).

Currency and risk appetite¶

USD/CNY: 6.7038 (Oct 2). The yuan was flat against the dollar from Sep 9 to Oct 2 while the broad dollar index rose about 3.3% (117.88 to 121.79). So the yuan strengthened against most other currencies, which looks like China's central bank (the PBoC) holding it steady. That is a partial cushion for BABA: it helps the dollar value of yuan earnings and suggests policymakers are focused on stability.
VIX: 15.08. Volatility is low compared with the macro stress described above. If VIX jumps, high-beta China stocks (shares that swing more than the market) like BABA usually fall more than the market.
Other markets: gold is at $4,131.80, Bitcoin is below $83K, chip stocks fell even though Samsung guided to record profit, and the Nasdaq and S&P held weekly gains while small caps and the Dow slipped. Markets are rewarding only top-quality large caps, and speculative assets are being sold.

Prediction markets¶

Not available. Polymarket odds are withheld for the 2026-10-08 analysis date to avoid leaking information from after that date. I could not get market-implied odds for Fed moves, China tariffs or Iran escalation.

4. Trading Takeaways¶

List risk is the most important near-term factor. The key question is whether the "defense list" stays a purchasing restriction (manageable) or becomes an investment ban (forced selling). With midterms close, headlines can cause price gaps. A sector hedge (KWEB/FXI) does not cover this, because the risk is specific to BABA. Smaller positions or put protection fit better.
Rates set the overall pressure. The 10Y between 5.30% and 5.31% is the level to watch. A sustained break above it, especially with real yields above 3%, likely means more downside for China ADRs. A drop back below 5.0% would be the clearest macro relief.
Oil. A sustained Brent move toward $100 or below would help China's trade balance and its consumers. A new Brent spike above $130 would hurt BABA's commerce businesses.
The AI case gives a floor for buyers on dips, not a reason to chase. Strong news (the Jefferies view, the chip, the 4% one-day jump) shows buyers return on AI headlines. Those rallies have not lasted against the macro and policy headwinds, as the 16.2% six-month decline shows.
Seasonal selling. Tax-loss selling from October to December could weigh on the stock into year-end. A clean break of that selling pressure, plus good September-quarter results, would be a better time to add.
The yuan is a quiet positive. USD/CNY holding at or below 6.70 while the dollar rises suggests official support for China assets and helps the dollar value of BABA's yuan earnings.

Upcoming catalysts¶

China Golden Week (Oct 1–8) spending data
US September CPI (mid-October)
China Q3 GDP (mid/late October)
Next FOMC meeting (late October)
US midterms on Nov 3 (the Iran "no attack" pledge runs until then)
Singles' Day on Nov 11
BABA September-quarter earnings (usually mid/late November)
Any formal update to the Defense Department or Treasury list

Limitations¶

The news tool gave headlines only, with no article text and limited publication dates. Which defense list was involved, the lawsuit's details, and whether BABA is on Burry's list are my inferences.
No price, volume or options data was available.
BABA news coverage for Sep 15–30 was missing (the vendor only returns a sample).
Prediction-market odds were withheld.

5. Key Points Summary¶

Category	Data / Event	Signal for BABA	Evidence / Source
Regulatory risk	Defense Department list designation plus lawsuit	🔴 Bearish (biggest near-term risk)	Simply Wall St. headline
Political risk	House panel targets China ties (Webull); midterms Nov 3	🔴 Bearish (more headlines likely)	Barron's
AI / cloud	Jefferies Buy; cloud growth >50% expected in FY2028	🟢 Bullish (long-term)	Proactive
AI chips	New Alibaba chip 3x faster than predecessor	🟢 Bullish (less exposed to export controls)	Barchart
AI ecosystem	Qwen spreading abroad; Tsai's Europe pitch; "westernized Qwen"	🟡 Mixed (adoption vs. censorship image)	Quartz, Business Wire
China AI funding	Tencent $5B bond, Kling IPO, Moonshot at $50B, record HK fundraising	🟡 Mixed (valuation support vs. spending race and new share supply)	Quartz, Bloomberg, GuruFocus
Price momentum	Down 16.2% in 6 months; recently lagging the market	🔴 Bearish	Zacks
Seasonality	Tax-loss selling risk (Burry)	🔴 Bearish into December	Stocktwits
Fed policy	Fed Funds 3.63% to 3.88% (Sep 17 hike)	🔴 Bearish (tighter global money)	FRED DFF
Long rates	10Y 5.28% (2002 high); real yield 2.92% (+60bp)	🔴 Bearish (higher discount rate, EM outflows)	FRED DGS10, DFII10
Inflation	Core PCE about 3.1% annualized; CPI +0.40% in Aug	🔴 Little room for Fed cuts	FRED
Jobs	Unemployment 4.2%	⚪ Neutral	FRED UNRATE
Oil	Brent $125 (+69% since July; peak $135.51); WTI $96	🔴 Bearish (hurts China and logistics costs)	FRED; Yahoo (Iran)
Geopolitics	Trump: no Iran strike before midterms; oil eased to ~$103	🟡 Short-term relief, ends Nov 3	Yahoo Finance
Yuan	USD/CNY 6.70, flat while the dollar rose 3.3%	🟢 Mild positive (stable yuan, earnings support)	FRED DEXCHUS, DTWEXBGS
Volatility	VIX 15.08, low despite stress	🟡 Risk of a sharp jump	FRED VIXCLS
Prediction markets	Withheld for this date	n/a	Polymarket (not available)
Overall	Long-term AI story improving vs. heavy macro and policy pressure	🟡/🔴 Cautious near term; AI case favors buying dips	All of the above

Fundamentals Analyst¶

BABA (Alibaba Group Holding Limited): Fundamental Research Report¶

As of: 2026-10-08 | Exchange: NYSE (ADS; 1 ADS = 8 ordinary shares) | Fiscal year ends: March 31 | Reporting currency: RMB

1. Summary¶

The latest audited year is FY2026 (April 2025 to March 2026), and BABA spent heavily in it. Revenue reached about RMB 1.02 trillion, up 2.7%. Gross margin held at about 39.8%. But operating income fell 64%, from RMB 140.9B to RMB 50.2B, because operating expenses grew by about RMB 100B (+39%). Operating cash flow fell by more than half, from RMB 163.5B to RMB 76.2B. Reported net income was RMB 103.6B, but about half of it came from outside the core business. The balance sheet is still strong, with RMB 1.06T of equity. However, liquidity has been falling for two straight years as money moves out of liquid assets and into long-lived ones.

My fundamental read: Neutral, leaning toward the turnaround case. Whether this is a good trade depends mostly on whether operating margins have bottomed, and these tools can't answer that. Gross margin held up, and the expense surge looks largely discretionary, so earnings could rebound sharply if spending normalizes. For now, earnings quality and cash generation are clearly weaker.

2. Data coverage and limitations (read first)¶

Item	Status
Company profile, market cap, valuation multiples, 52-week range	Withheld by the vendor for this date (it only has present-day values, so using them would leak future data)
Insider transactions	Withheld. BABA is also a foreign private issuer, so it doesn't file Section 16 Form 4s; US insider data would be thin anyway
Annual statements	Available FY2013 to FY2026 (from the 20-F filings)
Quarterly statements	Only stale six-month periods (Sept 2019, Sept 2020). BABA reports quarters on 6-K forms, which aren't tagged in this data source
Capex, gross profit, segment data	Not tagged. Gross profit is calculated here as revenue minus cost of revenue
Units	The tool header says "USD in millions," but the values are raw RMB. Everything below is in RMB billions unless noted

Gap for the next agent: The June 2026 quarter (FY2027 Q1, probably reported in late August 2026) is public but not in these tools. It's the most important missing piece. The September 2026 quarter will probably be reported in mid-to-late November 2026, and that's the next catalyst. No news from the past week was available through these tools.

3. Company profile (general background, not from the tools)¶

Alibaba is China's largest e-commerce company. Its main businesses are: - China e-commerce: Taobao, Tmall, and the newer instant/quick-commerce business, Taobao Instant Commerce with Ele.me - International digital commerce: AliExpress, Lazada, Trendyol - Cloud Intelligence: Alibaba Cloud and the Qwen AI models - Other: Cainiao logistics, Amap, and digital media

It also holds about a third of Ant Group. In February 2025 the company publicly committed to large multi-year spending on AI and cloud infrastructure (RMB 380B+ over three years). During 2025 it also entered a costly subsidy war in quick commerce against Meituan and JD. Both affect the FY2026 numbers below.

4. Income statement analysis¶

Multi-year trend (RMB B)¶

FY (Mar)	Revenue	YoY	Gross margin*	Operating income	Op. margin	Net income	Net margin	Diluted EPS per ADS**
FY2020	509.7	+35.3%	44.6%	91.4	17.9%	149.4	29.3%	55.92
FY2021	717.3	+40.7%	41.3%	89.7	12.5%	150.6	21.0%	54.72
FY2022	853.1	+18.9%	36.8%	69.6	8.2%	62.2	7.3%	22.72
FY2023	868.7	+1.8%	36.7%	100.4	11.6%	72.8	8.4%	27.44
FY2024	941.2	+8.3%	37.7%	113.4	12.0%	80.0	8.5%	31.28
FY2025	996.3	+5.9%	40.0%	140.9	14.1%	130.1	13.1%	53.60
FY2026	1,023.7	+2.7%	39.8%	50.2	4.9%	103.6	10.1%	44.00

*Gross margin = (revenue − cost of revenue) / revenue. **Diluted EPS per ordinary share × 8. FY2026 = RMB 5.50 × 8 = RMB 44.0, roughly $6.15 at an illustrative 7.15 RMB/USD.

Key observations¶

Revenue growth is slowing. Growth went from +8.3% in FY2024 to +5.9% in FY2025 to +2.7% in FY2026. The 3-year compound annual growth rate is about 5.6% and the 5-year rate about 7.4%, compared with about 26% over 10 years. The FY2026 figure was probably held down by the sale of non-core retail businesses (Sun Art and Intime, per public announcements), so organic growth was likely somewhat higher. The tools can't confirm this.
Gross margin held, so the problem is below gross profit. Gross profit rose RMB 9.5B to RMB 407.5B, and gross margin barely moved (39.95% → 39.81%). Margin is still about 3 points above the FY2022–FY2023 low of about 36.7%.
Operating expenses jumped. Operating costs below gross profit (sales and marketing, R&D, G&A, amortization and any impairments):
FY2025: RMB 257.2B, or 25.8% of revenue
FY2026: RMB 357.4B, or 34.9% of revenue (+RMB 100.2B, +39%)
From FY2023 to FY2025 this ratio was steady at 25–26%, so FY2026 is a sharp break. That fits the quick-commerce subsidies and AI/cloud spending.
Recovery math. At FY2026 revenue, each 1 point of operating expenses as a share of revenue is worth about RMB 10.2B of operating income, roughly 20% of FY2026's total.
If the ratio drops back to 30%, operating income would be about RMB 100B, double FY2026.
If it returns to the FY2025 level of 25.8%, operating income would be about RMB 143B.
This is the core bull case. The bear case is that subsidies and AI costs are permanent features of a more competitive market.

5. Earnings quality¶

Metric	FY2024	FY2025	FY2026
Net income / operating income	0.71x	0.92x	2.07x
Net income − operating income (RMB B)	−33.3	−10.8	+53.4
Operating cash flow / net income	2.28x	1.26x	0.74x

Net income was double operating income in FY2026. More than RMB 53B came from non-operating sources: investment gains and fair-value changes, interest income, equity-method income (including Ant), or disposal gains. In past years where net income far exceeded operating income (FY2016, FY2020, FY2021), the cause was one-off revaluation gains. Those years were followed by sharp drops in net income (for example, FY2022 net income fell 59%).
Cash flow didn't keep up with earnings. FY2026 is the first year since FY2016 in which operating cash flow was below net income.
A rough core-earnings check: taxing only operating income at a notional 20% gives about RMB 17 per ADS (about $2.40), versus GAAP EPS of RMB 44 per ADS. Interest income on BABA's large investment holdings is real and recurring, so the true figure sits somewhere between the two. Even so, trailing GAAP EPS overstates the earnings power of the core business.

6. Cash flow analysis (RMB B)¶

FY	Operating CF	Investing CF	Financing CF	Net change	Operating CF / revenue
FY2021	231.8	−244.2	+30.1	+17.7	32.3%
FY2022	142.8	−198.6	−64.4	−120.3	16.7%
FY2023	199.8	−135.5	−65.6	−1.4	23.0%
FY2024	182.6	−21.8	−108.2	+52.5	19.4%
FY2025	163.5	−185.4	−76.2	−98.1	16.4%
FY2026	76.2	−67.3	−20.6	−11.7	7.4%

Operating cash flow has fallen three years in a row: 199.8 → 182.6 → 163.5 → 76.2 (−53% in FY2026, −67% from the FY2021 peak).
Free cash flow was probably negative in FY2026. Capex isn't in the tool data, but publicly disclosed AI/data-center spending was very high. With only RMB 76B of operating cash flow, free cash flow was most likely below zero (this is an inference). Investing outflows fell to RMB 67B even so. Together with a RMB 63B drop in current assets, that suggests BABA sold short-term investments and/or received sale proceeds to pay for the build-out.
Shareholder returns are shrinking. Net financing outflow fell from RMB 108B (FY2024) to RMB 76B to RMB 21B. Either buybacks and dividends were cut, or they were partly funded with new debt. Non-current liabilities rose RMB 28B, which fits convertible or exchangeable bond issuance.

7. Balance sheet and liquidity (RMB B)¶

As of Mar 31	FY2022	FY2023	FY2024	FY2025	FY2026
Total assets	1,695.6	1,753.0	1,764.8	1,804.2	1,909.6
Current assets	638.5	698.0	752.9	674.0	610.8
Cash & equivalents	189.9	193.1	248.1	145.5	131.5
Non-current assets	1,057.0	1,055.1	1,012.0	1,130.2	1,298.8
Total liabilities	613.4	630.1	652.2	714.1	783.3
Current liabilities	383.8	385.4	421.5	435.3	476.4
Shareholders' equity	948.5	989.7	986.5	1,009.9	1,060.9
Current ratio	1.66	1.81	1.79	1.55	1.28
Working capital	254.8	312.6	331.4	238.7	134.4
Liabilities / equity	0.65	0.64	0.66	0.71	0.74
Cash / current liabilities	0.49	0.50	0.59	0.33	0.28

Solvency is solid. Equity is RMB 1.06T, about 56% of assets, and liabilities/equity of 0.74x is moderate. There's no sign of distress.
Liquidity has worsened two years running.
Current ratio: 1.79 → 1.28
Working capital: down 59%, from RMB 331B to RMB 134B
Cash: down 47% since FY2024
Liabilities grew +9.7% in FY2026 and +20.1% over two years, faster than assets (+5.8%) or equity (+5.1%).
Money is moving from liquid to long-lived assets. Since FY2024, current assets fell RMB 142B while non-current assets rose RMB 287B (+28%). This fits the AI and cloud infrastructure build-out (property and equipment) and possibly reclassified long-term investments. Those assets are less flexible than cash and need to earn a return over time.
Minority interests are shrinking. Assets minus liabilities minus shareholders' equity (non-controlling and mezzanine interests) fell from RMB 126B to RMB 80B to RMB 65B. That fits the company simplifying its portfolio and selling off subsidiaries.
Note: "Cash & equivalents" excludes BABA's large short-term investments and treasury holdings, so its total liquidity is much higher than RMB 131.5B. These tools can't calculate net cash.

Metric	FY2024	FY2025	FY2026
ROE (on average equity)	8.1%	13.0%	10.0%
ROA (on average assets)	~4.5%	7.3%	5.6%
Operating income / average equity	~11.5%	~14.1%	4.8%
Implied diluted shares (net income ÷ EPS)	~20.46B	~19.42B	~18.84B
Share count change YoY	n/a	−5.1%	−3.0%
Approx. book value per ADS	n/a	~RMB 416	~RMB 451 (~$63)

The diluted share count is down about 14% since FY2021 (~22.0B → ~18.8B). Buybacks have meaningfully supported per-share figures, but the pace slowed in FY2026 (−3.0% vs −5.1%), which matches the smaller financing outflow.
Valuation shortcut for the agent with live prices: trailing GAAP P/E ≈ ADS price (USD) ÷ about $6.15, and P/B ≈ ADS price ÷ about $63, using an illustrative 7.15 RMB/USD. Because so much of net income is non-operating, GAAP P/E will look cheaper than the core business really is.

9. Insider activity¶

The tool withheld this data, so there's nothing to report. Because BABA is a foreign private issuer, changes in major holders show up through Hong Kong exchange disclosures (BABA's other listing is 9988.HK) and SEC 13D/G filings, not Form 4. Another agent should check for buyback announcements and for major-holder or SoftBank-type stake changes.

10. Actionable insights for traders¶

Gross margin held while operating margin fell from 14.1% to 4.9%. That points to a spending choice, not damage to the core franchise, and spending can be reversed. Any evidence that operating expenses as a share of revenue are falling, such as narrower quick-commerce losses or slower subsidy spending, would be a strong upside catalyst. Each point is worth about RMB 10B of operating income.
Don't anchor on GAAP EPS of RMB 44 per ADS. About half of FY2026 net income was non-operating. Use adjusted EBITA (earnings before interest, taxes and amortization) and segment profit from the earnings releases instead.
Watch cash burn and capex. Operating cash flow of RMB 76B probably doesn't cover the AI capex plan. If free cash flow stays negative, expect more convertible or bond issuance and smaller buybacks.
Liquidity is ample but declining. This isn't a solvency risk. It does limit how fast BABA can keep buying back stock while spending on both AI and quick commerce.
Upcoming events:
The June 2026 quarter is public but not in these tools; it's the biggest gap.
The September 2026 quarter is expected around mid-to-late November 2026. Key items: whether operating income or adjusted EBITA has bottomed, Cloud growth and AI revenue, quick-commerce unit economics, capex guidance, free cash flow, and buyback pace.
Risk factors: a long subsidy war in China (Meituan, JD), China's consumer slowdown, US–China and ADR/delisting policy, the AI capex not paying off, and possible reversal of non-operating gains.

11. Key metrics summary¶

Category	Metric	Value	Trend / signal
Growth	FY2026 revenue	RMB 1,023.7B (~$143B)	+2.7% YoY, slowing (+8.3% → +5.9% → +2.7%) 🔻
Profitability	Gross margin	39.8%	Stable vs 40.0%; well above the FY2023 low of 36.7% ✅
Profitability	Operating income / margin	RMB 50.2B / 4.9%	−64% YoY; margin was 14.1% 🔻🔻
Cost	Operating expenses / revenue	34.9%	+9.1 pts YoY (RMB +100B) 🔻
Profitability	Net income / margin	RMB 103.6B / 10.1%	−20.4% YoY
Earnings quality	Net income / operating income	2.07x	About half of net income is non-operating ⚠️
EPS	Diluted EPS per ADS	RMB 44.0 (~$6.15)	−17.9% YoY (FY2025: RMB 53.6)
Cash flow	Operating cash flow	RMB 76.2B	−53% YoY; third straight annual decline 🔻🔻
Cash flow	Operating CF / net income	0.74x	First year below 1x since FY2016 ⚠️
Cash flow	Free cash flow	Not tagged	Probably negative because of AI capex (inference) ⚠️
Capital return	Net financing outflow	RMB 20.6B	Down from RMB 108B in FY2024; buybacks slowing
Balance sheet	Shareholders' equity	RMB 1,060.9B	+5.1% YoY ✅
Balance sheet	Liabilities / equity	0.74x	Rising from 0.66x two years ago
Liquidity	Current ratio	1.28	Down from 1.79 in FY2024 🔻
Liquidity	Cash & equivalents	RMB 131.5B	−9.6% YoY, −47% over two years 🔻
Liquidity	Working capital	RMB 134.4B	−44% YoY, −59% over two years 🔻
Asset mix	Non-current assets	RMB 1,298.8B	+14.9% YoY; fits AI/cloud build-out
Returns	ROE / ROA	10.0% / 5.6%	Down from 13.0% / 7.3%
Per share	Diluted share count	~18.8B (−3.0% YoY)	−14% since FY2021; buybacks slowing
Per share	Book value per ADS	~RMB 451 (~$63)	+8% YoY
Valuation	P/E, P/B, market cap	Withheld	P/E ≈ price ÷ $6.15; P/B ≈ price ÷ $63
Insiders	Transactions	Withheld	Foreign private issuer, no Form 4s; check HKEX disclosures
Data gaps	Latest quarter	June 2026 quarter not in tools	Next agent should get it
Catalyst	Next earnings	September 2026 quarter, expected mid/late November 2026	Key question: have margins bottomed?
Overall	Fundamental lean	Neutral, leaning toward turnaround	Solid franchise and balance sheet; weak earnings quality and cash flow; upside if spending normalizes

II. Research Team Decision¶

Bull Researcher¶

Bull Analyst: # Bull Opening: BABA. The market is pricing a broken company, but the numbers show a company that chose to spend.

I'll start with the number the bear will probably lead with, because I think it's actually the best argument for owning BABA.

Operating income fell 64% in FY2026, from RMB 140.9B to RMB 50.2B. That sounds like a franchise in trouble. Now look one line higher on the income statement:

Revenue passed RMB 1 trillion.
Gross profit hit a record RMB 407.5B.
Gross margin held at 39.8%, against 40.0% the year before.

The customers, the pricing power and the core economics did not break. What changed is that Alibaba spent about RMB 100B more below the gross profit line, on quick-commerce subsidies and the AI and cloud build-out. Operating expenses ran at 25–26% of revenue for three straight years (FY2023–FY2025), then jumped to 34.9% in FY2026.

That spike reflects a management decision, not a decaying business, and decisions can be reversed.

1. The recovery math the market is ignoring¶

Each point of operating expenses as a share of revenue is worth about RMB 10.2B of operating income. The table below shows BABA's earnings from the core business only, taxed at 20%. It deliberately excludes all interest income and all equity income from Ant Group. Figures are converted at today's USD/CNY rate of 6.70 and measured against the $105.70 share price. These are my calculations from the fundamentals data.

Opex as % of revenue	Operating income	Core EPS per ADS	P/E at $105.70
34.9% (FY2026, peak spending)	RMB 50.2B	~$2.55	~41x
30% (halfway back)	~RMB 100B	~$5.07	~21x
25.8% (FY2025 level)	~RMB 143B	~$7.25	~14.6x

Several other measures point the same way:

FY2025 was a clean year. Net income was below operating income, so there were no gains inflating it. EPS was RMB 53.6 per ADS, or about $8.00. At $105.70 the stock trades at about 13x that clean earnings base.
Price to book is about 1.6x, on book value of roughly $67 per ADS. That is for a business that earned a 13% ROE in FY2025.
The share count is down about 14% since FY2021, so every recovered yuan of profit is spread over fewer shares.
I'll concede the trailing GAAP P/E of about 16x flatters the stock. Roughly half of FY2026 net income came from outside the core business. That is exactly why I didn't use it above.

The bear has to argue that FY2026's cost base is permanent. If spending even partly normalizes, this is a mid-teens multiple on core earnings for a company with an accelerating AI cloud business.

2. The growth engine: Alibaba owns the whole AI stack¶

Cloud is accelerating. Jefferies kept its Buy rating and expects cloud revenue growth above 50% in FY2028. That forecast is for faster growth, not a slowdown.
It designs its own chips. Its new AI chip is described as 3x better than its predecessor. That reduces dependence on Nvidia, whose sales to China are limited by US export controls, and supports cloud margins over time.
Its AI model is spreading abroad. Third parties call Qwen "the leading Chinese AI model" and are building commercial products on it; Hirundo's "Westernized Qwen" is one example. Chairman Joe Tsai is pitching Qwen to Europe as an open-source route to tech independence, which opens markets beyond China.
It has stakes in other AI companies. Alibaba is reportedly an investor in Moonshot. If Moonshot raises money at a $50B valuation, that supports the value of Alibaba's AI holdings.
It is counted among the global cloud giants. Industry reports list it alongside Microsoft, Amazon and Google as a hyperscale provider.
The market still rewards the story. The stock jumped 4% on "AI Cloud Growth Reclaims the Narrative."

Very few companies own chips, cloud, a leading open-source model and the biggest consumer app ecosystem in their home market. Non-current assets are up RMB 287B since FY2024. That is the bear's "liquidity drain," and it is also the infrastructure behind the cloud growth.

3. The chart: the trend is down, but sellers are losing steam¶

I won't pretend the trend is up. Every SuperTrend timeframe points down, and the moving averages are stacked in bearish order. But the internals are improving:

Date	Close	RSI	MACD	MACD histogram low
Sep 16	107.27	33.73	−3.29	−1.38 (Sep 9)
Oct 2	105.85	35.63	−2.39	−0.21
Oct 8	105.70	39.09	−2.11	−0.015

Bullish divergence. Closes are slightly lower, but RSI and MACD are rising. Each wave of selling is a fraction of the one before.
The weekly downtrend is near exhaustion. The weekly TD Sequential count is at 7 of 9, and a completed 9 is possible as early as the week of Oct 19–23.
The decline is orderly. RSI never reached 30. That fits headline-driven and tax-season selling, not holders abandoning the thesis.
Price is at strong support zones. The stock has given back about 66% of the summer rally. It sits at the top of the July gap (99.74–105.65), the 78.6% retracement level is at about 100.67, and the 2026 low zone is 92–95.
Oct 8 may have been a failed breakdown. Price dipped below the Oct 2 low and then closed back above it.

The bear's strongest technical point is OBV at a 60-day low, and I'll grant it. My answer is not to ignore it but to buy in stages (see section 5).

Risk and reward from $105.70: - Downside: about −13% to the 2026 low at 91.99. - Upside: about +22–25% to the 200-day SMA and August high (129.37–132.57). - Earnings-based upside: $128–144 (+21% to +36%) if FY2025 earnings of about $8 get a 16–18x multiple.

4. Answering the bear's best points in advance¶

"The defense list and lawsuit are a big new risk." - This risk is real. - The most likely reading is the Pentagon's Section 1260H list. That list restricts what the Defense Department can buy. It does not ban investors from owning the shares. We haven't confirmed which list it is. - An escalation to Treasury's investment-ban list would be a different conversation. That is a reason to size the position carefully, not to avoid it. - BABA also has a primary listing in Hong Kong (9988.HK), so holders aren't stranded even in a bad ADR scenario. - The headline itself asks "bargain or priced in?" With the stock down 44% in a year, a lot of this tail risk is already in the price.

"Cash flow fell by half and liquidity is shrinking." - Operating cash flow of RMB 76B is weak. I agree. - But there is RMB 1.06T of equity, and liabilities are only 0.74x equity. - The RMB 131.5B cash figure excludes BABA's large short-term investment holdings. - This is a company building data centers during an AI race, not a company in financial distress.

"Competitors like Tencent, Moonshot and Kling are raising billions." - The bear can't argue both that BABA's AI spending is wasteful and that rivals are a threat because they're spending. - The record Hong Kong AI fundraising shows strong investor demand for China AI. - BABA is the cheapest listed way to own a full-stack China AI player, and it holds a stake in at least one of those rivals.

"10-year yields at 5.28% and real yields at 2.92% hurt growth stocks." - High real yields mostly hurt long-duration, high-multiple stocks. At about 14x normalized core earnings and 1.6x book, BABA isn't one. - The yuan has held at 6.70 while the dollar index rose about 3.3%. That suggests China's central bank wants stability, and it raises the dollar value of BABA's yuan earnings. - Brent oil has eased toward about $103 from its peak of $135.

"Revenue growth slowed to 2.7%." - Part of that likely reflects the sales of Sun Art and Intime. That comes from public company announcements, not from our tools. - Gross profit still reached a record.

"Tax-loss selling is coming." - That is a flow of shares, not a change in fundamentals. - Forced sellers in Oct–Dec create the entry price. The timing also matches the possible weekly exhaustion signal.

5. How I'd own it¶

Tranche 1 (about ⅓ of the position): buy now in the 104–106 area.
Tranche 2: buy on either of two signals:
a completed weekly TD 9 in the 95–101 zone, with the RSI/MACD divergence still intact, or
a daily close above 111.40, which breaks the pattern of lower highs.
Tranche 3: buy after the September-quarter results in mid-to-late November, if operating expenses are falling as a share of revenue.
Thesis stop: a weekly close below 91.99, the 2026 low.
Sizing: ATR is $3.11, and a 2-ATR move is about $6.22. Size each tranche to that.
Targets:
first, 114–116 (the daily SuperTrend flip and the 50-day SMA);
then 129–133;
longer term, $128–144 as earnings re-rate.
Catalysts:
Golden Week spending data
China Q3 GDP
The Nov 3 US midterms, after which that event risk passes
Singles' Day on Nov 11
September-quarter earnings

My call: BUY BABA. Accumulate in tranches, with a defined stop below 91.99.¶

My question for the bear: gross profit is at a record, the cost spike breaks a three-year pattern, there's over a trillion yuan of equity, and the cloud business is accelerating. What evidence shows FY2026's cost base is permanent? Without that evidence, you're asking investors to sell at about 14x the company's own normal-year earnings power, just as the selling is losing momentum. Bull Analyst: # Bull Rebuttal: BABA. The trade doesn't need the whole RMB 100B back.

The bear caught real errors in my opening, and I'll own them first. Then I'll show that his corrected math values some of Alibaba's assets at zero, with no good reason to. Once that's fixed, the trade doesn't need the full RMB 100B of extra spending reversed. It needs roughly RMB 54–67B reversed, and our own data shows Alibaba has cut costs at that pace before. After that, I'll answer his probability question with actual numbers.

Items marked † come from public reporting, not our tools. Per-ADS figures use USD/CNY 6.70.

1. What I got wrong¶

FY2025 wasn't "clean." I compared after-tax net income with pre-tax operating income, which proved nothing. On my own core-only method, FY2025 EPS was about $6.93. The stock is about 15x that year's earnings, not 13x.
My $128–144 target mixed two bases. I'm withdrawing it. The replacement below uses one consistent method.
The Hong Kong listing doesn't protect against a Treasury ban. That ban follows the company, not the exchange.
A weekly-close stop doesn't protect well against price gaps. I'm changing it.
Free cash flow was likely negative, and buybacks are slowing. My new valuation assumes no buybacks at all.

2. "One or the other" works in both directions¶

Your rule is right. I can't strip non-core income out of earnings and then add it back for the target. But the rule has a second half. If you strip out the income, you have to value the assets that produce it. Your $81–91 halfway value puts Alibaba's Ant stake, treasury portfolio and other holdings at zero. Our own fundamentals report calls that interest income "real and recurring."

Here is a deliberately low value for those assets:

Start from your own number. FY2025 non-core income after tax was about RMB 17B, or $1.10 per ADS. At 10x earnings, that's about $11 per ADS.
Cross-check against Ant alone. Ant's 2023 buyback valued it at about $79B.† Alibaba's roughly 33% stake is worth about $26B, which is also about $11 per ADS. So the $11 roughly covers Ant by itself. It gives nothing for the treasury portfolio, the reported Moonshot stake, or anything else.
It's harsh on cash. Suppose that cash earns 2%. Valuing it at 10x its after-tax interest prices each RMB of cash at about RMB 0.16. Cash is worth its face value.

The table below keeps your scenarios, your 16–18x multiple, and flat revenue and share count. The only change is adding the $11:

Opex as % of revenue	Core EPS/ADS	Core at 16–18x	+ non-core ($11)	vs. $105.70
30% (halfway)	$5.07	$81–91	$92–102	−13% to −3%
28%	$6.12	$98–110	$109–121	+3% to +15%
25.8% (FY2025 level)	$7.25	$116–130	$127–141	+20% to +34%

Break-even is opex at 28.4–29.7% of revenue. - That means reversing 57–71% of the spike, about RMB 54–67B, not the full RMB 100B. - Your halfway case becomes $92–102. That is at or above my stop, not below it.

3. Evidence that the higher cost base isn't permanent¶

Alibaba has done this before, and it's in our data¶

	FY2022	FY2023
Opex as % of revenue	~28.6%	~25.1%
Opex (RMB)	~244B	~218B
Revenue growth	—	+1.8%
Operating income	RMB 69.6B	RMB 100.4B (+44%)

Management cut opex by about RMB 26B in absolute terms in one year. That was 3.5 points of revenue, achieved while revenue grew less than 2%.
At that pace, two years would take FY2026's 34.9% to about 28%. That is past break-even.
Caveat: some of FY2022's opex may have been one-time impairments. The same may be true of FY2026's RMB 100B. We can't separate them in either year, so that uncertainty cuts both ways.

Cash fell because profit fell: one decision, not two problems¶

Operating income fell RMB 90.7B. Operating cash flow fell RMB 87.3B. Those are almost the same number.
The earlier declines were gentle. Cash flow slipped about 9% and 10% in the two years before. The FY2026 collapse is the same subsidy and AI spending that hit operating income.
If the spending comes down, both lines recover together.

Arms races end, and this one is costly for every player¶

Competitors set the subsidy level, but they also pay for it.
Alibaba's RMB 407.5B of gross profit is roughly three times Meituan's and twice JD's, based on their 2024 filings.†
Meituan swung to quarterly losses in 2025.†
The company with the most gross profit to spend usually decides when a price war ends. You can argue the spending is both forced and wasted only if the race never ends.
China's last three big platform subsidy wars all ended within a few years.†
Ride-hailing, 2014–16
Food delivery, 2015–18
Community group buying, 2020–22
Each ended through mergers, exits or regulators stepping in.
Regulators pushed back in 2025. They publicly criticized "involution" price wars and summoned the food-delivery platforms over subsidies.† I can't confirm where that stands today.
The comparison quarter may be the easiest of the cycle. Public reporting at the time described the September-2025 quarter as the heaviest quick-commerce spending quarter.† If that's right, the September-2026 quarter is compared against the peak.

Depreciation is real, but it comes with revenue¶

Part of it is already in the numbers. Non-current assets rose RMB 118B in FY2025. That was depreciating through FY2026, and gross margin still held at 39.8%.
Not all of the RMB 287B depreciates. The fundamentals report says part of the increase may be reclassified long-term investments, which don't depreciate.
Data centers are built against demand. You can't count the cost of the servers and leave out the cloud revenue they produce. My table holds revenue flat, so it already leaves out both.

"RMB 10.5 of spending for RMB 1 of gross profit"¶

That ratio expects a same-year payoff from customer-acquisition spending and AI research, which are meant to pay off over several years. It also uses a revenue line held down by the Sun Art and Intime sales.†

4. Your question, answered with numbers¶

These scenarios cover 12–18 months. They are static: flat revenue, flat share count, 16–18x on core earnings, plus $11 of non-core value.

Scenario	My probability	Value	vs. $105.70
Full reversal (opex ~26%)	30%	$127–141	+20% to +34%
Most of the way (opex ~28%)	30%	$109–121	+3% to +15%
Halfway (opex ~30%)	20%	$92–102	−13% to −3%
Stuck, or Treasury escalation	20%	~$80 (≈1.2x book, below the 2026 low)	−24%

I put about a 60% chance on break-even or better. That rests on the FY2023 precedent, competitor losses and regulatory pressure.
The probability-weighted value is $105–115, roughly flat to +9%.

I'll be direct about what that means. On these deliberately static terms, BABA isn't a deep bargain. It's roughly fair value with a large possible upside. It is also not the stock trading at 41x that you described.

Every factor I left out points up: - Revenue growth. The 3-year compound growth rate is 5.6%. - Any buybacks at all. - The treasury portfolio and other stakes, which I valued at zero. - The multiple. A year ago, at $187.62, the market paid about 27x FY2025 core earnings (at today's exchange rate). I'm using 16–18x.

The one omitted factor that points down is depreciation. It comes with cloud revenue I've also left out.

Why buy any of it before the September quarter?¶

Waiting has a cost. In the roughly 60% case where costs are falling, the results reprice the stock overnight. BABA moved high single digits to double digits on some 2025 earnings days.† Buyers who wait for the evidence pay for it.
I'm meeting you most of the way. Half the position now waits for your own test, and the starter shrinks to a quarter.
Your short has the same gap problem you found in my stop. You'd short into that same report with a stop above 111.40, and the gap risk sits on the side where I put 60% odds.

5. The remaining points, briefly¶

"The stock got more expensive." On trailing earnings at the bottom of the cycle, yes, and every trough looks like that. On the earnings the business produced 18 months ago, the multiple fell from about 27x to about 15x. The only question is whether those earnings come back, which is what section 3 addresses.
Earnings yield versus the 10-year. Earnings grow with prices, so the fair comparison is the 2.92% real yield. A full reversal plus non-core income gives about a 7.9% yield. That is about 5 points above the real yield.
"This is a long-duration bet." The thesis resolves within quarters, not decades.
Real yields rose 60 basis points since July. That lowers the present value of earnings two years out by only about 1.2%.
The stock is down 20% from its August high.
So rates aren't the main driver. Earnings uncertainty is, and November's results speak to it.
Convertible dilution. The RMB 28B rise in non-current liabilities is about 1.7% of today's market value of roughly RMB 1.67T. Even full conversion would barely move the share count.
The defense list.
The closest precedent is Tencent, which was added to the Section 1260H list in January 2025.† Its shares fell about 7% that day, but it stayed investable and in the indexes, and the stock recovered. As far as I know from public reporting, it never escalated to the Treasury ban.
Escalation for Alibaba itself was reportedly considered and dropped in January 2021.†
I'll size the position for this risk rather than assume it away.
Eight StockTwits posts, three of them from one user, don't show what institutions have priced in.
Qwen is open source. Open models lead to paid cloud usage: developers build on the model, then pay to host and run it. That is how Qwen earns money on Alibaba Cloud.
Chips "flooding the market." Cheaper chips lower the cost of a cloud provider's main input. Alibaba Cloud is a large buyer, so it benefits.
"Cloud is a forecast." That's fair for FY2028. But reported cloud growth accelerated quarter after quarter through 2025.†
The chart.
I'll grant you OBV and the Oct 8 rejection at the 20-day average.
Your targets (100–101, then 92–95) sit in the same zone as my stop. Leaving aside the Treasury tail risk, we disagree about the upside, not the downside.
If the washout comes, tranche 2 buys it.

6. Revised plan¶

Tranche	Size	Trigger
1 (starter)	¼ (was ⅓)	Now, at 104–106
2	¼	A weekly TD 9 in 95–101 with the RSI/MACD divergence intact, or a daily close above 111.40 with OBV turning up (your condition)
3	½	September-quarter results show opex as a share of revenue down year over year and operating cash flow improving (your condition #1)

Size for gaps, not for normal daily ranges (ATR). Assume a headline gap to about $85 (about −20%, roughly 6.7 ATR). Size the starter so that gap fits your per-trade risk budget.
Consider a protective put through the November results and the midterms. Our data has no option prices, so I can't estimate the cost.
Stop: a daily close below 91.99. It was a weekly close before.
Hard exit: a Treasury investment-ban designation, regardless of price.
Targets:
114–116: the daily SuperTrend flip and the falling 50-day SMA.
Then 129–133.
Then $127–141, based on the corrected valuation.

My call: BUY BABA. Buy in stages, with half the position waiting on the bear's own evidence test.¶

Two questions for the bear:

What are Alibaba's Ant stake and treasury portfolio worth? If the answer isn't zero, your $81–91 halfway case is too low. Break-even is then about two-thirds of the reversal, not all of it.
Your short also runs into the September report, with a stop above 111.40. Suppose the quarter shows costs falling, as they did after the last spike in FY2023. Then the stock gaps straight through your stop. Why is that gap risk acceptable, while my quarter-sized starter isn't? Bull Analyst: # Bull Rebuttal: BABA. Your corrections move my entry price, not my call.

The bear landed three clean hits this round:

The FY2023 "precedent" was the reversal of a roughly RMB 25B goodwill write-off, not a cost cut.
My "stuck" case switched valuation methods.
My tranche-3 test was too easy against the peak-spending quarter.

He also asked the right question: why buy a stock near fair value when a 2-year Treasury pays 4.77%? At $105.70, mostly you shouldn't, and I'm halving my starter position below.

But two parts of his math are wrong:

His "one-in-five chance of losing half" assumes a holder with no stop.
His depreciation adjustment applies his "one or the other" rule to costs but not to revenue.

Fix those, and the trade is positive even on his own probabilities, at a price about 7% below today's. He names that zone as a buy area himself. So the bull case is now this: BABA is a buy on the right terms, and the terms are close.

† = public reporting, not our tools. Per-ADS figures use USD/CNY 6.70 and about 2.355B ADS.

1. What I concede¶

Alibaba has never reversed a cash spending surge this large. I'm withdrawing FY2023. Section 4 answers your question without it.
I'll take your $52–57 value for "stuck." That's about 0.8x book, and it requires the 34.9% opex ratio to be permanent. Section 2 shows it barely matters to a position with a stop.
Buying and holding at $105.70 has roughly zero expected return on my old probabilities. Your arithmetic is right.
Losing the FY2023 precedent should lower my odds. I'm moving 5 points from "full reversal" to "halfway." My probabilities are now 25/30/25/15/5, with "stuck" and "escalation" split into separate scenarios.
Qwen on AWS Bedrock is a fair point. Open-weight models don't tie anyone to Alibaba Cloud outside China.

2. "A one-in-five chance of losing half" assumes no stop¶

Your $52–57 is what a holder gets by riding "stuck" all the way down. My plan has a daily-close stop at 91.99 on every share bought before the September-quarter report. Half the position is only bought after that report passes a test designed to rule out "stuck."

The table below shows 12–18 month returns from two entry prices. It uses your scenario values, your $52–57, and two exits: the stop (about $90 after slippage) and a Treasury-ban gap (about $80). For your probabilities, I split your 25% into 20% stuck and 5% escalation, following your concession on the Tencent precedent.

Scenario	Value	From $105.70	From ~$98
Full reversal	$127–141	+27%	+37%
Most of the way	$109–121	+9%	+17%
Halfway	$92–102	−8%	−1%
Stuck ($52–57)	stopped near $90	−15%	−8%
Treasury escalation	gap to ~$80	−24%	−18%
Expected value, my revised odds (25/30/25/15/5)		≈ +4%	≈ +12%
Expected value, your odds (15/25/35/20/5)		≈ −1%	≈ +7%

These use scenario midpoints. A false break below 91.99 in a good scenario would knock a point or two off each figure.

What the table shows:

You're right about $105.70. It's slightly negative on your odds and below a Treasury on mine. That doesn't justify a quarter of the position, so the starter drops to ⅛.
At about $98, the trade is positive on your probabilities. That's not a trick. Entering near the 2026 low makes the distance to the stop short and the distance to the upside long. Your own condition #5 says a washout into 92–101 "changes the math even without new information." We agree.
Against the Treasury: 4.77% over 12–18 months is roughly 5–7%.
At about $98, your odds give about the same return.
My odds give roughly double.
So the decision now rests entirely on the odds of a cost reversal. That's section 4.
The evidence tranche costs something too. It buys after a good report, so it pays up. In exchange, it only gets bought in scenarios where "stuck" has been ruled out. Waiting for evidence costs whatever the stock gaps on report day.

3. Depreciation: you applied only half of your own rule¶

You charged me with mixing frames. Then you moved the cost of the new servers two years forward while holding the revenue they produce flat. That's the same mistake from the other side.

The servers are already earning money. - Cloud revenue growth went from about 13% to 18% to 26% to 34%, across the December-2024 through September-2025 quarters†. Capex ran far above prior years over the same period. - In the September-2025 quarter, cloud adjusted EBITA grew about as fast as revenue†. - EBITA is calculated after depreciation. Your own figure, RMB 10–11B on RMB 118B, is a margin of about 9% after paying for the servers.

"Three times the segment's profit" is the wrong comparison. New depreciation is paid for by new revenue, not by old profit. By your test, every growth business funded by capital spending would fail.

Here is the consistent version, with costs and revenue both moved to FY2028. - Cloud starts from roughly RMB 150B in FY2026. That's 118B × about 1.3, assuming FY2026 grew at the 2025 pace†. - It then grows 30% a year, well below Jefferies' forecast.

Change to operating income, FY2026 → FY2028 (RMB B)	Your version	Consistent version
Depreciation on servers serving paying customers	−20 to −30	Already covered inside cloud's ~9% margin
Depreciation on compute used to train Qwen (no direct revenue)	(included in the line above)	~−10 (1 point of revenue, conceded)
Cloud profit after depreciation, on ~RMB 104B of new revenue	0	~+9
Net change	−20 to −30	~0
Break-even opex ratio	25.4–27.7%	28.4–29.7% (unchanged)

At Jefferies' forecast of more than 50% cloud growth in FY2028, the cloud line rises to about +13, and the net turns slightly positive.

Where you'd be right: if capex outruns demand, cloud's after-depreciation margin will shrink, and your drag becomes real. That's testable in November, so it's now part of my tranche-3 test.

4. "When has Alibaba ever reversed a cash surge of this size?"¶

Never at this size. The closest examples are smaller: - International commerce posted its first profitable quarter in December 2024†. - The local services unit narrowed its losses through FY2025†. - Sun Art and Intime were sold†.

Those show that management tends to fix or sell loss-making units. They don't show it can cut RMB 60B or more.

But this reversal doesn't need a precedent. It needs three conditions, and all three are already visible.

1. The rules changed after the spending peaked. - China's top leadership made fighting "involution," meaning destructive price wars, a stated priority in July 2025†. - A revised Anti-Unfair Competition Law took effect on October 15, 2025†. It bars platforms from forcing merchants to sell below cost. - Your timing point is correct: the regulators' summons didn't stop the September-2025 quarter's spending. But that quarter ended two weeks before the new law took effect.

2. Cutting is cheap, by your own ratio. - In FY2026, Alibaba added RMB 27.4B of revenue but only RMB 9.5B of gross profit. - If cutting subsidies gave back all of that new revenue, gross profit would fall about RMB 9.5B, roughly 1 point of revenue. The savings would be RMB 54–67B. - You can't argue both that the spending bought almost nothing and that stopping it would cost a lot.

3. The core business didn't need the war. - FY2025, before the quick-commerce push, produced a record RMB 140.9B of operating income at a 40% gross margin. - If quick commerce is protecting Taobao traffic, the September quarter's customer-management revenue (the fees Alibaba earns from merchants) will show it.

On the price war itself: - I grant there's no merger exit, and Meituan can't walk away from food delivery. - But a war of attrition ends when the weaker side's losses become intolerable, not through a merger. - Meituan's entire profit pool is the battlefield. - Alibaba has the most gross profit, so it doesn't have to stop first. That's how a truce gets set on its terms.

What neither of us knows: - FY2026's annual opex mixes the peak quarter with whatever came after it. - Management signaled at the time that it expected quick-commerce losses to narrow after September 2025†. I can't verify whether they did. - The September-2026 quarter will show the current spending rate.

5. Tranche 3: I accept your level-based test, with two changes¶

Opex at or below about 30% of revenue for the quarter, with management pointing to the high 20s. (Your condition.)
Gross margin at or above about 39%. (Your condition.)
Cloud growth of at least about 30%, with the after-depreciation margin holding near 9%. (New. This settles the section 3 dispute.)
Cash flow: operating cash flow up year over year, and trailing-12-month operating cash flow covering a growing share of capex. (Changed from your "covering capex.")

Why I changed #4: - Your own free-cash-flow table puts free cash flow at about zero in the halfway case. - Requiring one quarter of full capex coverage means waiting until the best case is already visible. - That guarantees buying after the stock has already re-rated.

6. Quick replies¶

Ant and the debt. My core EPS starts from operating income, which excludes both interest income and interest expense. So the treasury portfolio minus the debt is valued at zero, not ignored on one side only. Alibaba's own releases have reported net cash for years†, but I'm not counting it. I never counted the cash either.
A 2.4% free-cash-flow yield through FY2028. Agreed. That's why my valuation assumes no buybacks. Capex is also the most discretionary line. If AI returns disappoint, capex gets cut and free cash flow rises.
Rates. I set my 16–18x multiple with the 10-year yield already at 5.28% and real yields at 2.92%. Your −9% applies only to a further 60 basis point rise. Your own condition #4 (the 10-year back below 5%) is the same math in reverse.
The moat is China, not AWS Bedrock.
US cloud giants operate in mainland China only in limited form, through local partners, and export controls keep frontier AI chips out of the country.
Alibaba Cloud is the largest provider there, with roughly a third of the market by third-party estimates†.
That domestic market is where cloud revenue grew 34%.
In-house chips matter more for secure supply than for price.
"We both expect 100–101."
I said our levels overlap, not that I forecast them.
Still, the technical report's main scenario is that the downtrend continues, and I'm respecting that by moving capital down there.
If Friday closes below 109.30, the weekly TD count stays at 7.
A completed 9 could then appear the week of October 19–23. That would land in the zone where the expected value is best.

7. Revised plan¶

Tranche	Size	Trigger
1	⅛ (was ¼)	Now, at 104–106
2a	⅛	Gap fill, at 99.7–101
2b	¼	A weekly TD 9 in 95–101 with the RSI/MACD divergence intact, or a daily close above 111.40 with OBV turning up
3	½	The level-based test in section 5

Stop: a daily close below 91.99, on everything bought before the September-quarter report.
Hard exit: a Treasury investment-ban designation, regardless of price.
Sizing: assume a headline gap down to about $80.
Holders:
Keep a core position with the same stop.
If you trim into 108–111, buy it back in the 95–101 zone.
Don't sell everything before the report. The stop already caps the downside, and selling the core means paying up if the spending figures surprise.
Targets:
114–116 first, then 129–133.
Fair value is $127–141 if the cost reversal happens.

My call: BUY BABA. Accumulate, with seven-eighths of the capital waiting for a lower price, a confirmed breakout, or the bear's own evidence test.¶

Two questions for the bear:

At about $98, with a stop at the 2026 low, the trade earns about +7% on your own probabilities. Your condition #5 says a washout there changes the math. In that zone, are you a buyer? If so, your real call is "buy lower." That's seven-eighths of my plan, and the gap between us is ⅛ of a position.
You counted the servers' depreciation but not the revenue they're producing. At your own ~9% cloud margin, where does the 2–3 point drag come from, unless cloud margins shrink? If shrinking margins are your claim, will you accept November's cloud margin as the test? Bull Analyst: # Bull Rebuttal: BABA. No new money at $105.70, but "wait" only wins if the market under-reacts to good news

The bear corrected two real errors and asked two fair questions. I accept the corrections, withdraw my starter tranche and lower my odds.

That leaves a much narrower disagreement than either of us started with. On what remains, the bear's own numbers support my side:

His "waiting wins" result rests on two assumptions. A passing report moves the stock only about 10%, and his five-part test never misfires. If a pass moves the stock by a realistic amount, the answer reverses.
He calculated that buying near $93 earns a risk premium on his own odds. His plan still goes neutral there.
His free-cash-flow test, applied to a September quarter, effectively requires a full reversal. He described it as a halfway test.

† = public reporting, not our tools. Per-ADS figures use USD/CNY 6.70.

1. What I concede¶

Tranche 1 at $105.70 is withdrawn. With your stop corrections, it earns about +1–2% on my own odds, which is below a Treasury. Cutting it to ⅛ didn't make it right.
Stops fill where the gap lands. I accept a "stuck" exit at $86–88 from a ~$98 entry.
The halfway scenario sits on top of my stop. I accept a halfway exit of about $95.
The 111.40 breakout trigger is dropped. On my own scenario values, buying at $111 before the report has a negative expected return. If I hold you to consistency, I have to hold myself to it too.
Opex threshold of 29% or lower, or quantified guidance. Accepted. A 30% print is my halfway case, and I shouldn't be buying half a position on it.
Holders: trimming into 108–111 fits my numbers. Keep a hedged core, for reasons I give in section 3.

So the gap between us is now about ⅛ of a position plus what each of us does in a washout. It is no longer half a position plus every holder.

2. Your second question: why 25% and not 15%?¶

Nothing available today settles 15 versus 25. I'm moving to 20%, and I've built the plan so that its main pre-report tranche pays off even at your 15%.

Your section 5 is the strongest argument against full reversal, and it moved me. Taking your arithmetic at face value: - The peak quarter carried RMB 35–40B of excess spending. - The other three quarters carried a bit over RMB 20B each, including the two after the new law. - So the spending pace at the end of FY2026 still annualizes near the full-year excess. - Part of what remains is AI opex, which won't come back down.

Getting all the way back to 25.8% of revenue needs nearly all of that gone. That's why I'm cutting the full-reversal probability.

The same arithmetic is why I don't go to 15: - The excess fell by a third or more from the peak quarter within two quarters of the law. Break-even needs about RMB 8–11B a quarter (the RMB 33–46B a year that remains after a 54–67B cut), down from roughly 20–25B. That's a big further cut, but it's in the direction spending is already moving. - Your prisoner's dilemma is a one-shot game. This one repeats every quarter. There are three players and a regulator that has made forcing merchants to sell below cost illegal†. Tacit truces come from exactly that setup: repeated play with an enforcer. - Meituan posted its largest quarterly loss on record in the September-2025 quarter†. You say food delivery is its whole business, so it can't walk away. That also means it can't absorb losses like that for long, which pushes toward a truce.

My new odds: 20 / 35 / 25 / 15 / 5 (full reversal / most of the way / halfway / stuck / escalation).

What would move me to 15: a September quarter with opex above ~31% of revenue and no quantified guidance toward lower levels.

3. Your "wait" comparison assumes the market under-reacts¶

Your waiting strategy buys at $110 after a +10% gap. Two assumptions drive its advantage.

1. A passing report moves the stock only 10%. - If the test passes, we're in the full or most-of-the-way scenarios. Those are worth about $122 on either of our odds. - If the stock has washed out to ~$94 before the report, a +10% gap leaves it about 20% below the value the report just revealed. - You argued last round that "down from the worst quarter" is already expected. A print that clears your five-part level test is well above that expectation. - BABA has moved high single digits to double digits on ordinary earnings days†. A report that changes the margin trajectory is not ordinary.

2. The test never misfires. - A joint test with five conditions will sometimes fail a good quarter. The waiter then sits in Treasuries while the stock re-rates. - It will sometimes pass a halfway quarter. The waiter then buys at $110 into a $95 outcome. - Both kinds of error reduce the edge you assigned to waiting. The table below ignores them anyway, which favors your side.

Here is the comparison with a consistent pre-report price of about $94, using your perfect-test assumption. The "buy" row uses exits made harsher for the lower entry: stuck at about $84, and about half of halfway paths stopped out (about $93).

Expected 12–18 month return	My odds (20/35/25/15/5)	Your odds (15/25/35/20/5)
Buy at ~$94, before the report	~+12–13%	~+7–8%
Wait; pass gaps +10% (buy ~$103)	~+12–13%	~+11%
Wait; pass gaps +20% (buy ~$113)	~+7%	~+7%
2-year Treasury	+5–7%	+5–7%

At a +10% gap, waiting ties on my odds and wins by 3–4 points on yours.
At a +20% gap, buying wins by 5–6 points on my odds and ties on yours.
The crossover is near a +15% gap. Last round you said to pick the strategy that is about equal on one set of odds and better on the other. Above a 15% gap, that rule favors buying the washout. I think a gap above 15% is the consistent assumption for a report that clears a test designed to beat consensus.

Waiting doesn't avoid escalation risk either. - The Treasury investment-ban order itself (EO 13959) was signed on Nov 12, 2020, nine days after an election†. - Alibaba's own near-designation came in January 2021†. - A waiter buying in mid-to-late November buys into the same window you say waiting avoids. - That risk applies to both of our plans. It's why I keep the hard exit and the hedge.

4. In a washout, your own odds say buy¶

You wrote: "Earning even a modest risk premium would mean buying near $93."

I took that and made it harsher, with lower exits for a $94 entry. It still earns about +7–8% on your odds, above the Treasury. But your plan says "cover and go neutral" in a washout.

At that price the trade also stops depending on one scenario. On my odds at $94: - "Most of the way" (a 76% reversal, not a full one) contributes about 7.4 points of expected return. - Full reversal contributes 8.0 points.

Your "85% from the scenario Alibaba has never achieved" was true at $98. It isn't true at $94, and $94 is where tranche B buys.

5. The evidence test: agreed, except one line that measures the wrong thing¶

I accept four of your five conditions as written: - opex at ~29% of revenue or lower, or quantified guidance into the high 20s; - gross margin at ~39% or higher; - cloud growth of ~30% or more with adjusted EBITA margin at ~9% or higher; - customer management revenue (merchant fees) roughly holding its recent growth.

"Quarterly free cash flow at zero or better" is a full-reversal test when applied to a September quarter: - Alibaba's cash flow is seasonal. In FY2025, the December quarter alone produced about half the year's free cash flow†. - The September-2025 quarter had a free cash outflow of roughly RMB 22B†, with capex of about RMB 31B†. - A break-even level of cost cuts (RMB 54–67B a year) adds about RMB 13.5–17B of operating income per quarter. Operating cash flow tracks operating income; you pointed out last round that they fell by nearly the same amount. - At similar capex, break-even puts September-2026 free cash flow at about −RMB 5–9B. - Reaching zero needs about RMB 22B more per quarter, roughly RMB 88B a year. That is close to full reversal, not halfway.

My replacement: a September-quarter free cash outflow no worse than about RMB 7B, adjusted for any change in capex. That maps to break-even, which is what the test is meant to confirm.

6. AI: a wash on FY2028 earnings is not a wash on value¶

The ~9% cloud margin wasn't earned on a pre-plan asset base. - By the September-2025 quarter, Alibaba had spent roughly RMB 120B+ on capex over the prior four quarters†, a full year at the plan's pace. - Cloud still held about a 9% margin after depreciation†. - I agree depreciation lags installation, which is why November's cloud margin is our agreed test.

"A wash" withdraws your original claim. - You argued depreciation would push break-even back to full reversal, a drag of RMB 20–30B on operating income. - A net of about zero means the AI build-out no longer stands between the subsidy reversal and my values. That's what I needed the table to show.

My valuation method gives cloud almost no credit. - A 16–18x multiple on taxed cloud profit (9% of my ~RMB 150B revenue estimate) values cloud at about $11–12 per ADS. - At even 2x revenue, it would be about $19. - I'm not adding that difference to the tables. We built them on one basis and I'll keep it. But it shows the tables are conservative, and it's where "owns the whole AI stack" shows up: in the value of the asset, not in FY2028 EPS.

Qwen price cuts. Token prices fell sharply in 2024†, and cloud revenue growth still accelerated through 2025†. Cheaper models drove more usage.

7. Quick replies¶

"Multi-year strategic push." Staying in quick commerce is not the same as subsidizing at peak levels. Break-even needs lower subsidies, not an exit.
"Defensive spending protects about RMB 20B." If so, Alibaba is spending about RMB 100B to protect RMB 20B. Every player can see that math, and that's what makes a truce rational. November's customer management revenue tests whether the 20B is real.
Calendar risk. Tranche B only fills after a flush, and everything bought before the report is hedged through it. The late-October Fed meeting, the midterms and Singles' Day are covered by the put spread, not by a daily-close stop alone.

8. Revised plan¶

Tranche	Size	Trigger
—	0	Nothing at $105.70. The starter tranche is withdrawn.
A	⅛	Limit order at 97–99, below the gap fill. This is a bet on my odds; skip it if you hold the bear's.
B	¼	A washout in 92–96 by the bear's own definition: RSI below 30, a volume spike, OBV turning up, and a close off the lows.
C	⅝	After the September-quarter report, on the joint test in section 5.

Hedge: put spread on A and B through the report. Our data can't price it. On your odds it could eat most of B's premium; on mine it doesn't come close.
Stop: a daily close below the lower of 91.99 or the washout-day low.
Hard exit: a Treasury investment-ban designation, regardless of price.
Sizing: assume a headline gap to about $80.
Holders: trim into 108–111 and keep a hedged core. Rebuy in the A and B zones.
Targets: 114–116, then 129–133. Fair value of $127–141 if costs reverse.

My call: BUY BABA, with limit orders below $99, not at the market price.¶

Nothing at $105.70. Up to ⅜ of the position only on a washout, hedged. The remaining ⅝ after the September-quarter evidence. Every number in this note comes from the bear's own exit values and his own Treasury hurdle.

Two questions for the bear:

Your own math says buying near $93 earns a risk premium on your odds. If the washout you defined arrives, are you a buyer, yes or no? If not, what in your numbers says otherwise?
Your waiting advantage needs a passing report to lift the stock only about 10%, when the passing scenarios are worth 25–30% more than a washed-out price. Why would the market leave that much on the table? If it wouldn't, what's left of the case for waiting at washout prices? Bull Analyst: # Bull Rebuttal: BABA. Row 1, and tranche A is gone. But your "wait" row assumes a test that never misses.

The bear's symmetry point is right, and I'll run his table his way. I pick row 1. Tranche A doesn't survive that on my own odds, so it's withdrawn. I'm also lowering my odds again because of Aug 21.

His table has one inconsistency. It uses "one quarter doesn't settle it" to shrink the market's reaction, but not to question his own test. Once the test is allowed to misclassify a quarter:

At about $94, buying and waiting tie on my odds, and waiting still wins on his. I accept that, and tranche B no longer buys there.
At a capitulation near $92, buying leads by about 2 points on my odds and trails by about 1 on his. That's the mirror image of $94.
The bigger issue is the test itself. It now governs ⅞ of my new capital. Requiring all five conditions to pass on one seasonal quarter will fail many good quarters.

Per-ADS figures use USD/CNY 6.70.

1. What I concede¶

Row 1, a 35% reaction in both directions. BABA's usual ~10% earnings move, my own −12% "stuck" assumption and the −8.6% on Aug 21 all point there.
Tranche A is withdrawn. I ran it on my odds, old and new, at all three of your rows. It trails waiting every time. So your question "what is it for?" has the answer: nothing.
Aug 21 was probably the June-quarter print.
I treat it as evidence and move 5 points from "most of the way" to "halfway."
New odds: 20 / 30 / 30 / 15 / 5 (full / most of the way / halfway / stuck / escalation).
I'm not moving further because the drop came at the top of a two-month rally of about 42% (91.99 to 130.62). Part of that day was positioning, not spending.
The truce arguments slow the timeline:
The law as I described it doesn't bind subsidies Alibaba pays for itself.
JD's 2025 entry shows that breaking ranks can pay a new entrant.
Meituan's record loss hasn't produced a truce in two quarters.

That's why my good-scenario odds are now 50%, down from 60% when this debate started. - The cash-flow line at −RMB 3B is accepted. Section 4 covers where it belongs. - The hedge on tranche B is dropped. At ⅛ of a position, sizing for a gap does the same job without paying for options neither of us can price.

2. Your table assumes an uncertain market and a certain test¶

These are your reasons for a 35% reaction:

"One quarter doesn't settle a 12–18 month scenario."
"A 29% opex print in September tells you about September."
"The test can pass a halfway quarter. The market knows that too."

All three are true. They also mean your test can fail a good quarter. Yet your "wait" row passes every good scenario and fails every halfway one. That breaks your own one-or-the-other rule: if one quarter is too noisy for the market to trust fully, it's too noisy to classify perfectly.

How noisy is it?

"Most of the way" means opex near 28% within 12–18 months. The path there can easily include a 29.5% September quarter.
Cloud margin can dip from depreciation even while subsidies fall. You've argued that yourself.
September-quarter free cash flow is seasonal. We agree on that.
Suppose each of the five conditions has a 90–95% chance of passing in a good scenario. If they were independent, the chance all five pass would be 59–77%. They're correlated, so the real figure is higher. Still, "one good quarter in four fails" is a reasonable middle case.

My assumptions:

25% of good-scenario quarters fail the test.
10% of halfway quarters pass it.
When a good quarter fails, the waiter can still buy after the December quarter. By then the stock is around $115 against a value near $123, which is roughly a Treasury return. So a miss costs the waiter the post-pass return minus a Treasury.

Expected 12–18 month return at row 1, with your exits ($134 / $115 / ~$93 halfway / stop fill at 35% of the stuck gap / escalation −20%):

Entry	My odds (20/30/30/15/5): buy / wait	Your odds (15/25/35/20/5): buy / wait
~$98	~+7 / ~+8.5	~+3 / ~+8
~$94	~+10 / ~+10	~+6 / ~+8.5
~$92 (capitulation)	~+12 / ~+10.5	~+8 / ~+9
2-year Treasury	+5–7%	+5–7%

Buy rows include your 1.5-point false-break haircut. "Wait" means buying after a pass at the 35% reaction and holding Treasuries (~6%) otherwise, less your ~0.3 points for escalation risk.

What the table shows:

At $98: waiting wins on both sets of odds, so tranche A stays dead.
At $94: it's a tie on my odds and waiting wins by about 2.5 on yours. Your rule picks waiting, and I accept that.
At $92: buying leads by about 2 on my odds and trails by about 1 on yours. Your rule stops choosing waiting around there.
What decides it: with zero misfires, waiting wins at every price on your odds. So the comparison turns on one number, your test's miss rate. If you say zero, you need to explain how one seasonal quarter can be decisive for your test while the market is right not to trust it.

One caveat against my own case. A good quarter that narrowly misses one of our lines could still gap down far enough to hit a stop placed just below a $92 entry. I think that's uncommon, because the market isn't grading the quarter against our thresholds. A 29.5% opex print against about 35% a year earlier is good news. But it's a real risk, and it's part of why B is only ⅛.

3. Tranche B: cut to ⅛ and moved to $93 or lower¶

Trigger: your full capitulation signature, at or below about $93:
RSI below 30
a volume spike
OBV turning up
a close off the lows

For reference, the 2026 low is 91.99. - Stop: a daily close below the low of the washout day. - Sizing: no hedge. Size it so a gap to about $74 fits the risk budget. - Timing: the weekly TD count could complete a 9 in the week of Oct 19–23. - If that happens at $92–93 with the capitulation signature, that's the setup. - If it happens at $96 on drifting volume, I don't buy. In that case your OBV point wins.

4. The test matters more than tranche B, because it governs ⅞ of new money¶

The −RMB 3B cash line: accepted, but not as a hard gate.

Your break-even range of −3 to +4B after tax assumes cutting subsidies costs no gross profit.
Your own figure says defensive spending protects about RMB 20B of gross profit a year, about 5B a quarter. My estimate is about 2.4B a quarter.
After tax, a break-even quarter gives back roughly 2–4B. That puts break-even free cash flow at about −7 to +2B.
−3B sits near the middle of that range, so a break-even quarter passes it only about half the time.

My proposal for tranche C:

Hard gate: opex at or below 29% of revenue, or quantified guidance into the high 20s. Opex is what separates the scenarios.
Plus any three of these four:
gross margin of 39% or higher
cloud growth of 30% or more, with adjusted EBITA margin of 9% or higher
free cash outflow no worse than ~RMB 3B, adjusted for capex
customer management revenue holding up
If the one miss is cloud margin: buy half of C on the report and the other half after the December quarter. Cloud margin is our depreciation dispute, and I agreed November would settle it. So a miss there gets a second look, not a free pass.

The opex line identifies the scenario, and the other four confirm it. Requiring all four confirmations in one seasonal quarter adds false negatives faster than it adds information.

5. The rest, briefly¶

AI: agreed that it isn't in the tables. It's the reason to own the stock for years once the evidence arrives: a cloud business growing 30%+ in a home market where US cloud providers operate only in limited form, with a capex plan that ends in FY2028.
Holders: we agree. Trim into 108–111, and keep a hedged core sized so a gap to ~$80 is survivable.
What's left between us:
⅛ of a position at a capitulation
the design of the test
10 points of probability that it passes (50% for me, 40% for you)
What moves me to your odds: a September quarter with opex above ~31% of revenue and no quantified guidance toward lower levels. I've named my trigger; I'd like to hear yours.

My call: BUY BABA, on the evidence. ⅞ of new money waits for the September quarter; ⅛ buys only a true capitulation near the 2026 low.¶

Tranche	Size	Trigger
A	0	Withdrawn
B	⅛	Full capitulation signature at or below ~$93. Stop: daily close below the washout-day low. No hedge; sized for a gap to ~$74.
C	⅞	September quarter: opex at ~29% or lower (or quantified guidance into the high 20s), plus 3 of the 4 checks. If the miss is cloud margin, half now and half after December.

Hard exit: a Treasury investment-ban designation, regardless of price.
Targets: 114–116, then 129–133. Fair value is $127–141 if the cost reversal happens.

Two questions for the bear:

What is your test's false-negative rate in a good scenario? If it's above zero, your "wait" row is overstated. If it's zero, why is one seasonal quarter decisive for your test but not for the market?
Opex gate plus 3 of 4: yes or no? If no, name the single miss that would keep you out of a quarter with opex at 29% or lower, and explain why it outweighs the opex print.

Bear Researcher¶

Bear Analyst: # Bear Rebuttal: BABA. The bull wants you to pay now for a cost reversal nobody has seen.

The bull built a careful case, and some of it holds up. Gross margin did hold. The balance sheet is not in distress. The yuan is stable.

But the whole thesis rests on one sentence: "decisions can be reversed." Every row of the bull's valuation table except the first is a hypothesis. The first row, the only one that has actually happened, prices BABA at about 41x core earnings.

Below I answer the bull's closing question directly. Then I show that the bull's own math is less generous than it looks.

1. "What evidence shows FY2026's cost base is permanent?" Here it is.¶

First, the burden of proof is backwards. The bull wants investors to buy before the September-quarter results, on the assumption that spending is coming down. Nothing in our data shows that. The June 2026 quarter isn't in our tools. Neither of us has evidence either way, but only one of us is asking for money up front.

Now the evidence that the spending is sticky:

The extra spending bought almost nothing.
Operating expenses rose RMB 100.2B.
Revenue rose RMB 27.4B.
Gross profit rose RMB 9.5B, or +2.4%. That is the "record" the bull cites.
That's about RMB 10.5 of new spending for every RMB 1 of new gross profit. That doesn't look like a choice to invest. It looks like spending just to hold position.
Quick commerce is a price war, not a budget line. Meituan and JD set the subsidy level as much as Alibaba does. If Alibaba cuts on its own, it hands them share inside its core franchise. "Management can reverse it" assumes competitors will go along.
The bull's own headlines show the AI race speeding up:
Tencent is weighing a $5B bond to fund AI.
Moonshot is testing a $50B valuation.
Kling is targeting a $1B+ IPO.
Hong Kong AI fundraising had a record summer.
Chinese AI chips "could flood the market."
Nobody in this race is cutting back.
Alibaba has publicly committed RMB 380B+ to AI and cloud over three years, announced in February 2025. That plan runs into the same FY2028 the bull is counting on for cloud growth.
The depreciation hasn't fully hit yet.
Non-current assets are up RMB 287B since FY2024, including RMB 169B in FY2026 alone.
Capex isn't broken out in our data, so this is an illustration. Suppose only half of that build-out is servers and data centers, depreciated over 5–6 years. That's roughly RMB 24–29B a year of new depreciation, about 2.3–2.8 points of revenue.
Much of that cost lands in cost of revenue. So the bull's assumption that gross margin stays at 39.8% while operating expenses fall is a best case stacked on a best case.

On "the bear can't have it both ways": yes, I can. That is exactly how an arms race works: - Alibaba has to spend to keep up, so the spending isn't discretionary. - Because everyone is spending, the returns get competed away.

Both are true at once. That's the problem, not a contradiction.

2. Checking the bull's own math¶

FY2025 was not a "clean" year. The bull reasons that because net income was below operating income, no gains inflated it. That compares after-tax net income with pre-tax operating income, which proves nothing. - Apply the bull's own 20% tax rate: FY2025 core earnings were RMB 112.7B. - Reported net income was RMB 130.1B. - So about RMB 17B still came from outside the core business.

FY2025 EPS per ADS	Bull's figure	Bull's own core-only method
EPS	~$8.00 (13x)	~$6.93 (~15x)

The target mixes two bases. The bull removes non-core income to make FY2026 look temporarily depressed. Then he adds it back ($8 × 16–18x) to set the price target. It has to be one or the other.

Here is the bull's own core EPS at the bull's own 16–18x multiple:

Scenario (from the bull's table)	Core EPS	Value at 16–18x	vs. $105.70
Halfway back (opex at 30%)	$5.07	$81–91	−14% to −23%
Full reversal (opex at 25.8%)	$7.25	$116–130	+10% to +23%

This is the key point. In the bull's own "halfway back" scenario, at the bull's own multiple, fair value is below the bull's stop. The trade only makes money if management reverses the entire RMB 100B, during an arms race, with no depreciation drag. That is a bet on the best case, not a margin of safety.

The stock has gotten more expensive, not cheaper. - On the same core basis, EPS per ADS fell from about RMB 46 to about RMB 17, a drop of ~63%. - The stock fell about 44% over the year. - The price fell less than the earnings it is priced on. "A lot is priced in" doesn't hold.

Compare the earnings yield with the 10-year Treasury at 5.28%:

Scenario	Core earnings yield	vs. 10Y at 5.28%
Actual FY2026	~2.4%	−2.9 pts
Halfway back	~4.8%	−0.5 pts
Full reversal	~6.9%	+1.6 pts

Even in the best case, you earn 1.6 points over a risk-free Treasury to own a Chinese ADR on a US defense list. That doesn't pay for the risk.

Book value is weaker support than it looks. The stock trades at 1.6x book. In FY2026, operating income was 4.8% of average equity, measured before tax. That's below the risk-free rate. A growing share of that book is the RMB 287B of new long-lived assets, which haven't yet shown they can earn a return.

The bull's "share count down 14% since FY2021" looks backward. Looking forward:

Operating cash flow has fallen three years running: 199.8 → 182.6 → 163.5 → RMB 76.2B. The last drop was −53%, and cash flow is now just 7.4% of revenue.
Earnings quality is weak.
Operating cash flow was 0.74x net income, the first time below 1x since FY2016.
Net income was 2.07x operating income.
The last time net income ran well ahead of operating income (FY2020–21), net income fell 59% the following year.
Free cash flow was very likely negative. RMB 76B of operating cash flow can't fund the AI plan.
Shareholder returns are shrinking.
Net financing outflow fell from RMB 108B to 76B to 21B.
The yearly share-count reduction slowed from 5.1% to 3.0%.
Non-current liabilities rose RMB 28B, which fits convertible bond issuance. That means possible future dilution, not more buybacks.
Liquidity is falling. Working capital is down 59% in two years. The current ratio fell from 1.79 to 1.28.

I agree there's no solvency problem. But the bull's per-share recovery assumes the share count keeps shrinking, and the cash that would do that is going into data centers.

4. The AI story is real, but it doesn't pay in the way the bull needs¶

"Cloud is accelerating" is a forecast, not a result. It is one broker's view of FY2028, a year that starts in April 2027.
Qwen is open source. Companies building on it, Hirundo included, don't pay Alibaba. Adoption is not revenue.
The Hirundo story is a warning sign. In Hirundo's testing, 89.8% of Qwen's unmodified answers were censored or Party-aligned. That's the product Joe Tsai is pitching to European businesses, in the same period the US Defense Department put Alibaba on a list.
The Moonshot stake is uncertain. It is only "reportedly" held, and its size is unknown. The headline describes a "$50 billion test," not a completed round. A well-funded Moonshot is also a well-funded competitor to Qwen.
The new chip is 3x better than the last one. But the headline says Chinese AI chips "could flood the market." That points to commoditization, not a lasting advantage.

5. The defense list: the bull's escape routes don't hold¶

The bull admits "we haven't confirmed which list it is," and then sizes the trade as if it's the benign one.

The Hong Kong listing doesn't protect US investors. If this escalates to Treasury's investment-ban list, the ban covers the company's publicly traded securities wherever they trade. 9988.HK doesn't help a US holder in that case. That is exactly the forced-selling and index-removal risk the news report flagged.
The calendar works against the bull.
The US midterms are Nov 3.
A House panel just went after Webull over its China ties.
There is also a lawsuit whose details we don't know.
Retail isn't pricing it in. None of the 8 StockTwits posts mentions the list. "Down 44%, so it's priced in" doesn't fit a risk the crowd isn't even discussing. Neither does the Oct 8 session described below.

6. Macro: this is a long-duration bet¶

The bull says high real yields don't hurt BABA because it trades at 14x normalized earnings.

On earnings that actually exist, it trades at 41x.
All of the cheapness sits in later years: normalized costs and cloud growth above 50% in FY2028.
Earnings two to three years out are exactly what a 2.92% real yield discounts most heavily.

The rest of the backdrop: - The Fed hiked on Sep 17. - The 10-year yield is at its highest since 2002. - A VIX of 15 looks complacent against that backdrop. - Brent's fall to about $103 rests on a promise not to strike Iran before the midterms. That cushion expires the same week the list risk peaks. - China is the world's largest crude importer.

I'll concede the stable yuan is a mild positive. It doesn't offset the rest.

7. The chart: the bullish signal is in the oscillators, the selling is in the volume¶

The bull calls OBV my strongest point. It's even stronger than he admits.

OBV fell from +64.4M on Sep 22 to −10.45M, erasing about 75M in 12 sessions. Over a similar stretch, price slipped only about 1.5%. RSI moving from 33 to 39 on a flat price is just the indicator resetting. Volume shows who is actually trading, and it's at a 60-day low.
Oct 8 was a distribution day, not a failed breakdown.
The stock opened higher at 108.25.
It was turned back at 109.39, just under the 20-day average.
It closed at 105.70, in the bottom 20% of the day's range.
Volume was 11.56M shares, the heaviest since Sep 23.
The same pattern on Sep 22 was followed by a 4.7% drop the next day.
The MACD also crossed down again below zero.
RSI never reaching 30 is not strength. It means there has been no capitulation, and bounces keep stalling at 48–54. That pattern is a slow bleed, and slow bleeds tend to end in a washout.
The July gap is a target, not support. Price sits at its top edge (105.65). Unfilled gaps tend to get filled, which points to 99.74.
Volatility is rising at the lows. The lower Bollinger Band is only 0.6 ATR away, and ATR has risen from 2.82 to 3.11 as price tests support.
The TD count is not a buy signal, as the technical report says. The bull's own second tranche waits for 95–101, so he expects more downside too.

The risk/reward is not −13% versus +23%. - The upside target is the line that defines the bear market. 129–131 is the 200-day SMA and the weekly SuperTrend. The 200-day is falling about 4.7 points a month. - The road up has five resistance levels: 108–109.5, 111.40, 114.44, 116.38 and 120.40. - The road down has one stop before the gap fill and 92–95: the lower band at 103.78. - The stop doesn't cap the loss at 13%. It triggers on a weekly close, in a stock exposed to headline gaps. A Friday close could land well below 91.99.

8. The bull's own tranche plan argues against itself¶

The bull says tax-loss selling in October–December "creates the entry price." Then why buy a third of the position now, in the second week of October?
Tranche 2 waits for 95–101. Tranche 3 waits for the September-quarter results. Two-thirds of the bull's plan is "wait for lower prices or more information." I agree with that part. I don't see why the first third shouldn't wait too.

My call: SELL / AVOID BABA¶

Holders: use rallies into 108–111 to cut exposure before the midterms and earnings.
Traders: follow the technical base case.
Sell rallies into 108.2–111.4.
Stop above 111.40, or above 114.44 to be more conservative.
Targets: 100–101 (the gap fill and 78.6% retracement), then 92–95.
Would-be buyers: the September-quarter results, due in mid-to-late November, are the one data point that settles this debate. Buying before then means paying for the hope instead of the evidence.

What would change my mind: 1. September-quarter results showing operating expenses falling meaningfully as a share of revenue, without weaker revenue growth, and with operating cash flow recovering. 2. Confirmation that this is the Section 1260H list only, with no Treasury escalation through the midterms. 3. A daily close above 114.44, with OBV turning up. 4. The 10-year yield falling back below 5%.

My question back to the bull: In your own "halfway back" scenario, at your own 16–18x multiple, BABA is worth $81–91, which is below your stop. So the trade only works if management reverses the full RMB 100B, in the middle of a subsidy war and an AI arms race, while new depreciation lands. What probability do you put on that? And is it high enough to buy today rather than in six weeks, when the September quarter gives us the answer? Bear Analyst: # Bear Rebuttal: BABA. Corrected, the bull's math says "fair value," and three errors remain.

The bull withdrew the mixed-basis target, tightened his stop, and conceded the Hong Kong point. He also made the most important admission of this debate: "On these deliberately static terms, BABA isn't a deep bargain. It's roughly fair value."

I agree, and that is the problem with buying it. A stock at fair value, with a Treasury-ban tail risk, an ongoing subsidy war and an earnings report five weeks away, is a reason to hold cash. His "fair value" also contains three errors, and all of them push it lower:

His cost-cutting precedent is mostly a goodwill write-off.
His "stuck" scenario quietly switches valuation methods.
Depreciation and capex consume the margin of safety his $11 created.

First, his two questions.

† = public reporting, not our tools. Per-ADS figures use USD/CNY 6.70 and about 2.355B ADS.

1. Your two questions¶

"What are the Ant stake and treasury portfolio worth?"¶

Not zero. I'll grant $11 per ADS for Ant and use it for the rest of this note. Your two routes to $11 still don't check each other the way you think.

The income route uses your best year of an unstable line. Using your own method (net income minus operating income taxed at 20%), non-core income was:

FY	2022	2023	2024	2025	2026
Non-core income after tax (RMB B)	+6.5	−7.5	−10.7	+17.4	+63.4

It was negative in two of the four years before FY2026.
It averaged about RMB 1.4B across FY2022–25.
That line nets interest income against investment write-downs, minority interests and tax differences. The fundamentals report called the interest income "real and recurring." That description doesn't apply to this whole line.

The Ant route counts assets without the debt against them. - Your core EPS starts from operating income, which is calculated before interest expense. - Adding Ant at full value without subtracting any of BABA's bonds and convertibles counts the assets and ignores the claims on them. - Our data can't tell us whether the treasury portfolio exceeds the debt, and yours can't either. That makes it unknown, not upside.

Cash isn't worth face value if it's already committed. - Working capital is down 59% in two years. - Free cash flow was likely negative. - The cash is paying for the data-center build-out. - You can count it once: as cash, or as the data centers it buys. You can't count it as both.

So Ant at about $11 is granted. Section 3 shows it doesn't rescue the trade.

"Why is your short's gap risk acceptable?"¶

It isn't acceptable at full size through the earnings report. That's a fair hit, and I'm revising:

The tactical short (selling at 108–111) is a pre-earnings trade. It should be closed, or converted to defined risk with puts or put spreads, before the September-quarter report.
My main call was never "short into the report." It was sell or avoid. Not owning BABA into the report carries no gap risk. Your plan adds exposure before it.

2. The FY2023 "precedent" was a write-off, not a cost cut¶

Alibaba's FY2022 operating income included a goodwill impairment of about RMB 25B related to Sun Art and digital media.† An impairment is a one-time write-down of an asset's value.
Your "RMB 26B cut" is almost exactly that write-down not happening again.

	FY2022	FY2023
Opex as reported	~RMB 244B (28.6%)	~RMB 218B (25.1%)
Opex excluding the write-down	~RMB 219B (25.7%)	~RMB 218B (25.1%)

Underlying spending was roughly flat, and the ratio moved about 0.6 points.
That gives no precedent for reversing a 9-point spike in cash spending.
So "at that pace, two years to 28%" has nothing behind it.

"The uncertainty cuts both ways" doesn't hold either. - Impairments are non-cash. - You pointed out that operating income fell RMB 90.7B and operating cash flow fell RMB 87.3B. That match shows the FY2026 spike was cash actually leaving the company. - Alibaba's own release showed sales and marketing spending roughly doubling year over year in the September-2025 quarter.† That reflects subsidies, not write-downs.

So I'll ask the question again, more precisely: when has Alibaba ever reversed a cash spending surge of this size?

3. Your "stuck" scenario switches methods¶

Every scenario in your table uses core EPS × 16–18, plus $11. The worst scenario instead uses 1.2x book value.

On your own method, "stuck" at 34.9% opex is $2.55 × 16–18 + $11 = $52–57, not $80.
1.2x book is generous anyway. Core return on equity in FY2026 was about 3.9% (RMB 40.2B on about RMB 1.04T of average equity). A business earning about 4% on equity rarely trades above book value.

Here is the table recalculated. I keep your values for the other three scenarios and ignore depreciation entirely:

Scenario	Value per ADS	Your probability	My probability
Full reversal	$127–141	30%	15%
Most of the way	$109–121	30%	25%
Halfway	$92–102	20%	35%
Stuck or escalation (your method)	$52–57	20%	25%
Probability-weighted value		$100–110	$91–101
vs. $105.70		−6% to +4%	−13% to −4%

On your own probabilities, the midpoint is about $105. That is roughly zero expected return over 12–18 months.
A two-year Treasury pays 4.77% with no tail risk. You're offering zero expected return plus a one-in-five chance of losing roughly half.
Any protective put you buy reduces that zero further.
My lower probabilities rest on sections 2, 4 and 5: there's no real cost-cutting precedent, this war has no merger exit, and depreciation moves the break-even point.

4. Depreciation takes back the margin of safety¶

Your break-even (opex at 28.4–29.7% of revenue) assumes gross margin stays at 39.8%. That assumption carries a lot of weight.

Each point of gross margin lost moves the break-even by one full point. At 16–18x, it also costs about $8–9 per ADS.

The AI plan's depreciation is large once it's fully running. - The RMB 380B plan works out to about RMB 127B a year.† - Suppose only half of it is depreciable hardware, written off over 5–6 years. That alone is RMB 32–38B a year once fully deployed, or 3–4 points of revenue. - Only part of that is in FY2026's numbers, because assets added during the year carry only part-year depreciation.

If 2–3 points of that reach cost of revenue, break-even moves to opex of 25.4–27.7%. That is roughly the full reversal again, which is exactly the bet you said you no longer needed.

On "depreciation comes with revenue": you made the "one or the other" rule, and it applies here. - If your frame is static, depreciation on servers already installed arrives with nothing to offset it. - If your frame is dynamic, you have to show the profit that offsets it. - The whole cloud segment earned about RMB 10–11B of adjusted EBITA (operating profit before amortization) on about RMB 118B of revenue in FY2025.† - Covering RMB 30B+ of new annual depreciation would take about three times the segment's entire current profit.

The cash picture is worse. - Before the spike, operating cash flow was already falling 9–10% a year, while operating income rose 40% (FY2023–25). - The gap between operating cash flow and operating income shrank from RMB 99B to RMB 23B. - The table below assumes that gap stays at its FY2025–26 level (about RMB 23–26B) and that capex runs at the plan's ~RMB 127B a year:

Scenario	Operating income	Est. operating cash flow	Free cash flow	FCF yield on RMB 1.67T market cap
Full reversal	~RMB 143B	~RMB 166–169B	~RMB 40B	~2.4%
Halfway	~RMB 100B	~RMB 123–126B	~zero	~0%

So even in your best case, you earn a 2.4% free cash flow yield, with little room for buybacks, through FY2028.

5. Your own evidence says the subsidy war won't end on your schedule¶

The exits in your examples aren't available here.
The ride-hailing war ended with the Didi–Kuaidi merger and then Uber China's sale to Didi.†
The food-delivery war ended with the Meituan–Dianping merger and Ele.me's sale to Alibaba.†
Today the fighters are Alibaba, Meituan and JD. None of them is going to exit, and China's tougher antitrust rules since 2021 make a merger among them very unlikely.
Regulators already tried. The summons you cite came in mid-2025. By your own account, the September-2025 quarter was the heaviest spending quarter of the cycle, and it came after the summons.
Losses make a truce possible, but they aren't a truce. Food delivery is Meituan's entire business, which makes it the competitor least able to walk away.
Having the most gross profit means Alibaba can keep spending the longest. That doesn't mean it stops first.
Your table holds revenue flat while cutting RMB 54–67B of subsidies.
Subsidies buy orders and bring traffic to Taobao.
Cut them, and some of FY2026's RMB 27.4B of revenue growth goes away too.
Holding revenue flat therefore flatters your case here as well.

6. Your third-tranche test is too easy to pass, and I'm tightening mine¶

Your test is too easy. - You set the September-quarter test as "opex as a share of revenue down year over year." - You've described the comparison quarter as the heaviest-spending quarter of the cycle. Against that, the test will almost certainly pass. - It's probably already what analysts expect. - Passing wouldn't tell us the business is anywhere near break-even.

My revised condition #1 is about levels, not direction: - an opex ratio on a credible path to the high 20s, not just below the peak quarter; - gross margin holding near 40% as depreciation rises; - operating cash flow covering capex.

This also answers "waiting has a cost." - An overnight repricing depends on results versus analyst expectations, and neither of us has those expectations. - "Down from the worst quarter" isn't a 60%-odds upside surprise. It's the expected outcome.

7. Quick replies¶

Rates.
Your 1.2% figure is correct for a single cash flow two years out.
A 16–18x multiple values earnings indefinitely, so it is far more sensitive to rates.
At 17x, if the full 60-basis-point rise in real yields passes through, the multiple falls to about 15.4x, roughly −9%.
Earnings yield vs. real yield. That comparison assumes earnings rise with inflation. Revenue grew only 2.7% in nominal terms.
Qwen.
Open-source models can run on any cloud, and Qwen models are available on AWS Bedrock.†
Tsai's European pitch is about independence. That points to hosting in Europe, not on a Chinese cloud whose parent is on a US defense list.
Cheaper chips.
Cheaper computing helps the clouds of Tencent, Huawei and ByteDance too, so the savings get competed away in pricing.
It also narrows the in-house chip advantage you cited in your opening.
And it makes the RMB 287B of equipment already installed obsolete sooner.
27x a year ago. That multiple came before the cost spike and before the defense list. The market re-rated on new information.
The Tencent precedent and StockTwits. I concede both.
Tencent is the best precedent, and it lowers the odds of escalation.
Eight posts prove nothing about what institutions think.
But a "hard exit on designation" is executed after the price gap.

8. The chart: you agree on the downside, so why buy above it?¶

You said, "We disagree about the upside, not the downside."

Then we both expect 100–101, and quite possibly 92–95, before November.
Your cost-of-waiting argument applies on earnings day, not over the next five weeks.
Buying a starter at 104–106 means paying 5–12% above the zone we both expect, and getting nothing for it.

At about $95, even your corrected value of $100–110 starts to pay, at +5% to +16%. That is where a buyer should start running the numbers, not here.

My call: SELL / AVOID BABA¶

Holders: reduce into 108–111. Don't carry a full position into the midterms and the earnings report.
Traders:
Sell rallies into 108–111.4.
Stop above 111.40, or above 114.44 for more room.
Targets: 100–101, then 92–95.
Close the position, or switch to defined risk, before the September-quarter report.
Would-be buyers: wait for one of two things:
a lower price (the 92–101 washout), or
real evidence (the level-based test in section 6).

Waiting for either costs nothing. Buying now gets you neither.

What would change my mind: 1. The September quarter meets the level-based test in section 6. 2. Confirmation that this is the Section 1260H list only, with no escalation through the midterms. 3. A daily close above 114.44 with OBV turning up. 4. The 10-year yield falling back below 5%. 5. A washout into the 92–101 zone, which changes the math even without new information.

My questions to the bull: 1. On your own probabilities, with "stuck" valued by your own method, BABA is worth $100–110. Why commit capital today to a zero-expected-return trade with a one-in-five chance of losing half, when a two-year Treasury pays 4.8%? 2. Your FY2023 precedent turns out to be a RMB 25B goodwill write-off. When has Alibaba ever reversed a cash spending surge of this size? Bear Analyst: # Bear Rebuttal: BABA. Your own numbers now say "wait for November."

The bull gave up a lot of ground this round:

He conceded Alibaba has never reversed a cash spending surge this large.
He accepted my $52–57 value for "stuck."
He admitted his starter at $105.70 is "below a Treasury on mine."

His case is now narrower and more honest: buy lower, use a stop, and let half the position wait for my test. That's progress.

But his expected-value table still has two errors, and both push the result the same way. Separately, his "consistent" cloud table gives away the AI argument. Once those are corrected:

At $105.70, tranche 1 loses to a Treasury on both sets of odds.
At about $98, the trade beats a Treasury only on his odds. Nearly all of that comes from the one scenario he admits Alibaba has never pulled off.
Waiting for the report costs him roughly nothing on his own odds and roughly doubles the return on mine.

† = public reporting, not our tools. Per-ADS figures use USD/CNY 6.70.

1. What I concede¶

Ant and the debt. You're right. Starting from operating income leaves out both interest income and interest expense. That values the treasury portfolio minus debt at zero; it doesn't count one side only. I withdraw the point.
Rates. My −9% applies only to a further 60 basis point rise. It remains a risk, not a cut to the base case.
China cloud share. Alibaba Cloud leads its home market. My section 4 is about the return on the next RMB 380B, not about market share.
Your expected-value arithmetic is correct as built. I disagree with two of the inputs.

2. Your first question: at about $98, am I a buyer?¶

No. Here is the corrected math.

Correction 1: the stop fills where the gap lands¶

We find out whether costs are "stuck" on earnings day, not through a slow drift.
Last round you argued that BABA moves high single digits to double digits on earnings days, and that "the results reprice the stock overnight." You used that for the upside. It works on the downside too. That's your own "one or the other" rule.
A daily-close stop at 91.99 sells at the next open after the gapped close. From about $98–100, a −12% print lands near $86–88, not $90.

Correction 2: the "halfway" scenario straddles your stop¶

Halfway is worth $92–102, and the bottom of that range is your stop.
With ATR at $3.11 and an earnings gap along the way, some halfway paths will close below 91.99 and exit near $90 before the stock recovers. For illustration, assume a third of them do.
That lowers the halfway exit from $97 to about $95.

The corrected table¶

Exit values: $134 / $115 / ~$95 / ~$86 / $80. I've applied your own 1–2 point haircut for false breaks in the good scenarios.

Expected 12–18 month return	From $105.70	From ~$98
Your odds (25/30/25/15/5)	~+1–2% (was +4%)	~+9–10% (was +12%)
My odds (15/25/35/20/5)	~−3 to −4% (was −1%)	~+3–4% (was +7%)
2-year Treasury, same period	+5–7%	+5–7%

Tranche 1 loses to a Treasury on both sets of odds. You already said so for yours. Cutting it from ¼ to ⅛ makes the mistake smaller. It's still a mistake.
At about $98 on my odds, it's still below a Treasury. That's my answer to your question.
On my odds, no entry price before the evidence works.
My probability-weighted exit is about $103. Yours is about $108–109.
Just matching a Treasury would mean buying near $96.
Earning even a modest risk premium would mean buying near $93, one dollar above your stop.

On my condition #5¶

You're holding me to it, and that's fair. I said a washout "changes the math even without new information." It does: on my odds, it moves the trade from about −1% to roughly even with a Treasury. That still isn't a buy.

What I'd act on is capitulation: RSI below 30, a volume spike, and OBV turning up. Those tell you the sellers are finished. A drift to $98 with OBV still falling, which is the technical report's base case, tells you nothing of the kind. At a real capitulation, I'd cover the tactical short and go neutral. A buy still needs the report.

"The gap between us is ⅛ of a position"¶

It isn't.

Before the report, your plan commits ⅛ + ⅛ + ¼ = half the position. It also tells holders to keep a full core position through the report.
Mine commits nothing.
The gap is half a position plus every existing holder.

3. Where your expected return comes from¶

Break the corrected ~$98 figures down by scenario:

On your odds, full reversal contributes about 9 of roughly 11 points. That's about 85% of the expected return.
On my odds, full reversal contributes about 5.5 points, and the other four scenarios together come to slightly negative. The entire return rests on that one scenario.

"Full reversal" means opex back at 25.8% of revenue. That was the FY2025 level, before Alibaba ran quick commerce at scale and before the AI build-out started depreciating.

You've conceded Alibaba has never reversed a cash surge this size. Yet you put 55% on "full reversal" plus "most of the way" (opex at 28%, which reverses about 76% of the spike), all within 12–18 months.

A truce would lower spending. It wouldn't return Alibaba to a world where its quick-commerce business barely existed.

4. Your second question: where does the drag come from, at a 9% cloud margin?¶

Yes, I accept November's cloud margin as the test¶

If the September quarter shows cloud growth of at least ~30% with an adjusted EBITA margin at or above ~9%, I drop the cloud depreciation drag.
Your group gross-margin test (at least ~39%) catches costs booked outside the cloud segment, such as training Qwen.
Together, those two tests settle this in November.

Until then, the average margin is not the incremental margin¶

The ~9% margin was earned on a capital base built before the AI plan.
Capex ran at roughly RMB 30B in FY2024†.
The plan runs at about RMB 127B a year†, roughly four times as much.
Your table charges the new RMB 104B of cloud revenue at the old depreciation rate.
On my earlier estimate, the plan's depreciation at full deployment is RMB 32–38B a year.
That equals about a third of the new revenue, before power, bandwidth and staff costs.
A 9% margin on top of that would require pricing power that China's cloud market hasn't shown.
China's cloud market has its own price war.
Alibaba cut Qwen API prices by up to 97% in 2024†, after ByteDance's aggressive pricing†.
Cheaper chips "flooding the market" also lower what customers pay, not just Alibaba's costs.

Read your own consistent table again¶

It shows RMB 380B of investment, about +9B of cloud profit, and about −10B of training compute. That nets to about zero operating income by FY2028.
That doesn't rebut the bear case on AI capex. It is the bear case on AI capex. In your best consistent framing, the build-out adds nothing to the earnings behind your target, while consuming about RMB 127B of cash a year.
In your opening, "Alibaba owns the whole AI stack" was the growth engine. In this round's table it's a wash. Your thesis now rests entirely on reversing the subsidies.

5. The law took effect, and the spending continued¶

Timing. FY2026 ran from April 2025 to March 2026. The revised Anti-Unfair Competition Law took effect on October 15, 2025, so five and a half months of FY2026 came after it.
The arithmetic.
Excess opex for the year was RMB 100.2B.
Public reporting put the September-2025 quarter's sales and marketing roughly RMB 35B above the prior year†.
Even if the peak quarter carried as much as RMB 40B of the year's excess, that leaves RMB 60–65B in the other three quarters. That's more than RMB 20B a quarter, including the two quarters after the law.
Either way, the cost is sticky.
If that excess is subsidies, the law didn't stop them.
If it's AI research spending, it's part of the arms race, and nobody in that race is cutting back.
Both policy signals you cite were followed by high spending: the July 2025 "anti-involution" priority and the new law.
Management has described instant commerce as a multi-year strategic push†, not a unit to fix or sell.

6. "You can't argue both that it bought nothing and that stopping is costly"¶

I can, because the spending is defensive. It didn't buy new gross profit; it protects the existing base.

The cost of stopping isn't the RMB 27.4B of new revenue. It's losing traffic share in the core business, where merchant fees (customer management revenue) carry the highest margins.
An illustration of the size:
China commerce produces most of the RMB 407.5B of gross profit.
Each 1% of total gross profit is about RMB 4B.
Losing 5% to Meituan and JD would cost about RMB 20B, a third of the RMB 54–67B you need to save.
This is a prisoner's dilemma, not a contradiction. Each player loses by spending, and each loses more by stopping alone.
Your own check of customer management revenue in the September quarter tests exactly this. That's another reason the report is the decision point.

7. Your tranche-3 test can pass on a print below your own break-even¶

Opex at or below 30% is above your break-even of 28.4–29.7%.
A 30% print is your halfway scenario, which your own table values at $92–102.
So your test could buy half the position on a print you value at or below today's price.
The threshold should be 29% or lower, or management guidance that quantifies a path into the high 20s.
"Operating cash flow covering a growing share of capex" is too easy.
Measured against FY2026's RMB 76B low point, it's the same "down from the worst quarter" test I flagged last round.
A level test that doesn't require the best case: quarterly free cash flow at or above zero.
My own table puts that at the halfway outcome. So it doesn't make you wait for the stock to re-rate. It confirms you're out of the "stuck" scenario.

8. What waiting actually costs¶

Compare two ways to own BABA:

Buy at about $98 before the report, using the corrected figures above.
Wait. Buy after a passing report, assuming a +10% gap to about $110. Hold Treasuries in every case where the test fails.

Expected 12–18 month return	Your odds	My odds
Buy at ~$98 before the report	~+9–10%	~+3–4%
Wait: buy at ~$110 after a pass, Treasury otherwise	~+9%	~+8%

How I got the waiting row: if the test passes, the probability-weighted value of the full and most-of-the-way scenarios is about $124 on your odds and about $122 on mine. From $110, that's +11–12%.

On your odds, waiting costs roughly nothing. On mine, it roughly doubles the return.
Waiting also removes the "stuck" and "halfway" losses. And it means buying after the Nov 3 midterms, once the window for the defense list to escalate has passed.
When we can't agree whose odds are right, pick the strategy that's about equal on yours and twice as good on mine.

9. The chart and the calendar¶

Nothing has changed since Oct 8:
All SuperTrend timeframes point down.
OBV is at a 60-day low.
There's a fresh MACD sell crossover below zero.
Your tranche 2a buys the gap fill at 99.7–101. That's the technical report's first breakdown target, and volume confirms the sellers are in control.
Tranches 2a and 2b will most likely fill in late October. That's just ahead of the densest run of event risk this year:
the late-October FOMC meeting;
the Nov 3 midterms, when the pledge not to strike Iran lapses;
Singles' Day on Nov 11;
earnings in mid-to-late November.

That means holding half a position, with only a daily-close stop, through three weeks of possible headline gaps.

My call: SELL / AVOID BABA. Buy the evidence, not the drift.¶

Holders:
Trim into 108–111.
If you keep a core position, size it so that a gap to about $80 is survivable. That's your own sizing assumption.
Hedge it through the report.
Traders:
Sell rallies into 108–111.4.
Stop above 111.40, or above 114.44 for more room.
Targets: 100–101, then 92–95.
Close the position or switch to defined risk before the report.
Cover early on capitulation: RSI below 30, a volume spike, and OBV turning up.
Would-be buyers: wait for the September quarter. The joint test:
Opex at ~29% of revenue or lower, or guidance that quantifies a path into the high 20s
Gross margin at ~39% or higher
Cloud growth of ~30% or more, with adjusted EBITA margin at ~9% or higher
Quarterly free cash flow at zero or better
Customer management revenue holding up, which would show quick commerce is defending the core

If it passes, I'm a buyer, even after the gap.

What would change my mind: 1. The joint test above. 2. Confirmation that this is the Section 1260H list only, with no escalation through the midterms. 3. A daily close above 114.44 with OBV turning up. 4. The 10-year yield falling back below 5%. 5. A capitulation low (not a drift) in 92–101. In that case I'd move to neutral.

My questions to the bull: 1. On your own odds, tranche 1 at $105.70 is below a Treasury. After correcting the stop fills, it's about +1–2%. Why buy any of it? 2. Your consistent cloud table says RMB 380B of AI investment nets about zero operating income by FY2028. And about 85% of your edge at $98 comes from full reversal, which you concede Alibaba has never achieved. What evidence available today puts that scenario at 25% instead of 15%? Bear Analyst: # Bear Rebuttal: BABA. With equal-sized gaps in both directions, waiting wins even on the bull's odds

The bull withdrew his starter tranche, dropped the 111.40 breakout trigger, accepted the 29% opex line and cut his full-reversal odds. On holders we now agree: trim into 108–111 and hedge the rest through the report. What's left between us is ⅜ of a position bought before the September quarter.

He says every number in his case comes from my exit values and my Treasury hurdle. One doesn't: the size of the jump on a passing report. He supplied that one, and it decides the result. It also contradicts the drop he assumes on a "stuck" report. Once the two match:

Tranche A (97–99) loses to waiting on his own odds.
Tranche B (92–96) roughly ties waiting on his odds at realistic reaction sizes, and loses on mine at every size.
His replacement cash-flow test would pass a quarter in which spending hasn't improved since March.

† = public reporting, not our tools. Per-ADS figures use USD/CNY 6.70.

1. What I concede¶

Waiting doesn't avoid escalation risk. The EO 13959 timing point stands, so I drop it as an advantage of waiting. Moving escalation risk into the waiting rows costs them under half a point. The tables below don't change.
Test misfires cost the waiter. True. They also cost your tranche C, which puts ⅝ of your capital on the same test.
My "$93" line was too generous. I used exit values built for a $98 entry. At $93, a stuck print fills the stop lower. I'm applying the same correction to myself that I applied to you.
September free cash flow is seasonal. Zero isn't automatic in a September quarter. Section 4 explains why it's still about the right line, and where I'll meet you.
The ~9% cloud margin was earned after about a year of plan-pace capex. Partly granted. November settles the rest.

2. Your question: "Why would the market leave that much on the table?"¶

Your own table leaves money on the table, on the downside.

In a stuck scenario the stock is worth $52–57.
From a $94 entry, your table fills the stop at $84. That's a −12% day against news that cuts value by about 40%.
So the market prices about 30% of the bad news on day one and leaves roughly $30 a share unpriced.
On a pass, you need it to price about 70% of the good news (+20%).

That's your own "one or the other" rule. Pick one reaction share and apply it both ways.

Why the reaction is partial in both directions: - One quarter doesn't settle a 12–18 month scenario. A 29% opex print in September tells you about September. - The December quarter carries Singles' Day promotions, and depreciation from the build-out is still arriving. - The market prices a higher probability of the good scenarios, not certainty. - Your misfire point says the test can pass a halfway quarter. The market knows that too, which argues for a smaller jump on a pass.

What the evidence says about reaction size: - You cited high-single to double-digit earnings-day moves. - Your own stuck assumption was −12%. - The likely June-quarter print (section 5) was −8.6%.

All of that points to the first row below.

Expected 12–18 month return, with the same reaction share in both directions:

Day-one reaction (share of value gap priced)	Pass: price after report	Stuck: where the stop fills	Your odds: buy ~$94 / wait	My odds: buy ~$94 / wait
~35% (BABA's usual ~10% earnings move)	+10% → ~$104	−15% → ~$80	~+11.5% / ~+12%	~+6% / ~+10.5%
~50%	+15% → ~$108	−21% → ~$74	~+10.5% / ~+10%	~+5% / ~+9%
~70% (your +20% case)	+21% → ~$114	−29% → ~$66	~+9% / ~+6.5%	~+3% / ~+6.5%
2-year Treasury			+5–7%	+5–7%

Other exits are yours: $134 / $115 / ~$93 halfway. Escalation is a −20% gap from entry (~$75). Buy rows include a 1.5-point false-break haircut. "Wait" means buy after a pass and hold Treasuries otherwise.

What the table shows:

At realistic reaction sizes (rows 1–2), waiting ties on your odds and wins by about 4 points on mine. Your own rule, "about equal on one set of odds and better on the other," picks waiting.
Only at 70% does buying win on your odds, by about 2.5 points. On mine, waiting still wins by about 3.5.
Buying on my odds never clears a Treasury in any row. Waiting never falls below one.

3. Your question: at a washout, am I a buyer? No.¶

At about $94 with gaps that match in both directions, my odds give +3% to +6%. That's a Treasury at best.
That's before the hedge. You said the put spread "could eat most of B's premium" on my odds. Hedged, it's below a Treasury.
On my odds, a pre-report buy only ties waiting at around $88–90. That's below your stop.
What a capitulation does change: I cover the tactical short and go flat. That's a move from sell to neutral. A buy still needs the report.

Tranche A fails on your own odds. At $98 with the ~35% reaction:

	Buy at $98	Wait
Your odds	~+8%	~+10.5%
My odds	~+3%	~+9.5%

You wrote "skip it if you hold the bear's odds." Corrected, you should skip it on yours too.

4. The cash-flow test: zero is the break-even line for this quarter¶

Your arithmetic spreads the annual break-even cut evenly over four quarters, then compares one quarter of it to the peak quarter. That mixes two bases.

Using numbers you've already accepted: - The September-2025 quarter carried RMB 35–40B of excess spending. - Break-even is RMB 8–11B of excess per quarter. - So a break-even September-2026 quarter spends RMB 24–32B less than its comparison quarter, not 13.5–17B less.

What that does to free cash flow: - At flat capex, the RMB 22B outflow becomes roughly +2 to +10B before tax. - If a fifth of the saving goes to tax, it's about −3 to +4B.

Your −7B line is calibrated to the wrong thing. - It implies only about a RMB 15B improvement. - That leaves excess spending at about RMB 20–25B a quarter, which is the post-law pace you already described. - Your opex line would catch that particular quarter. But then the cash line does no work. A cash test exists to catch a quarter where opex passes and cash doesn't. Calibrated to an opex pass, it belongs near zero.

I'll meet you at a free cash outflow no worse than about RMB 3B, adjusted for capex.

5. Your odds: the last quarter the market saw was sold hard¶

Our tools don't carry the June-2026 quarter or its date. Alibaba usually reports its June quarter in mid-to-late August†.

On Aug 21 the stock fell 8.6% (130.53 → 119.34) on 32.55M shares. That was one of the heaviest volume days since July, and the stock has made lower highs ever since.

If that was the print (an inference): - The latest look at the spending trend was sold hard. - That makes it hard to put 55% on reversing at least 76% of the spike within 12–18 months. - It also gives a day-one move of about 9%, which is row 1 of my table.

If it wasn't the print, something else of that size hit during the reporting window, and neither of us knows what.

On the truce: - Repeated play supports a spending equilibrium as easily as a truce. What tips it is whether breaking ranks pays. JD entered food delivery in 2025 with heavy subsidies to take share†. - The "enforcer" doesn't cover this. As you described it, the law bars platforms from forcing merchants to sell below cost. Subsidies Alibaba pays for itself aren't that. On your own accepted numbers, both quarters after the law ran over RMB 20B of excess. - Meituan's record loss didn't produce a truce. By your numbers, Alibaba kept spending over RMB 20B of excess a quarter for two more quarters.

6. AI value¶

You're not adding cloud value to your tables, so it doesn't change the trade.
On "2x revenue": the plan reinvests about RMB 127B a year against roughly RMB 150B of cloud revenue. Your own table shows that spending adding about zero operating income by FY2028. A shareholder can't collect a revenue multiple on that.
On the 9% margin: depreciation starts when assets go into service, not when cash is spent. Data centers under construction don't depreciate yet. I've already agreed November's cloud margin settles this.

7. The chart¶

Nothing has changed since Oct 8: - All SuperTrend timeframes point down. - OBV is at a 60-day low. - There's a fresh MACD sell crossover below zero.

Today's close decides whether the weekly count holds at 7.

My call: SELL / AVOID BABA. Buy the evidence, not the washout.¶

Holders: trim into 108–111 and hedge the rest through the report. We agree on this.
Traders:
Sell rallies into 108–111.4.
Stop above 111.40, or above 114.44 for more room.
Targets: 100–101, then 92–95.
Cover on capitulation: RSI below 30, a volume spike, OBV turning up.
Close the position, or switch to defined risk, before the report.
Would-be buyers: wait for the joint test:
Opex at ~29% of revenue or lower
Gross margin at ~39% or higher
Cloud growth of ~30% or more, with adjusted EBITA margin at ~9% or higher
Free cash outflow no worse than ~RMB 3B, adjusted for capex
Customer management revenue holding up

If it passes, I buy, even after the jump.

What would change my mind: 1. The joint test passes. 2. Confirmation that this is the Section 1260H list only, with no escalation through the midterms. 3. A daily close above 114.44 with OBV turning up. 4. The 10-year yield falling back below 5%. 5. A capitulation low, which takes me to neutral.

My questions to the bull: 1. On a stuck print, your table closes the stock at $84 against a $52–57 value, leaving $30 unpriced. On a pass, you need it to leave almost nothing. Pick one reaction size and run it in both directions. Which row of my table are you in? 2. Tranche A loses to waiting on your own odds once the gaps match (~+8% vs ~+10.5%). What is it for? Bear Analyst: # Bear Rebuttal: BABA. Your table lets our test misread a quarter but never lets the market misread one

The bull has withdrawn tranche A, accepted a 35% reaction in both directions, cut his good-scenario odds to 50%, and moved tranche B down to a true capitulation at or below $93. Three things are still in dispute:

⅛ of a position bought at a capitulation
the design of the test that governs the other ⅞
10 points of probability

His misfire point is the best argument he's made, and I accept it. My test can fail a good quarter, so my "wait" rows were overstated. But he has again applied the noise to only one side. His buy row assumes the market reads every good-scenario quarter correctly on report day. Only our test is allowed to make mistakes. Once the market can misread a quarter too:

Tranche B's stop sits inside a single earnings-day move. It is about one ATR below entry.
Waiting beats tranche B on his own odds once the market sells about 3 in 10 of the good quarters our test would fail. On my odds, waiting wins at any share.
The false negatives that actually cost the waiter can be fixed in the test design. That is his second question, and my answer is yes, with the slack placed elsewhere.

† = public reporting, not our tools. Per-ADS figures use USD/CNY 6.70.

1. What I concede¶

My test has false negatives, so my "wait" rows were overstated. For my original five-of-five test, your ~25% estimate is fair.
Your misfire table is right as built. At $92 on your odds, buying leads, about +12 versus +10.5.
An opex gate plus 3 of 4 is a better structure than five of five. Section 4 covers where the slack should go.
A cloud-margin miss gets half of C on the report and half after December. Accepted.
Dropping the hedge on an ⅛ position sized for a gap to $74 is reasonable.

2. Your question 1: the false-negative rate, and the side you left out¶

My answer: above zero. About 25% for my original test, and about 10–15% for the amended version in section 4.

Now I'll turn your rule around. If one seasonal quarter is too noisy for our test to classify perfectly, it is too noisy for the market to classify perfectly. Your two rows treat these differently:

Your buy row gives every good scenario its full $115–134 exit, less the 1.5-point haircut. That describes a market that never sells a good quarter on report day.
Your wait row charges the waiter for every good quarter our test misreads.

A good quarter that misses one of our lines either looks bad to the market or it doesn't.

If it doesn't, the waiter misses the move. That's the case you priced.
If it does, BABA gaps about 8–10%, its usual earnings move. Tranche B's stop is a close below the washout-day low, roughly one ATR under a $92 entry. An 8% gap is more than two ATRs. The buyer is out near $85 in a scenario worth $115–134. Meanwhile the waiter is in Treasuries and gets a cheaper entry once the December quarter confirms the good scenario.

You called this uncommon. Two reasons it isn't:

By your own estimate, a quarter of good-scenario quarters miss at least one line. The lines the sell side grades hardest, merchant fees (CMR) and cloud margin, are among them. You're right that the market isn't grading against our thresholds. That is why, for B, what matters is the market's reading, not our test's.
By your own odds, the market may already have done this once this year. You now accept that Aug 21 was probably the June print, and after it you still put 50% on a good scenario. In that half, the market sold a quarter from a good-scenario path by 8.6%.

Here is the table at $92. I hold everything of yours fixed: your odds, exits, 35% reaction, 25% false-negative and 10% false-positive rates, and the 1.5-point haircut. I change one input: the share of test-failing good quarters that the market also sells.

Share of test-failing good quarters the market sells (~−8%)	Your odds: buy at $92 / wait	My odds: buy at $92 / wait
None (your table)	~+12 / ~+10.5	~+8 / ~+9
30%	~+11 / ~+11 (tie)	~+7 / ~+9.5
50%	~+10 / ~+11	~+6 / ~+9.5
2-year Treasury	+5–7%	+5–7%

Assumptions behind the table: - A good-scenario buyer who is stopped out exits near $85 (−8%). - A waiter facing a market-sold false negative buys after December at about $105, against a value near $123 (+17%), plus about 1.5 points of Treasury income while waiting. A 35% reaction from $85 would put the entry nearer $98, so $105 favors you. - I kept your 1.5-point haircut unchanged, even though B's stop is about half as far from entry as the stop that haircut was set for. - Not included: with the tighter stop, more halfway paths also get stopped out. That would lower the buy rows further.

What the table shows:

The crossover is about 30%. Below that, B slightly beats waiting on your odds. Above it, waiting wins on both sets of odds.
On my odds, waiting wins at every share.
The stakes are small. Even on your best row, B adds about a quarter of a point to the whole plan (roughly 2 points × ⅛). The test governs ⅞, which is why your second question matters more.

3. Which false negatives actually cost the waiter¶

A false negative costs the waiter only when the market reads that quarter as good. Here are your three noise sources, sorted by that:

Your noise source	How the market likely reads it	Cost to the waiter
A "most of the way" path printing opex at 29.5%	As good news against ~35% a year earlier. Your own point.	Costly: the waiter misses the move
Cloud margin dipping on depreciation, with growth ≥30% and opex falling	Plausibly good	Costly
A cash or CMR miss	CMR is the line the market grades hardest. A quarter where merchant fees weaken gets sold.	Cheap for the waiter, who re-enters lower. A stop-out for B.

So the fix is to add release valves on the first two and keep the last two as hard requirements. That is my answer to your second question.

4. Your question 2: opex gate plus 3 of 4? Yes, but the allowed miss is gross margin or cloud, not cash or CMR¶

My amended test:

Check	Status	How it handles your noise
Opex ≤29% of revenue, or quantified guidance into the high 20s	Hard gate	The guidance clause covers a 29.5% print on a good path
Free cash outflow no worse than ~RMB 3B, capex-adjusted	Required	Calibrated against the same quarter a year ago, so seasonality is built in. Or use the swap below.
CMR holding up	Required	Why it stays hard is below
Gross margin ≥39%	One of these two may miss	A miss means half of C on the report, half after December
Cloud growth ≥30%, adjusted EBITA margin ≥9%	One of these two may miss	Your half-now, half-December rule

Why cash can't be the miss¶

It catches the trap you already conceded. Your FY2023 "cost cut" turned out to be an impairment rolling off. An opex ratio can fall without cash spending falling. You showed that FY2026's excess was cash: operating income fell RMB 90.7B and operating cash flow fell RMB 87.3B. A real cut shows up in cash. An accounting improvement doesn't.
Your give-back argument applies to both lines.
You loosened the cash line to −7 to +2B by counting about RMB 2.4B a quarter of gross profit lost when subsidies are cut.
But your break-even opex range of 28.4–29.7% assumed gross profit stays flat.
Quarterly revenue is about RMB 256B, so RMB 2.4B is roughly one point.
With your own give-back included, break-even opex falls to about 27.5–28.8%. A 29% print then sits above break-even, on the way to your halfway case.

One pair or the other: - No give-back: cash at −3B, opex at 29%. - Your give-back: cash at −7B, opex at 28%.

I'll accept either pair. I won't accept −7B combined with 29%.

Why CMR can't be the miss¶

Your break-even math holds revenue flat, and CMR is the only check on that assumption.
You wrote that November's CMR "tests whether the 20B is real." If CMR misses, the answer is yes, it's real, and the break-even moves again.
Opex falling while CMR weakens is the prisoner's dilemma paying out within a single quarter.

In your version, ⅞ of the capital rests on one noisy line¶

A halfway quarter passes gross margin and cloud anyway. Those checks test depreciation, not subsidies.
It also passes CMR anyway, because in the halfway case subsidies are still flowing to protect traffic.
With cash optional, the opex print is the only subsidy check standing between ⅞ of your money and a halfway quarter. That is the same line you just argued is too noisy to trust in one quarter.

False-negative rate for this test: about 10–15%¶

Your first two noise sources now have release valves.
What remains are cash and CMR misses, which are the kind the market tends to sell.
Rerun at $92, with 15% false negatives and half of them sold:
On your odds: wait about +11.5 versus buy about +10.
On my odds: wait about +10 versus buy about +6.

5. You asked for my trigger to move to your odds. Here it is.¶

Before the report, any one of these moves 5 points from halfway or stuck into the good scenarios:

Alibaba states, at Singles' Day or any investor event, that quick-commerce losses have narrowed by a third or more from the September-2025 peak.
JD or Meituan reports a material cut in food-delivery or instant-retail subsidies in their September-quarter results, which usually come out in November†.
Regulators issue a measure that explicitly covers subsidies paid by the platforms themselves, not just merchant below-cost pricing.

After the report: if it passes the section 4 test, I move to your odds and buy C.

Why I haven't moved since round 2: the evidence since then has pointed the other way: - your three truce concessions; - the probable June-quarter print; - seven weeks of distribution, covered next.

6. The tape: positioning explains one day, not seven weeks¶

OBV went from +92.8M on Aug 20 to −10.45M on Oct 8. That is about 103M shares of net down volume, while price fell 19% (130.53 to 105.70).
Highs keep getting lower: 130.62, then 120.40, then 111.40.
The 50-day SMA turned down on Sep 22, and the 200-day is falling about 4.7 points a month.
If Aug 21 were only a crowded long position unwinding, the unwind would be over by now. OBV wouldn't still be falling, seven weeks later, to a 60-day low.
B's trigger hasn't fired at any point in this decline. RSI's low since mid-September is 33.73, so there has been no capitulation. The technical base case is a drift lower. If B never fills, your live plan is the same as mine: ⅞ waits for the report.

7. On the remaining ⅛¶

If B fills, treat it as a trade, not a position.

Take the bounce from the capitulation into the July gap (about 100–105).
Be flat before the report. That's the same rule I apply to my own tactical short.

This removes section 2's report-day stop problem entirely and leaves the report to C, where the test sits. I still wouldn't take that side; at a capitulation, I cover and go flat. But this version of B doesn't have the problem my table describes.

My call: SELL / AVOID BABA. Buy the evidence, and design the test so the evidence can actually arrive.¶

Holders: - Trim into 108–111. - Hedge the remaining core position through the report, sized so a gap to about $80 is survivable. We agree on this.

Traders: - Sell rallies into 108–111.4. - Stop above 111.40, or above 114.44 for more room. - Targets: 100–101, then 92–95. - Cover on capitulation. - Be flat, or switch to defined risk, before the report.

Would-be buyers, using the section 4 test: - Full pass: buy. - Gross margin or cloud is the only miss: half on the report, half after December. - Cash or CMR misses: wait for the December quarter.

What would change my mind: 1. The section 4 test passes. 2. Any of the three pre-report triggers in section 5. Each moves me 5 points. 3. Confirmation that this is the Section 1260H list only, with no escalation through the midterms. 4. A daily close above 114.44 with OBV turning up. 5. The 10-year yield falling back below 5%. 6. A capitulation low in 92–101, which takes me to neutral.

My questions to the bull:

In your buy row, what share of the good quarters our test would fail does the market also sell on report day?
Above about 30%, waiting beats tranche B on your own odds.
If you say zero, then why did the market sell a quarter by 8.6% when you give it a 50% chance of being on a good path?
Which pair do you take: (cash −3B, opex 29%) or (cash −7B, opex 28%)?
And if neither cash nor CMR is required, which check in your version keeps ⅞ of your capital from buying a halfway quarter that happens to print 29%?

Research Manager¶

Recommendation: Underweight

Rationale: Here is where I landed after six rounds. The bull's foundational point is real. FY2026 operating income fell from RMB 140.9B to RMB 50.2B, but the revenue and gross lines held up: revenue passed RMB 1T, gross profit hit a record RMB 407.5B, and gross margin was 39.8% versus 40.0%. The damage came from a roughly RMB 100B opex spike, with opex going from 25-26% of revenue for three years to 34.9%, driven by quick-commerce subsidies and the AI and cloud build-out. If that spend normalizes, BABA is a mid-teens multiple on core earnings plus about $11 per ADS for Ant. The balance sheet (RMB 1.06T of equity, liabilities 0.74x equity) is not distressed. That is why this is not a Sell. On price and timing, though, the bear won nearly every contested point. (1) The only earnings that actually exist put BABA at about 41x core; every cheaper multiple is a hypothesis. (2) The bull's FY2023 cost-cut precedent turned out to be a roughly RMB 25B goodwill impairment rolling off, and he conceded Alibaba has never reversed a cash surge this large. The FY2026 spike was real cash: operating income fell RMB 90.7B and operating cash flow fell RMB 87.3B. (3) On the bull's own accepted arithmetic, excess spend kept running above RMB 20B a quarter after the October 2025 competition law. The probable June-quarter print (Aug 21, down 8.6% on heavy volume) was sold hard. (4) Break-even opex is 28.4-29.7% of revenue before any gross-profit give-back and about 27.5-28.8% after it, so most of the spike has to reverse while AI depreciation lands. Free cash flow is likely negative: operating cash flow was RMB 76B, down 53%, the current ratio fell from 1.79 to 1.28, and buybacks are slowing. (5) Once stop fills were corrected for earnings-day gaps, the bull withdrew every tranche at or near today's price. On his own odds, $105.70 earns roughly 1-2% over 12-18 months, and it is negative on the bear's odds, against about 4.8% from a 2-year Treasury. (6) The chart agrees. Every SuperTrend timeframe points down. OBV fell from +92.8M on Aug 20 to -10.45M. Highs keep stepping lower (130.62, 120.40, 111.40). Oct 8 was rejected at the 20-day average on the heaviest volume since Sep 23, and there has been no capitulation (the RSI low is 33.73). On top of that sit an unconfirmed US defense-list designation, a lawsuit we know nothing about, the Nov 3 midterms, and a 10-year yield at 5.28%. The convergence is telling: both sides now say no new money at $105.70, trim into 108-111, hedge any core through the report, and let the September quarter decide. On the remaining dispute over the test, I side with the bear. Cash flow and customer management revenue must be hard requirements, because an opex print alone cannot tell a halfway quarter at 29% from a real reversal. A cash check is what catches another improvement that is accounting rather than cash. Why Underweight and not Sell: the bear's edge is about price and timing, not a broken franchise. The good-scenario odds (40-50% between the two sides) are real, and being fully out into a report that can gap 10% or more gives up hedged optionality. Why not Hold: both sides' math says today's price does not pay for the tail risk, and the chart still shows distribution. Gaps in our data: details of the June-2026 quarter (Aug 21 is inferred), consensus expectations for September, which defense list applies, a capex breakdown, and option prices for the hedge.

Strategic Actions: (1) Target weight: about 50% of a standard BABA allocation going into the September-quarter report, expected mid-to-late November. Make the trims into strength at 108-111.4, which is the Oct 8 rejection and 20-day zone up to the 111.40 lower high. Time stop: if 108 is not reached by Oct 30, trim to at least 60% of standard on any bounce, and complete that no later than Oct 30, ahead of the Nov 3 midterms. (2) No new buying at 104-106. Do not average down into the 99.7-101 gap fill or a slow drift to 92-96; both sides showed those entries trail waiting. (3) Hedge the remaining core through the report, for example a put spread of roughly long 100 / short 80 expiring after the report. Our data has no option prices, so if the hedge is too expensive, size the core so a gap to about $80 (roughly -24%, about 8 ATR at $3.11) fits the risk budget. (4) Hard exit of the whole position on any Treasury investment-ban designation, regardless of price. If there is a daily close below 91.99 (the 2026 low) without a capitulation signature, cut the core to about 25% of standard. (5) Optional capitulation trade, at most ⅛ of standard. Enter only at or below about $93, and only with all four signals: RSI below 30, a volume spike, OBV turning up, and a close off the lows. Stop on a daily close below the washout-day low. Target 100-105. Be flat before the report. Desks with a tactical mandate can sell rallies at 108-111.4 with a stop above 111.40 (or 114.44 for more room), targeting 100-101 and then 92-95. Cover on capitulation, and be flat or in defined-risk positions before the report. (6) September-quarter test. Hard gate: opex at or below 29% of revenue, or quantified guidance into the high 20s; if you use the looser -RMB 7B cash line below, the gate tightens to 28%. Required: free cash outflow no worse than about RMB 3B, adjusted for capex against the year-ago quarter, and customer management revenue holding its recent growth. Allowed: at most one miss between gross margin of 39% or higher and cloud growth of 30% or more with adjusted EBITA margin of 9% or higher. Outcomes: (a) Full pass: rebuild to 100% of standard on the report even after a gap, and move to Overweight (110-125%) once the December quarter confirms. (b) Gross margin or cloud is the only miss: go to about 75% on the report and the rest after December. © Cash or customer management revenue misses: hold about 50% and reassess after the December quarter. (d) Opex above 31% with no quantified guidance: move to Sell and exit the remainder. (7) Pre-report reasons to stop trimming or lift toward about 75% of standard: Alibaba says quick-commerce losses have narrowed by a third or more from the September-2025 peak; JD or Meituan report material subsidy cuts; regulators explicitly cover subsidies the platforms pay themselves; confirmation the listing is Section 1260H only, with no escalation through the midterms; a daily close above 114.44 with OBV rising; or the 10-year yield back below 5%. (8) Upside targets if the thesis turns: 114-116, then 129-133. Fair value of $127-141 applies only if opex returns near FY2025 levels.

III. Trading Team Plan¶

Trader¶

Action: Sell

Reasoning: The research plan is Underweight, which maps to a Sell executed as a trim into strength rather than a full exit. Only existing earnings put BABA at about 41x core, the FY2026 opex spike (34.9% of revenue) was real cash with free cash flow likely negative, and the risk-reward at 105.70 roughly matches or trails a 4.8% Treasury. The tape agrees: all SuperTrend timeframes point down, the moving averages are fully bearish, OBV is at a 60-day low (-10.45M), highs keep stepping lower (130.62, 120.40, 111.40), and the Oct 8 rejection at the 20-day SMA came on the heaviest volume since Sep 23. This is not a full exit because the balance sheet is sound, the weekly TD count is at 7 of 9 with an unconfirmed RSI/MACD divergence, and the September-quarter report (opex at or below 29%, a cash check, customer management revenue) could re-rate the stock, so a hedged core should stay through the print.

Entry Price: 109.5

Stop Loss: 112.0

Position Sizing: Cut to about 50% of a standard BABA allocation before the mid-to-late November report. Trim into 108-111.4, with 109.5 as the primary level at the 20-day SMA. Time stop: if 108 is not reached by Oct 30, cut to at most 60% of standard on any bounce before the Nov 3 midterms. Do not add at 104-106 or into the 99.7-101 gap. Hedge the remaining core with a roughly 100/80 put spread expiring after the report; option prices are not in our data, so if the hedge is unavailable, size the core so a gap to about 80 (about 8 ATR at 3.11) fits the risk budget. Exit fully on any Treasury investment-ban designation, and cut to about 25% on a daily close below 91.99 without a capitulation signature. For tactical shorts: keep size small (stop distance about 2.5, or 0.8 ATR), stop on a daily close above 111.40 (112.0 level), targets 100-101 then 92-95, and be flat or in defined-risk positions before the report. Rebuild toward 75-100% only if the September-quarter gates pass or the stock closes above 114.44 with OBV rising.

FINAL TRANSACTION PROPOSAL: SELL

IV. Risk Management Team Decision¶

Aggressive Analyst¶

Aggressive Analyst: Let me open, since neither colleague has spoken yet. I'll also get ahead of the arguments I expect from both of them.

I'm the aggressive voice here, and I'm backing a Sell. That may sound backwards, but in this setup the passive choice is the risky one. Holding a full BABA position and hoping is passive. Dumping everything at 105.70 and hiding in Treasuries is also passive. This plan takes the high-reward route: harvest the downtrend, keep a hedged option on the November re-rating, and stay ready to rebuild size the moment the evidence turns.

The tactical short. Enter at 109.5, right where the Oct 8 rally died at 109.39 against the 20-day SMA at 109.51, with a stop at 112. That risks 2.5 points, about 0.8 ATR.

First target is 100 to 101. That's roughly a 9-point gain, about 3.6 times the risk.
Second target is 92 to 95, the 2026 low zone. That's 14.5 to 17.5 points, or 6 to 7 times the risk.

That's the kind of asymmetry I'm paid to chase, and the tape supports it:

Every SuperTrend timeframe points down.
The moving averages are stacked fully bearish.
Each high is lower than the last: 130.62, then 120.40, then 111.40.
OBV is at a 60-day low of minus 10.45 million, down about 75 million in twelve sessions while price barely moved. Volume is concentrated on down days.
Sellers have sold both recent gap-up opens, Sep 22 and Oct 8. The Oct 8 sell-off came on 11.56 million shares, the heaviest since Sep 23.
The 50-day SMA will keep falling as the 122 to 129 August closes drop out of its window. The ceiling is coming down toward the price, which tightens the short's risk over time.

To the conservative side. I expect you to say that with a defense-list designation, a lawsuit, a 10-year at 5.28%, a Fed hike, negative free cash flow and the Nov 3 midterms, we should simply get out. Here's why that gives up the best part of this setup.

The FY2026 damage was below the gross line. Gross margin held at 39.8% while operating expenses jumped to 34.9% of revenue. That looks like a spending choice, and spending choices can be reversed. Each point of opex is worth about RMB 10 billion of operating income.

If the September quarter shows opex back near 29%, operating income goes from about RMB 50 billion to roughly RMB 110 billion. That more than doubles core earnings in one print. Exiting fully hands that upside to someone else.

Your tail-risk worries are already priced into the plan:

We exit completely on any Treasury investment-ban designation.
We cut to 25% on a close below 91.99 without a capitulation signal.
The 100/80 put spread covers the gap scenario.
If the hedge can't be bought, we size the core so a drop to 80, about 8 ATR, fits the risk budget.

That's defined risk with open upside, which is exactly what a disciplined aggressive book looks for.

To the neutral side. I expect you to say we're selling at the lows. You'll point to price near the lower Bollinger Band at 103.78, the RSI and MACD divergence, the weekly TD count at 7 of 9, Jefferies' Buy rating, and a GAAP P/E around 16 times. Each of those has a problem.

The trim isn't at the lows. The plan sells into strength at 108 to 111.4, not at 105.70. That's about 3.6% better than today's print. If 108 doesn't come by Oct 30, the time stop handles it.
The divergence is unconfirmed. The price lows are only 1.5% apart, and OBV argues against it.
TD 7 is not TD 9. The earliest a completed weekly 9 can print is the week of Oct 19 to 23. If it arrives near 95 to 100 with momentum still improving, that's a much better entry than paying 105 now.
The P/E is misleading. About half of FY2026 net income was non-operating. On core earnings, BABA trades around 41 times.
The risk-free rate is real competition. The 2-year pays roughly 4.8%, and real yields are 2.92%. Dead money in BABA is the real opportunity cost.
Jefferies' 50%-plus cloud growth is a FY2028 forecast. It isn't a reason to own full size through tax-loss season and a midterm headline cycle.

The rebuild trigger is part of the bold case. Get back to 75 to 100% the moment the September-quarter gates pass, or on a close above 114.44 with OBV rising. Paying a few points more for confirmation buys a much higher probability of being right. Meanwhile, the VIX sits at 15 while yields are at 2002 highs and Brent is above 125. If that complacency breaks, high-beta China names fall hardest, and the short book and put spread get paid.

This plan earns money in the most likely scenario, the continued downtrend. It keeps a hedged stake in the scenario with the most upside, the margin re-rating. And it cuts the scenario that could wipe you out, a formal investment ban.

Whatever your current BABA weight is, cut toward half into 109.5, hedge the rest, and run the short with discipline. That's the best risk-reward on the board. Aggressive Analyst: Aggressive Analyst: All three of us now agree on a Sell, done as a trim, with a hedged core carried through the September-quarter print. What's left to argue is how much upside we give away for comfort. I'll concede where you're both right, then push back where caution is costing real money.

My concessions first. Neutral, you're right that 41 times core earnings is the bear bound, not the estimate. Interest income on the investment book is real and recurring, so core earnings sit somewhere between about $2.40 and $6.15 per ADS. At the midpoint that's roughly 25 times, on a stock trading around 1.7 times book. That helps my case for keeping a real core. You're also right that my Oct 30 time stop left too much exposure into the FOMC, so I'll take the Oct 23 deadline. And I'll drop the capitulation exception on the 25% cut. Aggressive shouldn't mean leaving myself excuses.

Now the short. Conservative, you measured risk to 114.44, but the stop is a daily close above 111.40. Neutral got this right: a realistic fill on a bad day is 113 to 114, so call it four points. Against a nine-point first target that's about 2.25 to 1, and against the 92 to 95 zone it's 3.6 to 4.4 to 1. Even on your five-point number, the second target is still about 3 to 1. Neutral's own conclusion was that the trade pays if it works about a third of the time. Every SuperTrend points down, OBV is at a 60-day low, and every high is lower than the last. I'll take a one-in-three hurdle in that tape.

Your gap argument actually cuts my way. The "Alibaba Jumps 4%" headline is from this same week, and the stock is sitting at 105.70. Gap-up opens here get sold. On Sep 22 the stock opened at 120.15, closed at 116.31, and dropped 4.7% the next day. On Oct 8 it opened above the prior close, ran into the 20-day at 109.39, and closed in the bottom fifth of its range on the heaviest volume since Sep 23. The stop triggers on a close, and gap days here have been closing near the lows.

The stimulus squeeze story appears in exactly one StockTwits post and zero headlines. Neutral also pointed out this isn't a crowded short: RSI never reached 30 and retail is mildly bullish. Squeezes need crowded shorts as fuel, and there aren't any.

You also said the setup argues against shorting: the lower band, the top of the gap, TD 7, the divergence. But nobody is shorting 105.70. The entry is 109.5, and it only fills if the bounce you're predicting actually happens. Your counter-trend scenario is my entry condition. If it reaches 109.5, I sell into the falling 20-day where the last rally died. If it closes above 111.40, the lower-high pattern is broken and I'm out with a defined loss.

On "three positions doing the work of one," that's fair for anyone already holding the stock. We don't know the caller's book, so here are two versions. If you hold BABA, sell an extra slice at 109.5. Buy it back at 100 to 101, on a close above 111.40, or before the print, whichever comes first. Same asymmetry, no borrow cost, no unlimited upside. If you're flat, run the short sized to a four-point loss, roughly 60% of what the 2.5-point stop implied. Either way, the trade exists.

Conservative, here's the contradiction I can't let go. You listed reasons the next six weeks are dangerous for this stock: tax-loss season, a hawkish FOMC, the 10-year at a 2002 high, the midterms, list risk, the Iran pledge expiring. Then you told us to skip the one position that profits from that list. You can't call October a minefield for longs and refuse to get paid for it.

On the opex case, I accept that 29% in one quarter is the full-success outcome. I don't need it. Each point of opex is worth about RMB 10 billion. A three-point improvement takes operating margin from 4.9% to roughly 7.9%, and operating income from about RMB 50 billion to about 81 billion. That's roughly 60% more core earnings without anything heroic.

Look at the shape of the spike. Opex ran 25 to 26% of revenue for three straight years, then jumped nine points in one. That line includes amortization and possible impairments, which don't recur the same way. Meanwhile gross margin held at 39.8%. For a cloud business, most data-center depreciation typically lands in cost of revenue, and that line didn't break. The damage is concentrated below the gross line, where subsidies live. A three-way subsidy war is expensive for everyone in it, and that pressure pushes toward rationalization. I can't prove the timing from our data, which is exactly why the core is hedged.

On rivals arming up, Moonshot has been reported as an Alibaba investment. A raise at $50 billion marks up an asset Alibaba owns. Record Hong Kong AI fundraising shows investors paying up for what Alibaba already has: a hyperscale cloud, the leading Chinese open-source model, and an in-house chip that cuts exposure to export controls. Some of the money those rivals raise gets spent renting compute, and Alibaba is one of the few places in China to rent it.

On cash, yes, operating cash flow halved and free cash flow was probably negative. But this company has RMB 1.06 trillion of equity, liabilities at 0.74 times equity, and a reported cash figure that excludes a large book of short-term investments. That's a self-funded build-out, not a balance sheet in trouble. It's a reason to hedge, not a reason to sell at the lower band.

The hedge is where the math most favors my side. Conservative wants 30 to 35% unhedged, and Neutral wants 40% unhedged as the base. Take the gap you're both afraid of: an investment-ban headline drops the stock to 70. A 40% unhedged core loses about 13.5% of a full allocation. A 35% unhedged core loses about 11.8%. A 50% core with the 100/80 put spread loses the first 5.7 points, gets back close to 20 points from the spread near expiry, and eats the last 10. That's about 7.4% of a full allocation, plus whatever premium we paid, which we can't price yet. The hedged half position loses less than either of your smaller unhedged ones in the exact scenario you fear. Shrinking size without insurance just gives you a smaller position with the same exposed tail.

Neutral already corrected the idea that the puts pay nothing until 100, since a December put gains value as the stock slides. We don't have the option chain. A VIX at 15 says index volatility is cheap, but BABA may carry its own event premium. If that premium is ugly, the plan already says to size down instead.

On the collar, Neutral is right and Conservative isn't. Selling 120 calls caps us at the September lower high. This stock ran from 91.99 to 132.57, roughly 44%, in about six weeks this summer. That's what it does when it turns, and capturing that move is the whole reason we carry a core into November. If we collar, the short call goes at 130 or higher, at the 200-day and the weekly flip.

On the 99.74 cut, I'll take Neutral's split. If hedged, cut on a close below 91.99. Selling at 99.74 dumps shares right where the put spread starts paying. It's also the bottom of the gap, next to the 78.6% retracement near 100.67. That's the zone where the technical report says a completed weekly 9 would be a better long setup than anything available today.

On congressional actions, a committee letter in a midterm month is exactly the gap the put spread is bought for. Cutting to 25% on a non-binding mention while hedged is paying for insurance and then selling the house anyway. If hedged, hold and let the puts work. If unhedged, take Neutral's 25%. Exit fully only on a binding Treasury designation, an executive order, or a delisting mandate. Before the trim is finished, confirm which list BABA is on, read the lawsuit, and pull the June quarter. That's all public, so get it rather than size down blind.

On trim timing, Conservative, the last time the stock sat here, at the Oct 2 low of 105.00, it traded up to 111.40 the very next session. Selling half the trim 0.6 ATR above the lower band gives away a bounce this tape just delivered. I'll meet Neutral partway: Sell a quarter of the reduction now. Sell the rest into 108 to 109.5. Finish the next session after any close below 103.78. Be done by Oct 23.

The rebuild is where caution gets most expensive. Conservative wants both gates and full size only above 131 or after two clean quarters. Two clean quarters means February at the earliest. Buying above 131 means paying about 20% more than the 109.5 trim price. If the September quarter validates, that evidence gets priced in one opening gap, as Neutral said himself.

The "falling 50-day on top of you" problem also shrinks on its own. If price just sits here, each early-August close of 122 to 129 rolling out of the window pulls the 50-day down by roughly a third of a point per session. By the November print, that ceiling will be meaningfully lower.

My rebuild ladder: A clear earnings gate takes us to 65%. That means opex clearly down from 34.9%, quick-commerce losses narrowing, and operating cash flow improving. If that print also closes the stock above 114.44 with OBV rising, go straight to 75% that session rather than scaling in while the gap runs away. Full size comes on a weekly close above 120.40 with the gate passed, because that breaks the weekly lower-high sequence. Or on the weekly flip near 131 regardless. A price signal without the earnings gate gets us to 60%, not a full rebuild.

One more point on macro, because both of you underweight its upside. The headline has oil around $103 after the Iran pledge, against Brent's $135 spike on Oct 2. That's a big cut in input costs for the world's largest crude importer. The yuan also held flat while the broad dollar rose 3.3%, which looks like quiet policy support. I'll take Neutral's rates rule both ways. Shade the core down five to ten points on a sustained break above 5.31% with real yields through 3%. Hold the top of the range if the 10-year drops back under 5%.

Bottom line: Sell. Trim to a 50% core, hedged by default with a 100/80 put spread or a collar with the call at 130 or higher, expiring after the report. Drop to 40% only if the hedge can't be bought at a sensible price. Run the tactical trade, as a short for flat books or an extra trim slice for holders. Park the trimmed proceeds in short Treasuries at about 4.8%.

That gives us risk-free yield on half the money and insured upside on the other half. The tactical trade gets paid by the same six-week calendar my colleagues are worried about. Being smaller and unhedged doesn't make you safer, just smaller with the same exposed tail. Aggressive Analyst: Aggressive Analyst: We're close enough now that the remaining disagreements are worth real money. I'll be quick about what I'm giving up and spend my time where caution is still costing us.

First, my concessions. The arithmetic that sank Neutral's 40% unhedged sinks my fallback too: 40% loses the same 13.5% of a full allocation in a gap to 70. So 35 is the unhedged number. Neutral is also right that a resting order at 109.5 missed the Oct 8 rejection at 109.39 by eleven cents, so every tactical order gets scaled through 108.2 to 109.5.

Conservative, you won the amortization point fairly. Operating cash flow fell about RMB 87 billion while opex rose about 100 billion, so the spike was cash. I'll also take:

your OBV definition, a higher swing high at or above the Oct 5 level;
your 104.75 trigger;
the rule that size reverts to 35 and the cut reverts to 99.74 when the hedge comes off, unless the earnings gate has passed.

Neutral caught me on the rebuild too. If gap-up opens in BABA get sold, as I've argued all session, I shouldn't buy 75% at the open of one. The first step scales over three sessions.

Now the contradiction that matters most. Conservative, you closed by saying we can't recover from a ban gap at 50%, and your default is 35% unhedged. Use your own illustrative four-point premium. In the gap to 70, your unhedged 35 loses about 11.8% of a full allocation. The hedged 50 you say we can't survive loses about 9.3%. A hedged 45 loses about 8.4%. Every hedged tier on the table loses less than your default in the exact scenario you built your case on.

Run the rest of your table, comparing a hedged 45 with your unhedged 35:

In the grind to 93, the hedged 45 loses about 4.1% against your 4.2%.
On a gap to 120, your 35 edges it by about three-tenths of a point.
On a full re-rating to 130, where the 200-day and the weekly flip sit, the hedged 45 makes about 8.6% against your 8.0%. This stock covered that kind of move in six weeks this summer.
The only tape where your default clearly wins is one where nothing happens, and the hedged version has spent about 1.7% of a full allocation on premium.

So the real risk control in this plan isn't the share count. It's the spread. The question isn't 35 versus 45. It's whether the hedge gets filled, and that's where this desk's attention belongs this week.

Your table also picked 120 as the good case. At 130, the extra fifteen points of hedged stock earn about 2.9% net of premium and cost about 2.8% in the ban gap. That's a symmetric payoff between a tail event and the re-rating we're carrying the core for.

Neutral's tiers are close enough to my position, with a reading assignment attached, that I'll sign them: 35 unhedged, 45 with the spread filled at four points or less, and 50 once the list, lawsuit and June-quarter checks come back clean. On your mid-life point, with BABA at 70 both legs are in the money. The shortfall is only the leftover time value on the short 80 put. Because the spread is defined risk, nobody forces us to sell it the morning of the gap.

Your best argument was timing. The hedge expires after the report, while escalation risk runs through the lame duck and into a new Congress. Don't answer that with a smaller core. Answer it with a longer hedge. If a 100/80 spread running into January fits under Neutral's four-point cap, buy January and your timing objection is gone. If only the post-report expiry fits, we live with the revert-to-35 rule.

Either way, buy it now. We don't have BABA's option chain, but protection is cheapest before the headline. A VIX at 15 says the broad market isn't paying up for anything yet. Sell the 130 call only if it actually pays something, and no 120s.

On non-binding congressional action, Neutral's resize is right: a hedged core goes to 35 and an unhedged one to 25. But cut the stock, not the spread. Keep the puts on the original notional. The surplus becomes a defined-risk position on the escalation you're both afraid of, and that's my answer to the minefield line. I don't need a naked short to get paid if October turns ugly. I just need to not sell insurance I've already bought the moment the risk it covers gets more likely.

Conservative, cutting to 20 to 25 whether hedged or not means selling, at a gapped-down price, shares we've already insured down to 80. Webull is a retail brokerage built around US customer accounts, where a security flag goes to the heart of the business. BABA has already taken its defense-list headline, and the market is openly asking whether it's priced in.

Where I'll push back on Neutral is the pre-CPI deadline. Being two-thirds done before September CPI is a bet that the print is hot, and CPI cuts both ways. A cool number is exactly what produces the bounce into 108.2 to 109.5 we all want to sell into. We've also pre-committed a five-point shade if the hot tail shows up, meaning two closes above 5.31 with real yields through 3%. Forcing two-thirds out at 105 or 106, ahead of a print we already have a rule for, counts the same risk twice.

Make it a third now, half done by CPI, and the rest into the zone. Three things still finish the trim early: a close below 104.75 finishes it the next session, the rates rule finishes it if it fires, and Oct 23 stays a hard deadline.

On the short, Conservative, you've used two different stops in two speeches. When you wanted the reward-to-risk to look bad, you measured risk to 114.44 and called it five points. When you wanted stop-outs to look likely, you called it 1.9 points and 0.6 ATR. It can't be both. A close-based stop above 111.40 means a wider realized loss but a much harder trigger, which is how Neutral got about 2.2 to 1.

On adverse selection, the technical report itself names 108.2 to 109.5 as the lower-risk place to sell. Its counter-trend case needs three things before it's live: a close back above 108.23 and 109.51, a positive MACD histogram, and rising OBV. A touch of the zone isn't that bounce. I'll grant that the mid-September run from 106.64 to 120.40 would have stopped this trade out, which is exactly why it's half size with a defined stop. Since that lower high, the two rallies that reached our zone, Oct 5 and Oct 8, both closed at or below 111.40.

I'll take half size for flat books, scaled through the zone, with half off at 100 to 101 and flat before the print. For holders, the extra slice comes back only two ways. One is buying it back on a close above 111.40, which is simply the stop. The other is Neutral's exception: a completed weekly TD 9 in the 95 to 101 zone with RSI and MACD still rising. Today's close decides whether the weekly count holds at 7. A 9 can complete the week of Oct 19 to 23, our deadline week, heading into the end-October tax-loss window. If funds dump BABA into that, that's the price I want the slice back at.

On fundamentals, you're measuring a 4% earnings yield on trough margins against a bond. FY2026's 4.9% operating margin is the lowest in the seven-year table, where the prior six years ran 8.2% to 17.9%. At the FY2025 opex ratio, operating-only earnings come to about $6.80 per ADS. That's roughly 16 times earnings and a 6.4% yield before any interest income, about 3.5 points over the 2.92% real yield. That's not a reason to exit.

You won the cash point, and it actually helps my side. Amortization doesn't switch off, but cash subsidies do. The AI program was announced in February 2025, inside FY2025, and opex that year ran 25.8%. Spending ramps after an announcement, so I won't push this too far. Still, my inference is that the nine-point jump the next year lines up more with the quick-commerce war, the most switchable line in the cost base. Your disposal argument can't carry the weight either: the gross line moved 0.14 points while opex moved nine.

Two more points on fundamentals:

Moonshot. If fair-value gains don't count as earnings, the stake has to count as assets. You can't zero it on both sides.
The June quarter. If Aug 21 was the June print, the market has had seven weeks with that news and has taken another 11% off since that day's 119.34 close. Bad news that's been known for seven weeks has done most of its damage. We all agree the filing gets read this week.

On the rebuild, 50% on a passed gate only gets us back to the trader's starting point after the best realistic news. I'll take Neutral's ladder as written:

A passed gate takes us to 60, bought over three sessions.
The gate plus a close above 114.44, with OBV making a higher swing high, takes us to 70.
The gate plus a weekly close above 120.40 takes us to 80.
Full size comes on the trailing weekly SuperTrend or a second clean quarter.
A price signal without the gate caps us at 50.

Your catalyst list also includes only the dangerous ones. Golden Week spending data, China's Q3 GDP and Singles' Day on Nov 11 all land before the report. They're domestic consumption reads that can move BABA up, and they come behind a yuan the PBoC has held flat while the dollar rose 3.3%. The hedged core is what lets us collect on them.

So the decision is to sell BABA, executed as a trim:

Trim schedule. Sell a third now, have half done by CPI, and scale the rest through 108.2 to 109.5. Finish early on a close below 104.75 or if the rates rule fires, and be at target by Oct 23.
Core size. 35 unhedged. 45 with the 100/80 spread filled at four points or less, bought into January if that fits the cap. 50 once the list, lawsuit and June-quarter checks are clean.
When the hedge lapses. Revert to 35 and the 99.74 cut, unless the gate has passed.
Policy triggers. Exit fully on a binding Treasury, executive or delisting action. On a non-binding action naming BABA, cut the stock to 35 if hedged or 25 if unhedged, and keep the full spread.
Tactical. Flat books short half size through the zone and are flat before the print. The holders' extra slice comes back only on the stop or a completed weekly 9.
Rebuild and cash. Rebuild on the 60, 70, 80, full ladder, and park the proceeds in short Treasuries near 4.8%.

Being small without insurance isn't the safe choice; being insured is. Once we're insured, carrying enough stock to matter on the print is the right call. Aggressive Analyst: Aggressive Analyst: Neutral raised the most important idea of this debate last round, and neither of you has followed it through. Moving the short put from 80 down to 70 does more than patch the tail. It changes the answer on how big the core should be, and it changes it in my direction.

Start with how the 100/70 behaves. Assume it costs four and a half points, expiring in December. At expiry, the hedged stock loses the same amount anywhere between 100 and 70: 5.7 points from here down to the long strike, plus the 4.5 of premium. That's 10.2 points a share, about 9.7 percent of the position's value. It doesn't matter whether BABA grinds to 93 or gaps to 70.

Conservative, your table said extra size "loses more the deeper the tail goes." On this structure it doesn't. Ten extra points of hedged stock lose about 1 percent of a full allocation at 93, and the same 1 percent at 70. They make about 1.9 percent at 130, and about 2.1 percent if the stock just revisits the August high of 132.57.

The cost is real. Breakeven on the hedged shares is about 110.2 at expiry, so in a flat tape the premium bleeds. But a payoff with a floor around one point and upside around two is a bounded call option on the print. It isn't a bet.

Now set that beside the position you said you actually want, Conservative: the 100/80 on a 35 core. - In a gap to 70, a 45 core on the 100/70 loses about 4.3 percent of a full allocation. Yours loses 6.5. - At 60, the 45 loses about 8.6 percent. Yours loses 9.8. - The 45 stays inside the trader's 12.2 percent budget down to about 51.5. Yours breaks at about 52.9.

So a 45 on the 100/70 is safer than your own preferred hedge in every tail you've named. Even a 50 on the 100/70 loses about 4.8 at 70 and 9.6 at 60, less than your hedged 35 both times, and only breaks budget around 54.

What do you give up against your version? About six-tenths of a point in a flat tape, and about 1.1 points in the grind to 93. What do you get? About 1.7 points more at 130, and two points less pain in a ban gap. You said the real risk control is the spread, not the share count. This is that sentence with prices attached.

Neutral's caveat that the spread pays less before expiry doesn't change the ranking. Say a gap to 70 values the 100/70 at 26 instead of 30. The hedged 45 still loses only about 6 percent, which is less than Conservative's hedged 35 at its full expiry value.

So, Neutral, I disagree with cutting the hedged base to 40. Your reason was that once the tail is closed, size is purely directional, and we haven't read the June quarter. I agree with the first half, and that's exactly why the protection should set the size: - 35 unhedged. - 40 on the 100/80 at four points or less. That's five points below what Conservative himself signed last round, because your math showing the budget holds to about 57 is right. - 45 on the 100/70 at four and a half or less. - 50 with the list, lawsuit and June-quarter checks clean.

The filing should cut both ways. If the June quarter shows opex still climbing, drop five points. Defaulting to the low number until a document proves otherwise isn't neutral. It's a directional call that the filing will be bad.

On direction itself, look at what we're holding. The stock trades at 1.7 times book. Operating margin is 4.9 percent, against six prior years running from 8.2 to 17.9. The weekly TD count is at 7, and RSI and MACD are diverging. With the downside floored near a point per ten points of size, I'll take that.

Now the premium cap. Conservative, your sketch says the 100/80 at four is a coin flip, and the 100/70 prices a bit higher. Before we fall back to 35 unhedged, use the leg we've already agreed on. Run your own sketch on a ten-week 130 call and you get roughly a point at 40 vol, more at 45, minus a little for normal skew. That's about the gap between a 100/70 that misses the cap and one that fits.

So the rule becomes this. If the 100/70 prices above four and a half, sell a call at 130 or higher, and judge the net premium against the same cap. That isn't stretching anything; it's one more leg. Capping the core at 130 through December costs us very little, because the ladder only goes to full size on a weekly close above 130.62, and does it with new stock.

On carry, annualizing four points into twenty percent a year and comparing that to an earnings yield is the wrong yardstick. We aren't paying it every ten weeks forever. It's a one-time bridge over the print, the midterms, Singles' Day and the start of the lame duck. And as Neutral said, event premium drains after the report, so the roll costs less. The right comparison is what the hedge buys: in a gap to 70, an unhedged 45 loses about 15 percent of a full allocation, and on the 100/70 it loses about 4.3.

I'll concede January. Neutral is right. Buy December, which clears the report, the midterms and Singles' Day, and roll after the print when the volatility crush makes it cheaper.

On the revert rule, Conservative, the sequence of a good print followed by a ban gap is the best risk point anyone has made in this debate, so I'm dropping my gate exception. Neutral's version is the right one. Policy sets the unhedged ceiling and the gate sets the rungs. Any rung above the ceiling needs one of two things: a fresh spread bought after the print under the fifth-of-payout rule, or Congress adjourning with the list and lawsuit clean. I'm comfortable with that for the same reason as everything else I've argued. Protection gets cheap after the print, so this rule doesn't delay the rebuild; it insures it. A 70 core with a fresh spread under it is exactly my kind of position.

On non-binding action, Neutral settled it, and I'll take the result. Sell the surplus spread into the volatility spike, keep the spread on what's left, and drop the post-hedge ceiling to 25. Neutral also confirmed it was never a bearish bet against the core. Selling volatility at the spike is simply the right trade.

On pace before CPI, I'll accept two-thirds, done Neutral's way: limits scaled from 106.5 to 109.5 until the session before CPI, then sell whatever is unfilled at that close.

That's not because CPI is skewed hot. Breakevens are up only 11 basis points since July at 2.35. About 83 percent of the 10-year's rise has come from real yields. Since late September the 10-year is up 32 basis points while the 2-year is up about one. This is a term-premium story, and one CPI print doesn't own it. I'm accepting because Neutral's version works limits instead of dumping at 105, and the last third still waits for the bounce.

On the extra slice, Neutral has it right: if it's a trade, it needs a stop, and a close above 111.40 is the stop. Conservative's precedence rule sits on top of that. Cuts come first, and the slice never comes back past the tier the hedge allows. That's a good rule.

But Conservative, "a sold slice carries no downside risk, only opportunity cost" is the argument I've been pushing against all session. Opportunity cost on this stock isn't small. It ran 44 percent in six weeks this summer.

On the ladder, I'll take the fixed 130.62 level over the trailing SuperTrend, and Neutral's two paths to full size. Conservative, requiring the gate, a weekly close above 130.62 and a retired tail all at once means even two clean quarters can't earn full size until the stock is already up about a quarter. I'll also take a gate measured against the June quarter rather than year over year, since the year-ago quarter sat inside the subsidy war.

One thing on your Singles' Day point. November 11 falls in the December quarter, so its subsidy bill doesn't touch the September-quarter numbers the gate reads. It's a reason to listen closely to guidance on the call, not a reason the gate fails.

On fundamentals, yes, FY2026 was year one of a three-year AI program, and years two and three are still coming. That's why my case has never needed a full return to 25.8 percent opex. It needs direction.

Neutral's middle case is three points of opex improvement plus recurring interest income. That lands in the low-to-mid 20s on earnings, roughly a 4 percent yield: fair value, not cheap, at the lowest operating margin in seven years. Fair value at a trough is exactly where you want to own a floored call on the turn. And the 2.7 percent revenue growth was dragged by the Sun Art and Intime disposals, so organic growth was probably higher.

On the tape, Conservative is right that OBV says distribution is still underway. I've never argued otherwise. That's why we're selling, why the trim leans into 108 to 109.5, and why flat books run the half-size short scaled through that zone and go flat before the print. Distribution sets the price we trim at. The print sets the value of what we keep.

Neutral's point about the yuan helps me more than anyone. If the selling is specific to BABA (the list, the lawsuit, the opex), then it gets resolved by BABA-specific information: three public documents this week and one print in November. It doesn't depend on the 10-year or Brent, which we can't control. That's exactly the risk a hedged core is built to carry.

So here's where I land: sell BABA, executed as a trim.

The schedule: - Sell a third now. - Have two-thirds done by the session before CPI, using limits from 106.5 to 109.5. - Sell the rest into 108.2 to 109.5. - Finish the session after any close below 104.75, and be at target by Oct 23.

The hedge: price the December 100/70 and 100/80 before today's close. If the 100/70 misses the cap, price it again with a 130 call sold against it.

Size is set by protection: 35 unhedged, 40 on the 100/80, 45 on the 100/70, and 50 with all three checks clean. Drop five points if the June quarter shows opex still rising.

When the hedge comes off, policy sets the ceiling: 35, or 25 after a non-binding action. Rungs above that ceiling need a fresh post-print spread, or an adjourned Congress with the list and lawsuit clean.

Triggers: - Exit fully on any binding action. - On a non-binding action, cut a hedged core to 35 and sell the surplus spread into the spike. - Cut at 91.99 while hedged and 99.74 when not, with no exceptions. - Shade the core five points on two closes above 5.31 with real yields through 3 percent.

Rebuild and tactical: - Rebuild in steps of 60, 70 and 80 against a June-quarter gate written down before Oct 23. - Go to full size with the tail covered, plus either the gate and a weekly close above 130.62, or a second clean quarter. - Flat books can short half size and must be flat before the print. - The holders' extra slice comes back on a close above 111.40 or a completed weekly 9, with cuts always first. - Park the proceeds in short Treasuries near 4.8 percent.

Conservative wanted the spread to be the risk control. Neutral found a cheaper, deeper spread. Once it's on, the extra size has a floor of about one point and upside of about two. That's the trade worth taking. Aggressive Analyst: I'll start with the number that changed this debate, because neither of you followed it all the way through. Neutral's harsh-marking table assumes 80 vol, five weeks left, and the short leg bought back because compliance won't let us take assignment. Under that table, every tier on the 100/70 stays inside the trader's 12.2 percent budget. A hedged 45 loses about 7 percent at 70 and 9.7 at 60. Even the 50 tier loses only about 10.7 at 60, which is below the 2022 low.

So on the 100/70, the risk budget no longer decides anything. Neutral said it plainly: the extra points are a directional question. Conservative said the June quarter is already public and reading it costs us no price risk. Put those together and the five points we've argued over for three rounds get settled by a document we can read early next week.

So I'll take the 40 base on the 100/70. What I want in return is sequencing, and I'll come to that.

First, my concessions. Neutral's skew argument for putting the 100/80 on 35 is right. If the market charges more than half a point for the band between 80 and 70, it's telling us the tail below 80 is rich, and less stock is the cheaper protection. I'll also give up my "floor of one point." That's an expiry number. In a mid-life gap it's closer to a point and a half per ten points of size.

Conservative, on the risk reversal and the 111.2 breakeven: your argument proves too much. Your own hedged 35 has the identical structure and the identical breakeven. By your logic, every share of hedged core is a bet against the Sell, and that argues for zero, not 35.

The real answer is that the short and the core sit on different horizons. The flat-book short is a two-to-six-week trade that's flat before the print. The core is a December payoff that spans the print. BABA can fail at 111.40 on October 20 and gap to 120 on November 20. That isn't a contradiction. It's what this stock did this summer, from 91.99 to 132.57 and most of the way back.

Neutral, the same distinction answers your claim that we signed a Sell because the odds are worse than 40 percent. I signed a Sell because of the six weeks before the print: tax-loss season, the FOMC, the midterms, a 10-year three basis points from our trigger, and OBV at a 60-day low. On the print itself, gross margin held at 39.8 percent while opex jumped nine points in the most switchable cash line in the business. I'd call that a coin flip. On your own payoffs, a coin flip split between 120 and 130 leaves the increment about two-tenths of a point positive. The filing pushes that one way or the other, which is exactly why it gates the 45.

Now the mid-life mark, Conservative, because your compliance point helps my side once you price it. Neutral already showed your flipped ranking flips back on a like-for-like basis: a hedged 35 on the 100/80 loses about 7.4 at 70, against 7.0 for a hedged 45 on the 100/70. Here's why.

If compliance says we can't take assignment on a short put in a designated name, we have to buy back the short leg in the middle of a gap. By my rough sketch on the same assumptions (stock at 70, 80 vol, five weeks left), the short 80 put costs about 13.4 to buy back and the short 70 put about 7. The forced-buyback problem you raised costs nearly twice as much on the structure you preferred.

On the long leg, your "one-way market with a dealer who knows you're a forced seller" assumes we sell the put. We don't have to. Listed equity puts are American-style. Exercising delivers our shares at 100 to whoever gets assigned, with no dealer bid involved, and delivering shares is divesting. So the compliance question narrows to one thing: can we take assignment on a short put during the divestment window? If we can't, we pre-commit to buying back the 70 leg the session a binding action hits. Neutral's table has already priced that.

On the 130 call, I'm with Neutral's two-rule test. The put spread alone has to come in at roughly five and a half or less, and the net, after any call sold, at four and a half or less.

Conservative, you said the call finances a call spread "by writing the ban tail." But the short 70 put is in your 40 tier too. The call changes no downside number anywhere. Its only cost is upside above 130 by mid-December, and that's my concern to weigh, not yours. I'll pay it to bridge the bleed, on one condition: we sell the highest strike that closes the gap, never below 130, so we give away as little of a re-rating as possible.

On the cumulative premium cap, I'll take three percent with Neutral's clarification that post-print hedges cover only the shares above the policy ceiling. I want one addition: the cap counts net premium. That means premium spent minus premium recovered, whether from a call we sold, a surplus spread sold into a vol spike, or residual spread value we sell. A cap that counts every dollar out and none back in would punish us for collecting on the insurance.

Now the sequencing. This is where Conservative's own point turns into an aggressive one. If we finish trimming to 40 and the June quarter reads clean on the 20^th, we buy back five points at higher prices. If it reads badly, we sell five more into weakness. Either way we pay the spread twice for no reason.

So read all three documents before the session ahead of CPI: the June-quarter results, the designation notice, and the lawsuit complaint. Write the numeric gate against the June quarter that same day. Then size the last third, the slice working into 108.2 to 109.5, against a known target of 45, 40 or 35. That isn't more risk. It's not paying the bid-ask twice on information we already have.

The same logic applies to the hedge, so buy it today if it qualifies. The VIX is at 15, the 10-year is three basis points from our trigger, and CPI lands next week. Protection doesn't get cheaper after the headline.

On fundamentals, Conservative, your "operating return under 3 percent" divides trough-year operating income by total equity. That denominator includes the Ant stake, short-term investments and equity holdings, while their returns land below the operating line. Neutral showed FY2025's margin gives about 8.4 percent on the same math. And 4.9 percent is the lowest operating margin in seven years, against a range of 8.2 to 17.9.

You're right that "trough" is a label you earn after the turn. The June quarter is the first look at whether the turn has started, and we're reading it this week.

On rates, your term-premium point is real. But the 2-year has barely moved since late September, so the market isn't pricing another hike. And Beijing held the yuan flat through a 3.3 percent dollar rally. The rule is already pre-committed, so we don't need a new one.

On today's weekly close, a close above 109.30 resets the TD count but fills the trim inside our zone, which is fine. One piece of discipline from my side: if BABA also closes above 109.51 with the MACD histogram back positive and OBV turning up, all three of the technical report's counter-trend conditions are met. The flat-book short then stands aside until 111.40 gets rejected again. I've said all session that a touch of the zone isn't the bounce. If all three conditions confirm, it is.

On the rebuild, once the gate passes, buy the post-print spread the first morning after the vol crush, then add shares over three sessions. That satisfies Conservative's rule that the spread is filled before the step, without losing a session. Between now and then we have Golden Week spending data, China's Q3 GDP, Singles' Day guidance on the call, and an AI tape that just gave us a 4 percent day. That's what the hedged core is there to collect.

So here's where I land. Sell BABA, executed as a trim. Sell a third now. Have two-thirds done by the session before CPI, working limits from 106.5 to 109.5. Size the last third against the target the filings set, scaled through 108.2 to 109.5. Finish the session after any close below 104.75, and be at target by October 23.

For the hedge, price the December 100/70 and 100/80 today and buy if either qualifies. The 100/70 qualifies at about five and a half on the put spread alone and four and a half net after selling a call at 130 or higher. The 100/80 qualifies at four, with no netting.

Size is 35 unhedged, 35 on the 100/80, 40 on the 100/70, 45 once the June quarter reads clean, 50 with all three checks clean, and 35 if the June quarter is bad. All three documents get read before the CPI session, and compliance answers the assignment question before we lean on the spread.

The policy ceiling, revert rule, triggers, cuts, rates shade, flat-book terms and the holders' slice all stand as agreed. The 60, 70, 80 ladder stands too, with full size on the tail covered plus either a weekly close above 130.62 or a second clean quarter, inside a three percent net premium budget. Park the proceeds in short Treasuries near 4.8 percent.

The risk budget has stopped binding on every tier of the 100/70. What's left is opportunity. The cheapest way to capture it is to read a filing that's already public before we sell shares we might want back.

Conservative Analyst¶

Conservative Analyst: Conservative Analyst: I agree with the direction. This is a Sell. The disagreement is about how much risk we keep while we sell, and I think my aggressive colleague is keeping too much and calling it discipline.

The tactical short. The 3.6-to-1 and 6-to-1 ratios rest on a 2.5-point stop, which is 0.8 of an ATR. That is less than an ordinary day's movement right now. The Oct 8 session alone ranged 4.64 points, about 1.5 ATR, and ATR is rising again, from 2.82 to 3.11.

The trader's own plan also defines that stop as a daily close above 111.40, not an intraday trigger. So the real loss is wherever the stock closes, and gaps make it worse. The news feed this very week carries "Alibaba Stocks Jump 4% as AI Cloud Growth Reclaims the Narrative." A 4% gap from 109.5 lands near 114, right on top of the stop. One StockTwits poster is already talking about stimulus. China policy headlines can open a stock well past any stop.

Measured honestly against the daily SuperTrend flip at 114.44, the risk is about 5 points, not 2.5. That turns the first target into roughly 1.8 to 1 before we even assign a probability to it.

The setup itself also argues against shorting. We'd be shorting a stock that is: - sitting near its lower Bollinger Band - at the top of an unfilled gap - at a weekly TD count of 7 of 9 - showing a bullish RSI and MACD divergence, even if unconfirmed

The technical report itself calls the counter-trend bounce the live alternative, with upside to 115 or 116.

There's also a simpler objection. If you hold a long core and want less BABA exposure, the clean move is to sell more of the long. Shorting it separately brings borrow cost, unlimited upside risk and gap risk, all layered on top of a long you're hedging with puts. That isn't asymmetry. It's three positions doing the work of one.

The opex rebound case. My colleague says the opex spike is a spending choice that can be reversed, so we shouldn't hand the upside to someone else. Part of it is a choice, but much of it isn't: - The quick-commerce subsidy war with Meituan and JD is a competitive battle. Alibaba doesn't get to end it alone. - The AI build-out is a public multi-year commitment of more than RMB 380 billion. - This week's news shows Tencent weighing a $5 billion bond for AI, Kling heading to a billion-dollar IPO, and Moonshot raising at $50 billion. Rivals are arming up, not standing down.

Getting opex from 34.9% to 29% in a single quarter is a 6-point swing in one print. That is a hope, not a base case.

We also don't know what the June quarter showed. The fundamentals report says plainly that it's public but not in our tools. So we are proposing to hold half a position through the September print without the most recent data point on the very metric the thesis depends on.

Meanwhile the trends we can see point the wrong way: - Operating cash flow halved, to RMB 76 billion. - Free cash flow was probably negative. - Net shareholder returns fell from RMB 108 billion to RMB 21 billion, so the buyback cushion is fading. - The current ratio dropped from 1.79 to 1.28. - Net income ran at 2.07 times operating income. Past episodes like that were followed by sharp earnings drops; FY2022 net income fell 59%.

Every unknown here is a reason for smaller size, not bigger.

The tail-risk protections. I'm told my concerns are already priced into the plan. Each of those protections is weaker than it sounds.

The investment-ban exit. If Treasury escalates the defense listing to an investment ban, that headline arrives as a gap, so we exit at the opening print, not today's price. We saw what a single day can do on Aug 21: down 8.6% on 32.5 million shares. We saw Webull plummet on a House panel flag alone. And we still don't know which list BABA landed on or what the lawsuit is about.
The put spread. The 100/80 spread leaves the first 5.7 points from today's price completely unhedged, or 9.5 points from the 109.5 entry. Below 80 it also leaves us unprotected. And we have no option prices, while implied volatility around a defense listing, an earnings print and a midterm election is unlikely to be cheap.
The fallback sizing. Sizing to a gap to 80, called 8 ATR, treats a policy shock as a volatility event. ATR measures ordinary days. Nobody in this room can tell you where a stock prints the morning after a forced-selling designation.
The 25% cut. The cut only happens on a close below 91.99, and even then not if there's a "capitulation signature." That means we ride half the position down about 16% from 109.5 and then leave ourselves a subjective excuse not to act. That's a rationalization trigger, not a stop.

The calendar. All of this sits inside about six weeks: - tax-loss selling season, on a stock down nearly 44% in a year - the Nov 3 midterms - the Iran "no attack" pledge, which only runs until Nov 3 - a late-October FOMC that follows a surprise hike - a 10-year yield at 5.28%, the highest since 2002, with real yields near 2.9% - the earnings print

My colleague says a low VIX means the short and the puts get paid if complacency breaks. But the short is supposed to be flat before the report, and the puts pay nothing until 100. Meanwhile the long half takes the hit from the first dollar. When high-beta China names reprice in a volatility spike, a 50% core is the exposure that hurts.

The neutral case for holding. I expect someone to argue for holding near full weight on the divergence, the TD count, Jefferies and a 16 times P/E. - A weekly 9 marks a mature trend, not a bottom. - The bounce target, 115 to 116, is capped by a falling 50-day average. The downside to the 92s, or lower on a policy event, is larger and has fatter tails. - The 16 times P/E flatters the stock. On core earnings it's north of 40 times. - That valuation is competing with a two-year Treasury paying 4.77% with no defense list attached.

The rebuild trigger. Going back to 75% to 100% on one close above 114.44 means buying full size about two points under the upper Bollinger Band and the 50-day average, with the weekly trend down to 131. This tape has already trapped buyers twice, at 132.57 in August and at 120.40 in September.

My adjustments. I'd keep the Sell and change six things:

Core size. Take the core to about 30% to 35% of a standard allocation before the window. Hold 50% only if the put protection is actually in place at a known cost.
Timing of the trim. Do half the trim now, around 105 to 107, and the rest into 108 to 109.5. Waiting for 109.5 gains about 3.6%. But a break of 103.78 drops us into a gap that runs down to 99.74, a loss of about 5.6%.
Time stop. Make it hard: be at target size by Oct 23 regardless of whether a bounce shows up.
Hedge. Prefer a collar to the plain spread. Sell calls near 120, the September lower high that's heavy resistance anyway, to fund closer-to-the-money puts, assuming the chain prices it sensibly.
Firmer cuts.
Cut to 20% to 25% on a daily close below 99.74, the bottom of the gap, not 91.99, and with no capitulation exception.
Exit fully on any investment-ban designation or any formal congressional action naming BABA.
The short. Skip it, and express the bearish view by holding less stock. If the desk insists, size it so a five-point loss fits the per-trade budget, which means half the size implied by the 2.5-point stop.

On the rebuild, the earnings gates and the price confirmation should both be required, not either one. Rebuild in steps: first to 50%, then to 75%. Go to full size only above the weekly flip near 131, or after two consecutive quarters of opex normalization.

Park the proceeds in short Treasuries at nearly 4.8%. If the AI thesis is real, it will still be real in December, and we can buy it with evidence instead of hope. Conservative Analyst: Conservative Analyst: We agree on a lot now, so I'll start with what I'm conceding before I push back.

Neutral is right that the put spread gains value as the stock slides. I overstated it when I said it pays nothing until 100. Neutral is also right that a committee letter isn't a forced-selling event, so I'll take his binding versus non-binding split over my blanket congressional trigger. And I'll come up from selling half the trim now to a third now. But three decisions determine how much this firm can lose over the next six weeks: how big the core is, whether we short against it, and how fast we buy back. On all three, I think you're both underpricing what we don't know.

Start with the hedge math, since my aggressive colleague says it's where the numbers most favor him. In his drop-to-70 scenario, the hedged half loses 7.4% of a full allocation, "plus whatever premium we paid." That premium isn't a footnote. None of us has the option chain, so purely for illustration, say the 100/80 spread costs four points. Then the hedged half loses about 9.3%, not 7.4.

That still assumes the spread pays its full 20 points, which only happens at expiry. Our own rule says we exit fully on a Treasury ban. That means we'd sell the spread mid-life, right after a gap, when the short 80 put still carries a lot of time value, so we'd collect less than 20. The 9.3% is the optimistic number.

The bigger issue is that your math proves the hedge is worth buying, not that 50% is the right size. You compared a hedged half against unhedged smaller positions. Nothing stops us from hedging the smaller position. Here is the same spread and the same illustrative premium on a 35% core:

In the drop to 70, the hedged half loses about 9.3% and the hedged 35% loses about 6.5%.

In a grind down to 93, the technical report's main scenario, the half loses about 4.6% and the 35% about 3.2%.

If the print works and the stock gaps to 120, the half nets about 4.9% after premium and the 35% about 3.4%.

So the extra fifteen points of core earn about a point and a half in the good case. They cost about three points in the stress case and a point and a half in the most likely one. That isn't asymmetry in our favor.

Neutral, the same arithmetic is why I can't get to 40%. You said a 40% unhedged core gapping to the low 70s costs about 12.8%, "roughly the same" as the trader's 12.2% budget. It's over that budget, and at 70 it's 13.5%. A 35% unhedged core at 70 loses about 11.8%, which fits inside the trader's own number even in the deeper gap. Your loss-budget logic points to 35, not 40.

Neither of you has dealt with timing. The spread expires shortly after the November report. The risk that a Pentagon listing escalates to a Treasury ban runs through the lame-duck session and into a new Congress in January. Whatever size we carry with the hedge on is a size we'll be carrying without it a month later, unless we keep paying to roll. Size the core for the unhedged world and use the hedge to protect that size, not as a license to be bigger. I'll accept Neutral's split of 91.99 if hedged and 99.74 if not, but only while the protection is actually on. The moment the hedge expires or gets closed, the cut level goes back to 99.74 automatically.

On the collar, I hear you both that a 120 call caps us at the September lower high. But be honest about what moving the strike to 130 does. A call about 23% out of the money with roughly ten weeks left brings in a fraction of what a 120 call would. At 130, the "collar" is basically the put spread paid at full price. That's acceptable, but the premium then has to sit inside the loss budget, which is one more reason for a smaller core.

Now the tactical short. My aggressive colleague says nobody is shorting at 105.70, the entry only fills if the bounce happens, and my counter-trend scenario is his entry condition. That is exactly the problem: the fill is adversely selected. You only get short at 109.5 if the bounce the technical report describes is underway, and that bounce targets 115 to 116, above your stop. Once you're filled, the odds of being stopped go up, not down.

Your own example shows it. You used the Oct 2 low of 105.00 to argue against trimming now, because the stock traded to 111.40 the very next session. That's six points in one session, landing exactly at your stop level. You can't use that bounce against my trim and then assume it can't happen to your short. Your stop is about 1.9 points above entry, roughly 0.6 ATR, on a stock that printed a 4% up day this same week. You don't need a crowded short or a squeeze to get stopped out, just an ordinary BABA day.

You also say I can't call October a minefield and then refuse to profit from it. Calling it a minefield is a statement about variance, not direction. The same six weeks include a possible weekly TD 9, a possible failed breakdown at 104.75, AI headlines that just moved the stock 4%, stimulus chatter, and an Iran pledge that expires mid-window. You don't cross a minefield by sprinting the other way. You reduce what you have exposed. The position that gets paid in October without taking new risk is the two-year Treasury at 4.77%.

Your version for holders, selling an extra slice at 109.5 and buying it back at 100 to 101, breaks the trader's own rule. The plan says explicitly not to add into the 99.7 to 101 gap, and that's exactly where you'd be buying. If the extra slice gets sold at 109.5, good. Treat it as a permanent reduction that comes back only through the rebuild ladder. For a genuinely flat trading book, I'll accept half the size the 2.5-point stop implied, flat before the print, and it doesn't count as anyone's hedge.

On fundamentals, I'll grant the core multiple range. But look at what the midpoint means. At roughly 25 times, the earnings yield is 4%, below a two-year Treasury at 4.77%. Even at the generous end, about 17 times, the earnings yield is around 5.8%, roughly one point over the two-year while real yields sit at 2.92%. And the midpoint is generous, because the fundamentals report says only the interest income is reliably recurring. The rest of that non-operating gap is investment gains, fair-value changes and disposals. That's the same kind of earnings that inflated FY2021, which was followed by a 59% earnings drop in FY2022.

That's also my answer on Moonshot. A raise at $50 billion marking up an Alibaba stake is a fair-value gain, precisely the low-quality earnings we're discounting. The headline calls it a "test," and tests can be failed.

On the idea that the opex spike was mostly amortization and impairments that won't recur: operating cash flow fell by about RMB 87 billion while opex rose about 100 billion. Non-cash charges get added back in operating cash flow. If the spike were mostly amortization and impairments, cash flow wouldn't have fallen almost in step. Working capital explains some of the gap, but the spending was overwhelmingly cash.

On gross margin holding: model training and AI R&D typically sit in operating expenses, not cost of revenue. So "data-center depreciation lands in cost of revenue" doesn't clear the opex line of AI costs. The year also included the Sun Art and Intime disposals, which were low-margin retail businesses. Shedding them would flatter gross margin through mix. That part is my inference, but it cuts against reading the gross line as proof the core business is fine.

A three-point opex improvement is a reasonable hope. But we're heading into the print without the June quarter. The Aug 21 drop of 8.6% on 32.5 million shares fell in the window when Alibaba usually reports that quarter. If that was the earnings reaction, the market has already seen post-FY2026 data and sold it hard.

My aggressive colleague says get the data rather than size down blind, and I agree, so let's get it. But the trim finishes by Oct 23 whether or not we have it. The default has to be the conservative size, raised when the information arrives, not cut after a gap tells us.

On the balance sheet, I've never argued distress. The risk is price, not solvency. A trillion RMB of equity didn't prevent the 8.6% day, and it won't prevent a list-escalation gap. The fundamentals report also suggests short-term investments are being sold to fund the build-out, since current assets fell RMB 63 billion while investing outflows shrank. The cushion you're pointing to is the one being spent.

On trim timing, I'll move to a third now, as Neutral proposed, rather than a quarter. But the contingent trigger should be a close below 104.75, the Oct 8 low, not 103.78. A close below 104.75 is a new closing low under both recent lows, with nothing but an unfilled gap down to 99.74 beneath it. Waiting for 103.78 and then selling the next session means selling into that gap, possibly after an overnight move.

On the rebuild, two things in my aggressive colleague's ladder bother me. First, "OBV rising" on the day of a close above 114.44 is met by any up day on volume, because OBV is cumulative and one green session makes it rise. Define it as OBV making a higher high over several weeks, at or above its Oct 5 level. Second, you say the falling 50-day solves the ceiling problem. The 50-day is falling because the stock keeps closing far below its August levels. A trigger that gets easier to hit because the trend is getting worse doesn't measure what we want.

On missing the re-rating, you point to the 44% run from 91.99 to 132.57 as what this stock does when it turns. It then gave back two-thirds of that run, and anyone who chased it near the top is underwater. Every rally this year has offered a second chance. We can recover from missing the first leg of a real re-rating while holding a 35% core. We can't recover from a ban gap at 50%.

My rebuild works like this. The earnings gate alone takes us to 50%, bought over several sessions rather than into the opening gap. The gate plus a weekly close above 120.40, with OBV making a higher high, takes us to 65%. Going to 75% also requires the stock to hold above the 50-day. Full size comes only on a weekly close above the weekly SuperTrend flip near 131, or after a second clean quarter. A price signal without the earnings gate gets us back to 45% at most.

On macro, the oil relief comes from a pledge that expires Nov 3, before the print, and Brent was still at 125 on Oct 6. Relief with an expiry date isn't a cushion. The rates rule we've all agreed on is also about to fire. The 10-year is at 5.28%, three basis points under the 5.31% trigger, and real yields at 2.92% are eight basis points under 3%. September CPI lands mid-October, before our deadline, with CPI running about 3.7% annualized and core PCE about 3.1%. We should plan for the trigger instead of reacting to it: if it fires, shade the core down five to ten points.

So here's my position. Sell, trimming to a 35% base. Go to 40 to 45% only if the put spread is actually filled and its premium is counted inside the loss budget. I'd sign off on the trader's 50% only after three checks: the list is confirmed as the Pentagon's 1260H list, not Treasury's; the lawsuit isn't existential; the June quarter shows opex already turning down.

Execute a third now, the rest into 108.2 to 109.5, finish the next session after any close below 104.75, and be at target size by Oct 23. Exit fully on any binding Treasury, executive or delisting action. Cut to 20 to 25% on any non-binding action naming BABA specifically, hedged or not. Webull plummeted on a House panel flag alone, and our spread only fully protects between 100 and 80 and expires long before that political risk does. Cut at 91.99 while hedged and 99.74 otherwise, with no exceptions. Run no short against the core, allow half size in a flat book only, and make no buybacks into the 99.7 to 101 gap. Park the proceeds in short Treasuries at about 4.8%.

If the AI thesis is right, a 35% core participates and the ladder adds as proof arrives. If we're wrong about the list, the rates or the margin, we're still here to buy it lower. That's the version that protects the firm. Conservative Analyst: We've converged on most of this, so the remaining rules are where the plan can still lose real money. I'll start with concessions, then cover the three places where the current draft still carries risk nobody has priced.

Concessions

On the short, my aggressive colleague caught me fairly. Measuring the loss out to 114.44 overstated it. Neutral's three and a half to four and a half points is the honest figure, and I'll use it.

I'll drop my blanket 20 to 25 percent cut on any non-binding action and take Neutral's resize: hedged cores go to 35, unhedged to 25. I have one addition, which I'll come to.

The Sun Art and Intime disposals can't explain a nine-point move in opex when the gross line moved 0.14 points, so I'll let that go. And yes, if Moonshot's markup isn't earnings, it's an asset. It already sits in the 1.06 trillion of book that gives us 1.7 times. It doesn't fund a subsidy or change the print.

I'll also sign Neutral's tiers: 35 unhedged, 45 with the 100/80 filled at four points or less, and 50 with the spread on and the list, lawsuit and June-quarter checks clean. But the last round turned the hedge into an argument for size, so I want to be clear what those tiers mean.

The hedge comparison

You said every hedged tier loses less than my default in a ban gap. That's true, but you compared a hedged 45 to an unhedged 35, the same mismatch I called out last round. If the spread fills, I want it on the 35 as well. So compare hedged with hedged, using the same four-point premium and marking from 105.70. The extra ten points of stock produce, as a share of a full allocation:

about +1.9% if BABA re-rates to 130, and about +1.0% at 120
about -0.4% if nothing happens
about -0.9% in the grind to 93, which the technical report calls the main scenario
about -1.9% in a gap to 70, and about -2.8% in a gap to 60

You called that symmetric. It's roughly even between the best case and one tail. It loses across the middle, where most outcomes live, and it loses more the deeper the tail goes.

The tail can go deeper than 70, because the spread stops paying at 80. A hedged 45 breaks the trader's own 12.2 percent budget on a gap to about 61. A hedged 35 holds to about 53. BABA traded in the high 50s in late 2022, without an investment ban. You said the real risk control is the spread, not the share count. Agreed. So put the spread on the 35 and keep that control, instead of spending it on ten more points of stock.

Whether the 45 tier is even available

Nobody should assume it is. We don't have the option chain, so treat this as my own Black-Scholes sketch, not a quote. An ATR near 2.9 percent of price implies realized volatility of roughly 30 annualized, and options into an earnings print plus a defense listing usually price above realized. For a ten-week 100/80:

at 35 vol, about three and a half points
at 40, about four
at 45, closer to four and three-quarters

Skew might shave a little off. So Neutral's cap is roughly a coin flip. The January version is worse: the extra weeks add roughly another point, so it fits under four only if implied vol sits in the low thirties, barely above realized, with an earnings report inside the window. I don't expect that. Plan for 35 as the likely outcome, and don't let anyone stretch the cap to make the tier work.

Then there's the carry. Four points on a 45 core is about 1.7 percent of a full allocation for ten weeks. Annualized on the insured shares, that's roughly twenty percent a year for insurance on a stock whose realistic operating earnings yield is under four. The hedge is a bridge over one event. It can't be how we carry size.

The revert rule

The most dangerous rule in the current draft is that size reverts to 35 when the hedge lapses "unless the earnings gate has passed." The gate tells us about opex. It tells us nothing about Treasury, and the escalation risk runs through the lame duck and into a new Congress whatever the September quarter shows.

Under the draft ladder, a good print takes us to 60, then 70, then 80, all unhedged, straight into that window. Marked from here, a gap to 70 would cost:

an unhedged 60 about 20 percent of a full allocation
a 70 about 24 percent
an 80 about 27 percent

That's between 1.7 and 2.2 times the trader's budget, and it would arrive right after we'd been proven right about margins.

So my change is this. When the hedge lapses, size goes back to 35 and the cut goes back to 99.74, gate or no gate, unless one of two things is true:

We've re-hedged the rebuilt position under the same rule: struck near the then-price, premium no more than a fifth of the spread's maximum payout.
The policy tail is retired. That means 1260H is confirmed as the only list, the lawsuit is known and not existential, and the lame-duck session passes without a binding proposal naming BABA.

With that condition, I'll take Neutral's 60, 70, 80 ladder over my own 50, 65, 75. Without it, the ladder just rebuilds an unhedged tail one rung at a time.

The ladder

Two more points here. First, the gate can't be defined yet. "Opex clearly down from 34.9 percent" means nothing until we've read the June quarter and know the starting line. Writing down a numeric gate belongs in the reading assignment, done before Oct 23, not improvised the night of the print.

Second, full size on the trailing weekly SuperTrend has the same flaw Neutral and I just agreed to strip out of the 50-day: the level ratchets down every week the decline continues. Full size should require the passed gate, the weekly flip, and the policy tail covered, all three.

Non-binding congressional action

Here's the addition I promised. Neutral's logic is that a non-binding action raises escalation odds after the hedge lapses, so we resize for that world. Follow that logic all the way through: if such an action has occurred, the post-hedge size is 25, not 35.

On keeping the full spread after cutting the stock: insurance on a house you've sold isn't insurance, it's a bet. The surplus gets marked up the moment the headline hits, and that mark is the offset against the stock loss we just took. Sell the excess notional and bank it. Otherwise we've brought back, through the options book, the bearish trade we agreed not to run against the core.

Pace before CPI

I'm with Neutral: two-thirds done before the print. You say that double-counts the rates rule. It doesn't. The rule changes how much we hold, after two closes above 5.31. The pace decides where we sell shares we've already decided to sell. If CPI runs hot, the first close above 5.31 can come with a BABA gap through 104.75, and the rule fires a session later at a worse price.

The odds aren't fifty-fifty either. CPI has run about 3.7 percent annualized and core PCE about 3.1. The Fed just hiked. The 10-year is three basis points from the trigger, with real yields eight from three percent. One print can start the clock on both.

The gap between your half and Neutral's two-thirds is about a sixth of the reduction, roughly ten points of a full allocation. If CPI is cool and we miss a bounce to 109, that costs about 0.3 percent. If it's hot and we end up selling into the gap near 100, it costs nearly 0.6. Neutral's version still leaves a third for your cool-print bounce. Take the cheaper error.

The tactical trade

The terms are half size, flat books only, its own loss budget, flat before the print, and never counted as anyone's hedge. Two clean rejections since late September is two observations, and you've already conceded the September run from 106.64 to 120.40 would have stopped it out.

On the holders' extra slice, I object to buying it back on a bare close above 111.40. We just agreed a close above 114.44 isn't enough for the core without OBV making a higher swing high, and this trigger is three points lower with no volume test at all. A sold slice carries no downside risk; leaving it sold only costs opportunity. Keep it sold, and let it come back only through the ladder or the TD 9 exception.

That exception needs a precedence rule, because as written it collides with our cut rule. Picture an unhedged core when the weekly 9 completes at 97. The 99.74 cut says sell to 25, and the exception says buy the slice back. Cuts override buys. The slice comes back only while price is above the active cut level, and never past the tier the hedge status allows. If a cut has fired, it comes back only through the ladder.

Fundamentals

The AI program was announced in February 2025, in the final weeks of FY2025. That's why FY2025's 25.8 percent opex ratio carries almost none of it. It's a three-year program of more than RMB 380 billion, so FY2026 was year one, and the quarters we're betting on are years two and three. That spending and its depreciation keep arriving whatever happens to subsidies.

Neutral has already run the realistic case. A three-point improvement gives about $3.85 an ADS of operating earnings, about 27 times, a yield around 3.6 percent. That's below the 4.77 two-year and less than a point over real yields. Only a full return to FY2025's opex ratio gets you to 16 times, and you conceded that's the full-success case.

Neutral, "earnings grow, coupons don't" assumes growth we don't have. Revenue growth has slowed from 8.3 to 5.9 to 2.7 percent, and operating cash flow has fallen three years running.

On the idea that seven weeks of bad news has done most of its damage: if it had, we'd see sellers running out. Instead:

OBV dropped 75 million in twelve sessions to a 60-day low.
The Oct 8 gap-up was sold on the heaviest volume since Sep 23.
RSI has never touched 30.

That's distribution still in progress.

Your upside catalysts are two-sided. Singles' Day is peak subsidy season, which is exactly the cost line we need to fall, and as far as I know Alibaba stopped publishing a headline GMV figure a few years ago. Q3 GDP lands against Brent printing 125 on Oct 6, for the world's largest crude importer. And the PBoC held the yuan flat through September while BABA kept making lower lows, from 106.64 to 105.00. The cushion didn't cushion.

My position

Sell BABA, executed as a trim:

Trim schedule: a third now, two-thirds done before CPI, and the rest scaled through 108.2 to 109.5. Finish the session after any close below 104.75, and be at target by Oct 23.
Core size: 35 unhedged. 45 only if the 100/80 fills at four points or less, with no stretching. 50 only with the spread on and all three checks clean. If the spread fills, I'd rather it sit on the 35 anyway.
When the hedge lapses: back to 35 and the 99.74 cut, earnings gate or not, unless we've re-hedged within the rule or the policy tail is retired.
Binding action: exit fully.
Non-binding action: a hedged core goes to 35 and the surplus spread is sold; an unhedged core goes to 25; post-hedge size becomes 25.
Tactical: no short against a core. The extra slice stays sold except under the TD 9 exception, above the cut level and within the tier.
Rebuild: 60, 70, 80, each step hedged or with the tail retired, against a numeric gate written down after we read the June quarter. Full size needs the gate, the weekly flip, and the tail covered.
Proceeds: short Treasuries near 4.8 percent.

Both other versions are built to get paid if the print is good. Mine is built so that a good print followed by a bad headline doesn't cost the firm up to twice its own risk budget. Nobody else has priced that sequence, and it's the one we can least afford to discover live. Conservative Analyst: Neutral's move of the short put from 80 down to 70 is the best idea anyone has brought to this table, and I'm taking it. But my aggressive colleague used it to argue for more size, and his comparison has the same flaw I flagged two rounds ago. He set a 45 core on the 100/70 against my 35 on the 100/80, which is a different structure on a different size. If the 100/70 is the better hedge, and it is, then I want it on the 35 too.

So here is the like-for-like comparison, same December 100/70 at four and a half points, marked at expiry. Anywhere between 100 and 70, a hedged 35 loses about 3.4 percent of a full allocation and a hedged 45 loses about 4.3. At 60, it's about 6.7 against 8.6. The 35 doesn't break the trader's 12.2 percent budget until the low 40s, while the 45 breaks it around 51 and a half. At 130, the 35 makes about 6.6 and the 45 about 8.4. Your own numbers were right: the extra ten points cost about a point everywhere from here to 70 and make about 1.9 at 130. The question is what those ten points actually are, and how often they pay.

They aren't a "bounded call option on the print." Long stock plus a long 100 put is, by put-call parity, a long 100 call. Selling the 70 put on top of that makes the position a long 100 call plus a short 70 put. That's a risk reversal. The floor you keep describing ends exactly at 70, and below it you are short a put in the one region where a Treasury designation sends the stock. Your fallback adds a short 130 call to get under the cap, which turns it into a 100/130 call spread financed partly by writing the ban tail. That isn't insurance with upside. It's a call spread paid for by selling the scenario all three of us have spent six rounds saying we can't afford.

Then look at where that structure makes money. You put the breakeven at 110.2 yourself. Against the short Treasuries we're parking proceeds in, add about a point of ten-week yield at 4.8 percent and the breakeven is about 111.2. That's twenty cents under the 111.40 lower high, the level this whole desk uses to define whether the downtrend is still intact.

Put that next to the rest of your plan. We're selling shares into 108.2 to 109.5 because that's where rallies have died. You'd run a flat-book short from 109.5 with the stop at a close above 111.40. In the same breath, you want ten extra points of a position that loses to a T-bill unless BABA finishes the year above roughly that same 111.40. You can't believe both. The technical report's main scenario is 100 to 101, then 92 to 95. Every point of hedged stock above the base is a bet against the Sell we all signed.

The "floor of one point" is also an expiry number. Suppose the headline arrives in early November, with about five weeks left, and implied vol jumps to around 80, which isn't exotic for a stock that just got a Treasury designation. By my rough Black-Scholes sketch, the short 70 put is then at the money and carries about seven points of time value. The 100/70 is worth something like 23 or 24, not the 26 you assumed. At that price the hedged 45 loses about 7 percent, which is worse than my hedged 35 on the old 100/80 at its full expiry value. Your ranking flips. On the same structure, the hedged 35 loses about five and a half.

There's a mechanical issue too, and I'd like compliance to confirm it before we lean on the spread. The Treasury investment-ban program as written covers derivatives that give exposure to a listed security, not just the shares. Divestment is permitted, but the market you're unwinding into becomes one-way, and the dealer on the other side knows you're a forced seller. "Nothing forces us out of the spread" is true on paper. In practice, the exit price in a ban is the least reliable number on this table.

On the 130 call, I won't accept netting it against the cap. Neutral proposed the fifth-of-payout rule as a signal: if protection costs more than that, the market is pricing BABA's event risk richly, and the cheaper protection is less stock. Selling a call to sneak under the line doesn't make the protection cheaper. It ignores the signal and sells away the upside the extra size was supposed to capture. Judge the cap on the put spread alone. If a 130 call pays something worthwhile, that's a separate decision, and it never buys a size step.

On the default size, you said starting low until a document proves otherwise is a directional call that the filing will be bad. It isn't. The June quarter isn't a future event. It was reported in late August, so reading it costs us no price risk at all. The default only matters if we haven't done the reading by Oct 23, and an unread filing shouldn't earn more stock.

The asymmetry also runs the other way from how you framed it. If the filing is good, we step up five points at a price we can see. If we start high and it's bad, we sell five points into a market that's had seven weeks to digest it. And the only evidence we have on that quarter, the 8.6 percent drop on 32.5 million shares on Aug 21 in the reporting window, followed by another 11 percent lower since, doesn't point to good news. I'll take your symmetry, but from Neutral's base: plus five on a clean filing, minus five on a bad one.

So, Neutral, I'll sign your tiers with one change. The 40 hedged base requires the 100/70. If only the 100/80 fills, the hedge sits on the 35. Your own figure shows a 40 on the 100/80 breaking budget around 57 at expiry, which is the 2022 low, and earlier than that before expiry. I signed 45 on the 100/80 last round and said in the same breath I'd rather the spread sat on the 35. Your analysis since then showed the 80 short strike is exactly where my tail losses came from. I'm withdrawing that signature on new evidence, the same way my aggressive colleague dropped his gate exception.

The resulting tiers: - 35 unhedged. - 35 on the 100/80. - 40 on the 100/70. - 45 on the 100/70 once the June quarter is read and shows opex turning. - 50 with all three checks clean. - 35 regardless if the June quarter shows opex still rising.

On carry, "a one-time bridge" isn't what we've written. The revert rule says any rung above the unhedged ceiling needs a fresh post-print spread, and the escalation risk runs into a new Congress. Look at the sequence. A December spread on a 40 core at four and a half is about 1.7 percent of a full allocation. A post-print re-hedge on a 60 rung, even after the vol crush, is plausibly another 1.8 or so. That's three and a half percent of a full allocation on insurance by January.

So I want one more rule. Cap cumulative hedge premium at about 3 percent of a full allocation through the January window. Once it's spent, the unhedged ceiling governs, and rungs above it wait. Insurance should be a budget line, not an open tab. And any fresh spread has to be filled before the size step it protects, not after.

On pace, I'm glad two-thirds before CPI is settled, but your reasoning makes my case stronger. You said 83 percent of the 10-year's rise is real yield, breakevens are up just 11 basis points, and the long end rose 32 basis points while the 2-year barely moved. That's a term-premium and discount-rate shock. It's exactly what hits long-duration, high-beta emerging-market equity hardest, and it doesn't need a hot CPI to keep going.

Two closes above 5.31 can come in any session, and we sit three basis points away with a VIX at 15. Yahoo's chart of the day noted that fast yield moves like this have preceded nearly every major blowup. A rates trigger that doesn't wait for CPI is a reason to be early, not late.

On fundamentals, "fair value at a trough" assumes we know it's a trough. Here's the number neither of you has used. FY2026 operating income was 4.8 percent of average equity. At about 1.68 times book, that's an operating return on the price we're paying of under 3 percent before tax, below a 2.92 percent real yield.

The bull case needs operating margin to recover. Meanwhile, years two and three of a more-than-RMB-380-billion AI program are still ahead of us, operating cash flow has fallen three years running, and the quick-commerce war has no exit Alibaba controls alone. "Trough" is a label you earn after the turn, not before it.

Some concessions. You're right that Singles' Day falls in the December quarter, so its subsidy bill won't touch the gate. The flip side is that guidance on the call becomes the first read on that subsidy intensity, and the stock trades on guidance. Neutral, you're right that the disposals flatter the revenue slowdown. They don't explain three straight years of falling operating cash flow, though. On the extra slice, I'll take a close above 111.40 as the buyback with the precedence rule on top. That's a tenth of a percent, and it isn't worth another round.

On retiring the tail at adjournment, I'll accept it as the lame-duck answer. Just remember a new Congress sits in January with a fresh China-hawk mandate, so the 99.74 cut stays live on any unhedged rung. Today's weekly close also matters. If BABA closes above 109.30, the weekly count resets, no 9 arrives in our deadline week, and the TD-9 buyback exception drops out of the picture.

So here's my position: Sell BABA, executed as a trim.

The trim schedule: - Sell a third now. - Have two-thirds done by the session before CPI, working limits from 106.5 to 109.5. - Sell the rest into 108.2 to 109.5. - Finish the session after any close below 104.75, and be at target by Oct 23.

The hedge: - Price the December 100/70 and 100/80 before today's close. - The 100/70 qualifies at four and a half or less on the put spread alone. The 100/80 qualifies at four or less. - No netting the cap with a short call.

Size: 35 unhedged; 35 on the 100/80; 40 on the 100/70; 45 with the June quarter read and opex turning; 50 with all three checks clean; 35 if the June quarter is bad.

Housekeeping before any size above 35: - Read the list designation, the lawsuit and the June quarter before Oct 23. If they're unread by then, there's no step up. - Have compliance confirm how a Treasury designation would treat our options.

Rules that still apply: - Cap cumulative premium at about 3 percent of a full allocation through January. - The revert rule, triggers, cuts, rates shade, rebuild ladder and flat-book terms stand as agreed. - Park the proceeds in short Treasuries near 4.8 percent.

Neutral's deeper spread is a genuine improvement, and the right way to use it is to make the size we already agreed on safer, not to buy a risk reversal whose breakeven sits on the very lower high we're selling beneath. If the September quarter proves the turn, the ladder rebuilds us with fresh hedges at post-print prices. If it doesn't, or if Treasury moves first, we'll still have the capital to act on it. Conservative Analyst: We've settled more than we're still arguing about. I'll say what I'm signing, then cover three places where my aggressive colleague's last round still underprices risk, and one mechanical risk none of us has checked.

First, my concessions. Neutral, you were right to re-mark my hedge mid-life. Once both structures get the same 80-vol, five-week treatment, my hedged 35 on the 100/80 loses about 7.4 percent against 7.0 for the hedged 45 on the 100/70. The ranking I claimed doesn't flip. You're also right that the risk-reversal label fits my 35 as much as anyone's 45.

Aggressive, you're right about American exercise. We can deliver shares at 100 through the long put without needing a dealer's bid. That narrows the compliance question to the short leg. Your new stand-aside rule for the flat-book short is the discipline I asked for, and I'll take it. If BABA closes above 109.51 with the MACD histogram positive and OBV turning up, the short waits for another rejection at 111.40.

The tiers are now identical across all three of us: 35 unhedged, 35 on the 100/80, 40 on the 100/70, 45 with the June quarter read and turning, 50 with all three checks clean, and 35 if the June quarter is bad.

Now the claim that the risk budget "no longer decides anything" on the 100/70. It decides less, but not nothing. Use Neutral's own harsh-marking method one strike lower: BABA at 50, five weeks left, 80 vol, short 70 put bought back. The 100/70 is worth a little over 29. Net of premium, as a share of a full allocation:

The hedged 35 loses about 10.2 percent, the 40 about 11.7, the 45 about 13.1 and the 50 about 14.6.

At expiry the picture is nearly the same. The 45 breaks the trader's 12.2 percent budget around 51 and a half, the 40 around 48, and the 35 in the low 40s.

So the budget stops binding only if the tail stops near the 2022 low. That low was set in the high 50s with no ban in place, and a Treasury investment ban adds forced US selling on top. I'm not calling 50 the base case. My point is that the five and ten points above 40 are exactly the points that break the budget again in the one scenario that's the whole reason we're buying a hedge.

That table also only exists if three things hold at once. The spread is filled, compliance lets us transact both legs, and the ADR is still trading when the headline hits. Nobody has checked the third.

Under the original 2020 executive order, NYSE delisted three Chinese telecom ADRs roughly two months after the order, after announcing it, reversing it and reversing again. When an underlying stops trading on a US exchange, what happens to listed options on it is an operational question for the OCC and our broker. Black-Scholes can't model it.

BABA has the 9988 line in Hong Kong, so an exit probably exists. But it runs through ADR conversion and a custodian. Before anything above 35 goes on, I want operations to confirm we can convert and sell on the Hong Kong line, and what our options become if the ADR is suspended. That's no reason to drop the hedge. It's a reason the hedge isn't the whole risk control, and why the share count still matters.

Second, "what's left is opportunity." Run the increment honestly. Once you count the T-bill yield we give up, ten extra hedged points lose roughly 0.8 to 1.1 percent of a full allocation in every bad outcome from 103 down to 70. At your own coin-flip odds, the good half has to average about 120 to 122 at December expiry just to break even. That's at or above the September 22 lower high of 120.40, the level where the last real rally was sold.

Your "two-tenths positive" assumes every good print lands between 120 and 130 and stays there into mid-December. This tape hasn't let good news hold.

On Sep 22 the stock opened at 120.15, closed at 116.31, and fell 4.7 percent the next day.

The bounce off the Oct 2 low reached 111.40, in the same week as the "jumps 4%" headline. Three sessions later the stock printed a new low at 104.75.

The print also isn't one number. The September quarter comes with guidance for the December quarter, which contains Singles' Day, peak subsidy season, and year two of a RMB 380 billion AI program. A clean September quarter with heavy December guidance is an ordinary outcome, and it doesn't take the stock to 125.

So the extra size isn't money left on the table. At even odds it's roughly zero expected value, with a fatter left tail than right. Only a June quarter that's genuinely good, not just less bad, moves it positive.

That's why I'll accept your sequencing, with conditions. Reading the filings before the CPI session was my point. Sizing the last third against a known target is sensible, since it avoids paying the bid-ask spread twice. The conditions:

Read the list designation Monday, not by CPI. It's a precondition for holding anything. If it turns out to be Treasury's list rather than 1260H, we're exiting, and nobody should be resting limit orders at 109.5 on a stock we have to sell.
Write down what "clean" means before anyone opens the June-quarter filing. The opex ratio clearly below FY2026's 34.9 percent by a stated margin. Positive operating cash flow for the quarter, not flattered by working capital. Quick-commerce losses narrowing. Commit the numbers first, so the filing gets judged rather than interpreted. Given the breakeven I just walked through, the bar should be high enough to plausibly carry the stock through 120.40.
The first two-thirds of the trim proceed on schedule regardless. If any of the three reads isn't done by Oct 23, the last third sizes to 40 with the hedge or 35 without. No step up on an unread document.

Third, the 130 call. Neutral, I accept your separation in principle. The put-spread cost is a signal about the tail, the net is a limit on bleed, and the short call adds nothing to the downside table.

But look at when the netting actually does the work:

At about 40 implied vol, the 100/70 alone is around four and a half with skew. We don't need the call.

At about 50 vol, the 100/70 alone is five and a half to six, and the 130 call is worth roughly two.

So the call rescues the hedge test only in roughly the 42 to 50 vol band. That's where the options market prices BABA at one and a half to one and two-thirds times its realized volatility of about 30. Higher implied vol means a higher market-implied chance of finishing below 70, where every tier is naked again. The netting grants the size step precisely when the odds of landing below our floor are highest.

I'll accept netting for the bleed test, but the put-spread-alone signal should be five, a sixth of the payout, not five and a half. Above five, the market is telling us the tail is rich, and the spread goes on the 35. Aggressive, I'll also take your condition: sell the highest strike that closes the gap, never below 130.

Fourth, the premium budget. Counting call premium received as an offset is fine, because it's part of the structure's cost. But "premium recovered" can't include proceeds from selling a spread after a gap or a vol spike. That money isn't a refund on insurance. It's the claim check against the loss we just took on the stock. If it refills the budget, then the worse the headline, the more budget we'd have to re-hedge and climb the ladder. That's backwards.

So the cap counts gross premium paid, minus call premium collected when the structure goes on. Payouts and surplus-spread sales offset stock losses; they don't buy new insurance. Neutral's 3 percent path also assumes post-print spreads cost about three points after a vol crush. If the print is good but policy risk keeps vol elevated through the lame duck, re-hedges cost more and the budget binds before the 80 rung. That's the rule working.

On a binding action, I'll take Aggressive's pre-commitment: hold or exercise the long 100 put, and buy back the short 70 the same session if we can't take assignment. Add one question for compliance: confirm that buying to close a short put in a designated name counts as permitted divestment. If it doesn't, we're short a put we can neither close nor be assigned on. Also, Neutral's seven-point buyback is a mid price, not a fill. A deep 70 strike in an 80-vol session will trade on a wide market.

Two shorter points.

On fundamentals, I concede the denominator. My "under 3 percent" excluded investment income while keeping the investment book in equity. Split the difference and it's roughly 5 to 6 percent pretax on the price. That's a few points over a 2.92 percent real yield, for a stock with an unresolved list designation and three straight years of falling operating cash flow. It's a reason to own some, which we do, not a reason to stretch.

On rates, Aggressive, a flat 2-year next to a 32 basis-point rise in the 10-year isn't comfort. It means the pressure is coming from term premium, which no FOMC meeting can talk down, and it's sitting under a VIX of 15. The rule already covers it. I just wouldn't treat the flat 2-year as a reason to relax.

So here's where I land. Sell BABA, executed as a trim.

The trim: - Sell a third of the reduction now. - Have two-thirds done by the session before September CPI, working limits from 106.5 to 109.5, and sell whatever is unfilled at that close. - Size the last third against the target the documents set, scaled through 108.2 to 109.5. If any read is incomplete by Oct 23, default to 40 hedged or 35 unhedged. - Finish the session after any close below 104.75.

The reading, in order: the list designation Monday, then the June quarter, judged against a definition of clean written before the filing is opened.

The hedge: - Price the December 100/70 and 100/80 today. - The 100/70 qualifies with the put spread alone at five or less, and a net of four and a half or less after a call at 130 or higher. - The 100/80 qualifies at four with no netting. - Cap premium at 3 percent of a full allocation through January, measured gross of payouts.

Size: tiers of 35, 35, 40, 45 and 50 as agreed, and 35 on a bad June quarter.

Before anything above 35 goes on: - Compliance confirms both assignment and buy-to-close on a short put in a designated name. - Operations confirms the Hong Kong conversion route, and what happens to our options if the ADR is suspended.

Everything else stands. Exit on binding action. The non-binding resize. Cuts at 91.99 and 99.74 with no exceptions. The rates shade. The revert rule, with policy setting the ceiling. The 60/70/80 ladder, with the hedge filled before each step. The short in flat books only, under the new stand-aside rule. Proceeds in short Treasuries near 4.8 percent.

The 100/70 made this a much better plan. But a hedge is a contract, and contracts have conditions. The size above 40 pays only if the print carries BABA through a level it hasn't held since September. It stays safe only if the tail stops above the 2022 low and the market is open when we need it. Until those are confirmed, the share count is still doing real work, and 40 is where I'd hold it.

Neutral Analyst¶

Neutral Analyst: Neutral Analyst: I agree with both of you on direction. This is a Sell, executed as a trim. But each of you has built your version around the risk you personally fear most, and that leaves a blind spot on each side. Let me work through both, then put forward a version I think the desk can actually live with through the next six weeks.

Aggressive colleague, start with the contradiction in your own framing. You say the most likely scenario is continued downtrend and you want a short to harvest it. You also want to keep half a long, hedged with puts. If someone holds BABA and expects it to go lower, the cheapest way to act on that is to own less of it. A short layered on a hedged long isn't asymmetry. It's a more expensive way to reduce net exposure, adding borrow cost, close-based stop slippage and squeeze risk on stimulus headlines that StockTwits is already chattering about.

On the stop math, I think both of you are wrong in opposite directions. Measuring the risk to 114.44 overstates it, because the stop is a daily close above 111.40, not the SuperTrend flip. Calling it 2.5 points understates it. Oct 8 alone ranged 4.64 points, so a close-triggered stop on a bad day realistically fills around 113 to 114. Call it 3.5 to 4.5 points of real risk. At four points against a nine-point first target, that's about 2.2 to 1, which pays if it works roughly a third of the time. So the short isn't a bad trade in isolation. It's just the wrong tool for anyone who owns the stock. If there's a separate, flat trading book that wants it, run it at about half the size the 2.5-point stop implies. Take half off at the lower band or the 100 to 101 gap fill, and be flat before the print.

The opex rebound is where your case is most optimistic. The bull thesis needs two things that pull against each other. Jefferies' 50%-plus cloud growth depends on Alibaba continuing to spend heavily on AI. Non-current assets are up RMB 287 billion in two years, and the depreciation on that build-out keeps arriving whether management wants it or not. Cutting AI spending to fix the margin would undercut the very narrative that keeps buyers stepping in on dips. That leaves the quick-commerce subsidy as the only lever that moves fast, and that's a three-way fight with Meituan and JD that Alibaba can't end alone.

A six-point drop to 29% in one quarter is the full-success case, not the base case. I'd rewrite the earnings gate around direction. That means the opex ratio clearly down from the 34.9% run rate, quick-commerce losses narrowing, and operating cash flow improving. Hitting 29% earns a full rebuild step. Clear improvement short of that earns a partial one.

Your rebuild trigger also has a problem. Going to 75% to 100% on a single close above 114.44 means buying with the upper band at 115.24 and the falling 50-day at 116.38 sitting right on top of you. This tape has trapped buyers at 132.57 and 120.40 already. And your time stop doesn't "handle it" the way you say. If 108 never comes, the plan leaves you at 60% until Oct 30, unhedged, through the late-October FOMC and into the Nov 3 midterms. That's exactly the window all three of us agree is dangerous.

Conservative colleague, your critique of the protections is mostly right. A Treasury escalation arrives as a gap, ATR doesn't model policy shocks, and the capitulation exception is a rationalization trigger. One small correction, though. The put spread doesn't pay nothing until 100. That's only true at expiry. A December put gains value as the stock slides toward 100, so the hedge works earlier than you're giving it credit for.

Your other adjustments overcorrect, and in a couple of places they work against each other. Start with valuation. You and the aggressive side both quote roughly 41 times core earnings as if it were the estimate. It's the bear bound. The fundamentals report says plainly that interest income on Alibaba's investment holdings is real and recurring. True core earnings therefore sit somewhere between about $2.40 and $6.15 per ADS, which puts the multiple somewhere between roughly 17 and 44 times. You also have about 1.7 times book on RMB 1.06 trillion of equity. That isn't a screaming buy, but it isn't a reason to shrink the core to a third either.

Then there's the collar. Selling calls at 120 caps the position right at the September lower high, a level a good print could clear in a single session. The only reason any of us is keeping a core is that print. Your own rebuild rule says go to full size only above 131. So you'd be short 120 calls while waiting to buy above 131. If we collar, the short call belongs near 130, at the 200-day and the weekly flip, where a real trend change would have to happen anyway. Pair it with a long 100 put and a short 80 put, expiring after the report. If the chain makes that too expensive, skip the hedge and go smaller instead.

Selling half the trim right now at 105 to 107 means selling into the lower band at the top of an unfilled gap. That's with a weekly TD count at 7 and an RSI and MACD divergence forming. The technical report names 108.2 to 109.5 as the lower-risk selling zone. Your point about a break into the gap is fair, though, so make the trim conditional rather than arbitrary. Sell about a third of the planned reduction now and the rest into 108 to 109.5. Add a contingent rule: a daily close below 103.78 means finish the trim the next session. I'll take your hard deadline of Oct 23, because it puts us at target size before the FOMC and the midterms.

Your 99.74 cut should depend on whether the hedge is on. If the 100/80 spread is in place, it starts paying right around 100, so dumping stock at 99.74 just sells the portion you already paid to protect. If hedged, cut to 25% on a daily close below 91.99 with no capitulation exception. If unhedged, use your 99.74 level.

"Any formal congressional action naming BABA" is too broad a trigger for a midterm month. Committee letters and hearing mentions will be everywhere, and they don't force anyone to sell. Forced selling comes from a Treasury investment ban, an executive order, or a delisting mandate. Exit fully on those. A non-binding action that names BABA specifically should cut the position to 25%, not zero.

Finally, "buy it in December with evidence" sounds prudent, but if the September quarter validates, that evidence gets priced in an opening gap. Requiring two consecutive clean quarters before full size pushes the rebuild into spring 2027, after most of any re-rating has happened. That's the whole argument for carrying some core through the print.

There are a few things neither of you addressed. The first is that we still don't know which list BABA is on. Confirming whether it's the Defense Department's 1260H list or Treasury's investment-ban list, and what the lawsuit is about, should happen before the trim is finished. If it's already the Treasury list, this whole debate is moot and we exit.

The second is the missing June quarter. The Aug 21 drop, 8.6% on 32.5 million shares, fell in the window when Alibaba usually reports that quarter. I can't confirm it was the earnings reaction. If it was, though, the market has already delivered a verdict on the opex trend, and we need to know what it saw before betting on a November reversal.

The third is the evidence on each side. On the positive side, the yuan held flat while the broad dollar rose about 3.3%, which is quiet policy support you've both ignored. On the negative side, RSI never reached 30 and retail sentiment is still mildly bullish without engaging the list risk at all. There's been no capitulation, so the low isn't obviously in. That supports trimming, but it also means this isn't a crowded short.

The fourth is rates. The 10-year at 5.30 to 5.31% is the line to watch. A sustained break above it, with real yields through 3%, should shade the core five to ten points lower. A move back under 5%, with Brent heading toward 100, lets us hold the top of the range.

Here's my adjustment to the trader's plan. Sell, as a trim to a base core of about 40% of a standard allocation. Go up to 50% only if the put-spread collar with a call near 130 is actually filled at a sensible cost. Drop to 35% if no hedge is available.

The math on that base is what convinces me. A 40% unhedged core gapping to the low 70s costs about 12.8% of a full allocation. That's roughly the same as the trader's 50% core gapping to 80, which costs about 12.2%. Same loss budget, but it survives a deeper gap that ATR-based sizing can't see.

Execute the trim as described: a third now, the rest into 108 to 109.5, finish on a close below 103.78, and be done by Oct 23. Exit on any binding Treasury, executive or delisting action. Use 91.99 as the cut level if hedged and 99.74 if not, with no exceptions.

Rebuild in a ladder. A clear earnings gate takes the position to 60% over a few sessions. A close above 114.44 with OBV rising, ideally holding above the 50-day, takes it to 75%. Full size comes only on a weekly close above about 131 or a second clean quarter. A price signal without the earnings gate gets you back to 50% at most. Park the proceeds in short Treasuries at about 4.8%.

That keeps real exposure to the one event that could re-rate the stock without betting the book on a margin swing, a policy decision or a midterm headline we can't predict. Neutral Analyst: Neutral Analyst: We've narrowed this a long way. All three of us are at a Sell on BABA, executed as a trim. We agree on a hedged core into the September-quarter print and an Oct 23 deadline. We agree on a full exit on any binding Treasury, executive or delisting action. And we agree on cut levels of 91.99 hedged and 99.74 unhedged. What's left is the size of the core, the short, the non-binding trigger and the speed of the rebuild. On most of those the real gap is smaller than the rhetoric. Where it isn't, each of you is leaning on an argument that doesn't hold up.

Core size. I'll start by giving ground. Conservative, your arithmetic on my 40% is right. A 40% unhedged core gapping to 70 loses about 13.5% of a full allocation, which breaks the trader's own 12.2% budget. So the unhedged number has to be 35. Aggressive, that same arithmetic kills your fallback of 40% if the hedge can't be bought. It's the identical 13.5%. Nobody at this table gets to carry 40 unhedged.

Conservative, your hedged comparison has the mirror-image problem. Aggressive compared a hedged 50 against unhedged smaller cores, which flattered the hedge, and you were right to call it. But your own comparison, hedged 50 against hedged 35 with a four-point premium you picked, shows something narrower than you claimed. The extra fifteen points of hedged stock is purely a bet on the print. Its value depends on what we know going into November, and right now we know almost nothing about the three things that matter.

You said you'd sign off on 50 if three checks clear: the list turns out to be 1260H, the lawsuit isn't existential, and the June quarter shows opex already turning. Aggressive said to get the data rather than size down blind. Those are the same position. So let's write it that way: - 35% unhedged. - 45% with the put spread actually filled. - 50% only with the spread on and all three checks clean.

All three checks are public documents. Read them this week instead of arguing about them.

At your four-point premium, a hedged 45 loses about 8.4% of a full allocation in the drop to 70. That's comfortably inside budget, and it makes roughly 4.4% if the print gaps the stock to 120. Make the premium a rule rather than a guess. If the 100/80 costs more than about four points, a fifth of its maximum payout, the market is pricing BABA's event risk richly. At that point the cheaper protection is simply less stock, so sit at 35.

Hedge expiry. Conservative, your timing point is the best argument you've made, and it needs a rule, not just a smaller number. The spread expires after the report, but the escalation risk runs into January. A hedged 45 left on after expiry is an unhedged 45, and that loses about 15% in a ban gap. So when the hedge expires or is closed, size reverts to 35 unless the earnings gate has passed, just as the cut level reverts to 99.74. That covers the post-expiry world without forcing us to be small through the one event we're holding for.

One correction on your mid-life point. If a ban forces us out of the stock, nothing forces us out of the spread that same morning. It's defined risk, so we can work it rather than dump it at a discount.

The collar. On the strike, the aggressive side and I agree. Conservative, you're right about the consequence: at 130 the call brings in very little, so this is mostly a put spread at full price. I'd rather pay that than cap the core at the September high. Sell the 130 if it's worth anything, but don't sell 120s to make the hedge cheap.

The short. You two are arguing over whether a flat book runs half size or 60% of the original. That's a rounding error on a trade that doesn't touch anyone who owns the stock. Call it half and move on.

Both of you did misread the one live example, though. Conservative, you said the Oct 2 to Oct 5 bounce landed "exactly at your stop level." The stop is a close above 111.40, and 111.40 was the Oct 5 high, so the close was at or below it. A close-based short from 109.5 survived that day and was about 3.8 points in the money by Oct 8. That's the best evidence we have that the stop structure works.

Aggressive, the next instance cuts against you. The Oct 8 rally died at 109.39, eleven cents under your entry. A resting order at 109.5 missed the very rejection you've been citing all session. Whether it's a flat-book short or a holder's extra slice, scale the orders through 108.2 to 109.5 instead of parking them at one price.

On the extra slice for holders, conservative is right that buying it back at 100 to 101 breaks the trader's rule against adding into the gap. But the technical report offers a principled exception rather than a blanket ban. It calls a completed weekly TD 9 in the 95 to 101 zone, with RSI and MACD still rising, a better setup than anything available today. Make that the only way the slice comes back outside the earnings ladder.

On the minefield exchange, conservative, you're right that a list of risk events is a statement about variance, not direction. But your 35% is a directional call too: it says BABA trails a 4.77% two-year over six weeks. All three of us are expressing the same bearish view through size. The short only matters for someone with no stock to sell.

Fundamentals. Putting numbers on the opex case disciplines both of you. Aggressive, your three-point improvement takes operating income to about RMB 81 billion. Taxed at 20%, that's roughly $3.85 per ADS of operating earnings, so 105.70 is still about 27 times before interest income. Even a full return to the FY2025 opex ratio gets operating-only earnings near $6.80, about 16 times. The good case makes BABA fairly valued, not cheap. That supports carrying a core into the print, not paying up for one beforehand.

Conservative, comparing a 4% earnings yield to a 4.77% nominal two-year isn't quite fair. Earnings grow with the economy; a bond coupon doesn't. The better yardstick is the 2.92% real yield. Against that, the premium is about one point at the midpoint multiple and about three at 17 times. That's thin for a stock carrying list risk, which is why we're trimming. But it's positive, which is why we're not exiting.

Your cash-flow argument also cuts both ways. If operating cash flow fell almost in step with opex, the spike wasn't accounting noise, and you've won the point on amortization. But cash subsidies are the easiest line in the whole cost base to switch off, far easier than depreciation on data centers already built. Whether that switch gets flipped is exactly what the June quarter would show. And if Aug 21 was the June print, an 8.6% drop on 32.5 million shares says the market didn't see it then. That's one more reason to read the filing before Oct 23.

Execution. Aggressive, I'm holding at a third now. "It bounced last time" is a single observation, and the unfilled gap underneath is real.

Conservative, I'll take your 104.75 trigger over 103.78. It's a fixed swing low rather than a moving band, it's only about 0.3 ATR away, and a close below it erases the failed-breakdown setup, the one bullish footnote in the volume picture.

I'd add two timing points: - Be at least two-thirds done before September CPI in mid-October, since that print decides whether the rates rule fires. - Finishing by Oct 23 has a second benefit. Many US mutual funds close their tax year at the end of October, so we're out ahead of the heaviest institutional tax-loss window.

The weekly TD 9 can complete the same week as our deadline. That isn't a reason to stop trimming. A 9 signals a mature trend, not a bottom. It gives permission to buy back the slice near 95 to 101, nothing more.

Non-binding congressional action. You both overreach here. Aggressive, "hold and let the puts work" treats a six-week hedge like permanent insurance, when it's really a six-week rider against a risk that runs into a new Congress. Conservative, cutting to 20 to 25% while hedged sells shares we've paid to protect.

The middle ground is this. A non-binding action naming BABA raises the odds of escalation after the hedge lapses, so resize for that world: - If hedged, drop to the 35% unhedged base and keep the spread on what's left. - If unhedged, go to 25.

The rebuild. Aggressive, you can't have it both ways. Your case for the short is that gap-up opens in this stock get sold: on Sep 22 it opened at 120.15, closed at 116.31 and fell 4.7% the next day. Then you want to buy straight to 75% at the open of the earnings gap. By your own evidence, scaling in over three sessions costs very little.

Conservative, 50% on a passed earnings gate barely gets us back to the trader's starting point after the best news we could realistically get.

My ladder: - A passed gate takes the core to 60, bought over three sessions. - The gate plus a close above 114.44, with OBV making a higher swing high, takes it to 70. Conservative, your definition is right; one green day isn't confirmation. - The gate plus a weekly close above 120.40 takes it to 80, because that breaks the lower-high sequence. - Full size only on a weekly close above the weekly SuperTrend, which trails down from 131 the longer this lasts, or after a second clean quarter. - A price signal without the gate caps the core at 50.

Anchor these triggers to fixed swing levels and OBV, not the falling 50-day. Conservative is right that an average that gets easier to clear as the trend worsens isn't measuring strength. Use it as a map of resistance, not as a trigger.

The summer run actually makes my case. A 44% move in six weeks says being too small costs real money. Giving back two-thirds of it says being too big costs real money too. A stock that swings that hard both ways calls for moderate size and a ladder, not a high-conviction bet in either direction.

Macro. Conservative, the rates rule isn't "about to fire." The 10-year peaked at 5.31 on Oct 5 and sits at 5.28 now, right at the line. Pre-commit rather than pre-empt. Two consecutive closes above 5.31 with real yields through 3% shades the core five points. A move back under 5% lets us hold the top of the range.

Aggressive, the oil relief is real, but it rests on a pledge that expires Nov 3. That's inside our hedge window and before the print, which is one more reason the hedge has to expire after the report, not before it.

Bottom line: Sell BABA, executed as a trim. - Sell a third of the reduction now. - Scale the rest through 108.2 to 109.5, with two-thirds done before CPI. - Finish the session after any close below 104.75, and be at target by Oct 23. - Hold the core at 35% unhedged, 45% with the 100/80 filled at four points or less, and 50% only with the spread on and the list, lawsuit and June-quarter checks clean. - When the hedge comes off, revert to 35% and the 99.74 cut unless the gate has passed. - Exit on any binding action. A non-binding action naming BABA takes a hedged core to 35 and an unhedged core to 25. - No short against a core. Flat books run half size and are flat before the print. - Rebuild on the 60, 70, 80, full ladder. - Park the proceeds in short Treasuries near 4.8%.

That keeps the conservative default and the aggressive upside, and the choice between them gets settled by reading three documents rather than by whoever argues harder. Neutral Analyst: We're down to a handful of rules. On most of them, the gap between you two is worth about a tenth of a percent, or it gets settled by a filing we can read this week. Two of them are bigger: the floor on the hedge and the revert rule. I'll spend most of my time there.

Start with the two hedge tables, because each of you proved something different from what you claimed.

Aggressive, comparing a hedged 45 with an unhedged 35 answers one question: if the spread fills, is that safer than our fallback? Yes. Conservative, comparing hedged with hedged answers another: once we've paid for the spread, do we spend it on size or on safety? Neither table answers the other's question.

Look at what your table actually shows, Conservative. The middle losses, about four-tenths of a point flat and nine-tenths in the grind to 93, are the premium plus the stock drifting lower. Any stock in a downtrend costs that, hedged or not. That's the directional question, and we've agreed all along that the June quarter answers it.

The only part of your table that's a real hedge problem is the bottom: minus 1.9 at 70 and minus 2.8 at 60. That comes entirely from one choice nobody has questioned, which is selling the 80 put.

Use your own Black-Scholes sketch. At 40 vol, ten weeks out, the 80 put we're selling is worth about a third of a point. At 45 vol, or with normal put skew, it's closer to two-thirds. A 70 put is worth a dime or less. So moving the short leg from 80 down to 70 costs roughly a third to a half of a point, a bit more with skew. That buys ten more points of protection, right through the 70 stress we've all been using. It's the cheapest insurance on this table.

Run it with a December 100/70 at four and a half points: - A hedged 45 loses about 4.3 percent of a full allocation in the gap to 70, not 8.4. - It doesn't breach the trader's 12.2 percent budget until around 51, below the 2022 low you cited. - A hedged 40 holds into the high 40s.

Those are expiry values. Before expiry the spread pays a few points less, and that matters for the sizing below.

Conservative, this isn't stretching the cap. The rule I proposed, and the one you wrote into your own re-hedge condition, is premium no more than a fifth of maximum payout. Four points on the 100/80 is 20 percent of its payout. Four and a half on the 100/70 is 15 percent, which is better value. I'd still set an absolute ceiling of about four and a half, so a flat tape costs under 2 percent of an allocation.

If neither fits, meaning the 100/80 is over four and the 100/70 is over four and a half, we're at 35 unhedged. With an earnings print and a defense listing inside the window, I accept that's the likely planning case. Someone should price both spreads before today's close.

Once the tail is closed, size is purely a question of direction, and there I'll give Conservative some ground. Every point above a hedged base is a bet that the September quarter turns the margin. We haven't read the one document that tells us the odds. So the tiers should be: - 35 unhedged. - 40 hedged as the base, not 45. On the 100/80, forty holds the budget down to about 57 at expiry, roughly the 2022 low. On the 100/70 it has room to absorb the shortfall before expiry. - 45 hedged once the June quarter shows opex already turning. - 50 with all three checks clean.

Aggressive, that costs you five points of hedged stock until a filing gets read. By Conservative's own table, those five points are worth about one point in the re-rating case. If the June quarter is good, you're at 45 by Oct 23 anyway.

The revert rule is the most important open item.

Conservative is right on principle: the earnings gate tells us about opex and nothing about Treasury. Aggressive, your exception would carry us from 60 to 80 unhedged straight into the lame duck. Conservative's numbers on that are right. A ban gap would cost 20 to 27 percent of an allocation, roughly double the budget, right after we'd been proven right on margins. That's the worst sequence on the board, and the gate exception walks us into it.

But Conservative, your fix is less restrictive than it sounds. After an earnings report, the event premium drains out of the options, so re-hedging a rebuilt position after the print is usually cheaper than hedging into it. I'd write the rule this way: - Policy status sets the unhedged ceiling. - The earnings gate sets the rungs. - Any rung above the ceiling needs a fresh spread struck near the then-price, under the same fifth-of-payout rule.

That's your first condition, and it should usually be available. Your second condition, the tail being retired, needs a date so it can actually be met. I'd define it as Congress adjourning for the year without a binding proposal naming BABA, with the list and lawsuit checks already clean. That lets the unhedged rebuild happen in late December rather than never.

That also settles January. Aggressive, don't buy January now. A January spread pays event volatility for the print and keeps paying elevated volatility for weeks afterward. Conservative's sketch says it probably doesn't fit the cap anyway. Buy the December expiry, which clears the report, the midterms and Singles' Day, and roll after the print once the event premium is gone.

On non-binding action, Conservative gets the outcome, but not for the reason given. Keeping the surplus spread isn't a short against the core. With the stock in the high 90s, 35 shares against 45 spreads is still net long something like 15 to 20 points of stock, so "a bearish trade through the options book" doesn't hold. The real reason to sell the surplus is timing. Implied volatility spikes the session after a headline, and most of what the surplus is worth then is volatility that decays if escalation doesn't follow. Selling options into a vol spike is the right trade whatever your view. So sell the surplus then and keep the spread on what's left. Conservative's extension, that the post-hedge ceiling drops to 25 after a non-binding action, follows from my own argument last round, so I'll take it.

On pace, I'm holding at two-thirds before CPI, for the reason Conservative gave. Aggressive, the rates rule decides how much we hold. The pace decides what price we get for shares we've already decided to sell. Those are different risks, so nothing is counted twice.

But two-thirds before the print doesn't mean dumping at 105. Work the second third with limit orders scaled from about 106.5 up to 109.5 until the session before CPI, then sell whatever is unfilled at that close. The last third stays in the zone for exactly the cool-CPI bounce you want.

On the holders' extra slice, you're arguing over roughly a tenth of a percent. A five-point slice sold at 109 and bought back at 112 costs about 0.14 percent of an allocation. The logic matters more than the money. Conservative, if the slice is permanent, it's just a lower target size, and we've spent four rounds settling target size. If it's a trade, it needs a stop, and a stop that waits for OBV to make a higher swing high isn't a stop. So Aggressive keeps a close above 111.40 as the buyback trigger. Conservative's precedence rule sits on top, and it's a good one: cuts override buys, and the slice never comes back past the tier the hedge status allows.

On the ladder, Conservative is right on two counts. The gate can't be written until we've read the June quarter. And a trailing SuperTrend has the same flaw as the falling 50-day, which was my mistake.

I'd add one thing to the gate. Write it against the June quarter, not year over year. The year-ago September quarter sat inside the 2025 subsidy war, so a year-over-year opex comparison would flatter almost any print.

For full size, swap the trailing SuperTrend for a fixed level: a weekly close above 130.62, the August 20 high that started the lower-high sequence. But Conservative, requiring the gate, that price and the retired tail all at once means a second clean quarter can never earn full size until the stock has already run about 24 percent. Keep both paths. Full size needs the tail covered, plus either the gate with a weekly close above 130.62, or a second clean quarter.

Two corrections on fundamentals, one for each of you.

Conservative, "growth we don't have" leans on 2.7 percent revenue growth. The fundamentals report says FY2026 revenue was held down by the Sun Art and Intime disposals, so organic growth was probably higher. Growth is slowing, not gone.

Aggressive, 16 times at the FY2025 opex ratio is the full-success case, as you've conceded. The honest middle is a three-point opex improvement plus recurring interest income, which both of your multiples leave out. Suppose 10 to 15 billion RMB of the 53 billion non-operating line is genuinely recurring interest. That's my assumption, not something in our data. Then the good case moves from 27 times into the low-to-mid 20s, an earnings yield a little over 4 percent. That's fair value against a 2.92 percent real yield, not cheap. It justifies carrying a hedged core into the print, but not paying up for a bigger one beforehand.

One point neither of you has drawn out. Conservative, you're right that the flat yuan didn't stop BABA's lower lows, but that tells us something. If the policy-supported currency held while the stock fell, the selling is about BABA itself: the list, the lawsuit, the opex. It isn't China macro. That's why the news report warns that a KWEB or FXI hedge won't cover this, and why the protection has to be on BABA, sized to BABA's own tail.

On the tape, you're each half right. Aggressive, saying seven weeks of known news is fully priced doesn't square with OBV falling 75 million shares in twelve sessions. Conservative, RSI never touching 30 also means nobody has been forced out yet. That's distribution without capitulation, which is the textbook case for trimming rather than exiting. Today's close also tells us whether the weekly count holds at 7, so by tonight we'll know whether a 9 is possible in our deadline week.

Here's where I land: sell BABA, executed as a trim.

The trim schedule: - Sell a third now. - Have two-thirds done by the session before CPI, working limits up to 109.5. - Sell the rest into 108.2 to 109.5. - Finish the session after any close below 104.75, and be at target by Oct 23.

The hedge: - Price the December 100/80 and the December 100/70 today. - Take the 100/70 if it's under four and a half, otherwise the 100/80 at four or less. - If neither fits, stay unhedged.

Core size: - 35 unhedged. - 40 hedged. - 45 hedged once the June quarter shows opex turning. - 50 with all three checks clean.

When the hedge comes off, policy sets the ceiling: 35 by default, 25 after any non-binding action. The earnings gate earns rungs above that only with a fresh hedge after the print, or once Congress adjourns with the list and lawsuit clean.

Policy and price triggers: - Exit fully on any binding Treasury, executive or delisting action. - On a non-binding action, cut a hedged core to 35 and sell the surplus spread into the volatility spike. - Cut at 91.99 while hedged and at 99.74 when not, with no exceptions. - Shade the core five points on two closes above 5.31 with real yields through 3 percent.

Rebuild and tactical: - Rebuild 60, 70, 80 against a gate measured against the June quarter, written down before Oct 23. - Go to full size on a weekly close above 130.62 or a second clean quarter, with the tail covered either way. - Flat books can short half size and must be flat before the print. - The holders' extra slice comes back on a close above 111.40 or a completed weekly 9, and cuts always come first. - Park the proceeds in short Treasuries near 4.8 percent.

Aggressive gets a hedge that actually protects the size he wants to carry, and a rebuild path that doesn't wait until spring. Conservative gets the tail closed down past the 2022 low, and a revert rule the earnings print can't override. And the last five points of size get decided by a filing we can read this week, not by whoever argues hardest. Neutral Analyst: Since today is the weekly close, I'll start with a practical point and then settle what's still open.

If BABA closes above 109.30 today, the weekly TD count resets and the TD-9 buyback exception goes away. But that same close puts the stock inside our selling zone, and the trim fills at the prices we wanted. If it closes below, the count stays alive and we keep working limits. Either way the trim goes ahead.

What's left is five points of core, the 130 call and the premium cap. To get there, each of you made the same mistake: you compared things on different bases. Once the comparisons are like-for-like, most of the answer falls out.

Conservative, you were right to catch the aggressive side comparing a 45 core on the 100/70 with a 35 on the 100/80. Then you did the reverse. To make the ranking flip, you marked the hedged 45 mid-life, at 80 vol with five weeks left, and set it against your 35 on the 100/80 at full expiry value. Mark your own hedge the same way. Under those assumptions, with the stock at 70, your short 80 put is ten points in the money and carries a lot of time value. The same Black-Scholes sketch puts the 100/80 at about 17 and a quarter, not 20. Your hedged 35 then loses about 7.4 percent of a full allocation, against 7.0 for the hedged 45 on the 100/70. The ranking doesn't flip. What your mid-life point really shows is that the short leg costs more than any of us priced, on every structure, and the 80 short leg costs the most.

Calling the extra ten points a risk reversal is correct by put-call parity, but it's equally true of your own hedged 35. Long stock plus a long 100 put plus a short 70 put is a long 100 call and a short 70 put, whether you hold 35 units or 45. The breakeven works the same way: your hedged 35 also needs about 111.2 to beat T-bills. Neither the label nor the breakeven separates 35 from 45. And the 130 call doesn't "write the ban tail." The short 70 put sits in every hedged tier at this table, including yours. The call helps pay for the long 100 put and gives away whatever is above 130 by December. It adds nothing to the downside.

Aggressive, "a floored call on the print" is just as loose. The floor of about a point per ten points of size is an expiry number, and it only holds between 100 and 70. Mid-life in a gap it's closer to a point and a half, and below 70 losses resume at the full rate.

Here's the number that settles whether those extra points are worth carrying today. On your own payoffs, ten extra points: - lose about a point anywhere from 100 down to 70, - lose about four-tenths of a point in a flat tape, - make about nine-tenths at 120, - make about 1.9 at 130.

Add the T-bill yield we give up, and that increment needs roughly a 40 to 45 percent chance of a good print just to break even. All three of us signed a Sell because we think today's odds are worse than that. So the extra size isn't a bounded free option, and it isn't a bet against the Sell either. It's an increment with roughly zero expected value, and its sign depends on evidence we can read this week. That's why the 45 step is gated on the June quarter and the 40 isn't.

That also answers your point that defaulting low is a directional call. The 40 isn't a forecast of the filing. It's the size that fits the evidence we have now, and that evidence is what produced a Sell. Conservative, the same logic applies to you. The Aug 21 drop is an inference about that filing, just as the aggressive side's "seven weeks priced in" is. Neither of you gets to use it once the document is on the desk.

On the 100/80 tier, I'm moving to 35, and I'll justify it with my own rule rather than the conservative's. Ask when the 100/80 would be the only structure that qualifies. The 100/70 is just the 100/80 plus an 80/70 put spread. If the 100/80 comes in under four and the 100/70 comes in over four and a half, the market is charging more than half a point for the band between 80 and 70. That's at or above the top of the range I estimated last round. That's put skew telling us the tail below 80 is priced rich, and in that situation the cheaper protection is less stock. A 40 on the 100/80 also breaks the trader's 12.2 percent budget around 57 at expiry, right at the 2022 low, and earlier than that before expiry.

So it's 35 on the 100/80, and the 40 base requires the 100/70. Aggressive, that's five points off your proposal. But it only binds in the case where the options market is explicitly warning us about the deep tail.

On the 130 call, each of you has half of it right. My fifth-of-payout rule was a signal about how the market prices BABA's downside. The four-and-a-half ceiling was a separate limit on bleed, so that a flat tape costs under 2 percent of an allocation. Those are different rules doing different jobs.

Conservative is right that a short call can't change what the put spread says about the tail, so it can't be used to slip past the signal. But it does change the bleed, because in a flat tape the call expires worthless and the net premium is the real cost. So test the two separately: - The put spread alone must cost no more than about five and a half, which is under a fifth of its 30-point payout, so the signal hasn't fired. - If it costs more than four and a half, a call at 130 or higher can close the gap, and the net is what gets judged against the bleed ceiling.

Conservative, yes, that buys the 40 tier. I'm fine with it, because it doesn't change a single number in the downside table. What it gives up is BABA above 130 by mid-December, and our ladder buys full size above 130.62 with new stock anyway. The realistic print outcomes, a gap to 115 or 120, aren't affected.

The cumulative premium cap is a good rule, but as written it collides with the revert rule. Your own math puts the December spread on a 40 core at about 1.7 percent, plus about 1.8 for a post-print re-hedge on a 60 rung, which breaks three. But the re-hedge doesn't have to cover the whole core. The policy ceiling is, by definition, the size we're willing to carry unhedged through a ban gap. So a fresh spread only needs to cover the shares above it: 25 points on a 60 rung, not 60.

After the print, with the event premium gone, a three-month spread struck near the then-price might cost around three points. That's roughly 0.7 percent of an allocation for the 25 points above the ceiling, and about 1.3 percent for the 45 points above it at the 80 rung. The whole path, from the December bridge to the 80 rung, comes in around 3 percent. So take your 3 percent cap and your rule that the spread is filled before the step it protects, with one clarification: post-print hedges cover only the shares above the policy ceiling. That's the aggressive rebuild with your budget line attached.

Your compliance point is the most useful new item from last round, and I want to sharpen it, because I think it cuts both ways. If I have the existing Treasury investment-ban rules right, and compliance needs to confirm this, the prohibition doesn't bite until roughly 60 days after a listing, and selling to divest is allowed for up to a year. That's longer than a December spread lives. So the long put can be held or exercised, and exercising it counts as selling. The real problem is the short 70 put, because being assigned on it means buying a designated security. If compliance says we can't take that assignment, we have to buy the short leg back, and then your mid-life mark becomes the realized number rather than a paper one.

So plan on it. Using that mark, at 80 vol with the stock at 70: - a hedged 35 loses about 5.4 percent of an allocation, - a hedged 40 about 6.2, - a hedged 45 about 7.0.

At 60, those become about 7.5, 8.6 and 9.7, and even the 50 tier loses about 10.7. Every tier on the 100/70 stays inside the 12.2 percent budget under the harshest marking anyone has proposed. Aggressive, that's your strongest point, but it supports the tiers we already have, not bigger ones.

On fundamentals, conservative, your new number is accurate but mismatched. Operating income at 4.8 percent of average equity, about 2.9 percent pretax on the price, strips interest and investment income out of the numerator. But the denominator still includes the investment book that earns that income: the Ant stake and the short-term investments. Using FY2025's operating margin, the same calculation gives about 8.4 percent. The truth is somewhere in between, as we've said for three rounds.

Aggressive, "fair value at a trough" still assumes we're at the trough. Three straight years of falling operating cash flow is a trend, not one bad year. The June quarter is the first data point after the spike, which is exactly why it gates the 45.

On rates, you now both agree this move is driven by real yields and term premium, not inflation. That's what the rates rule already covers: two closes above 5.31 with real yields through 3 percent, whenever they happen. The pace is settled at two-thirds before CPI. We don't need a third mechanism.

So here's where I land. Sell BABA, executed as a trim.

Execution: - Sell a third of the reduction today. - Have two-thirds done by the session before September CPI, working limits from 106.5 to 109.5, and sell whatever is unfilled at that close. - Sell the rest into 108.2 to 109.5. - Finish the session after any close below 104.75, and be at target by Oct 23.

Hedge: - Price the December 100/70 and the December 100/80 before today's close. - The 100/70 qualifies if the put spread alone costs about five and a half or less, and the net, after selling a 130-or-higher call if needed, is four and a half or less. - The 100/80 qualifies at four or less, with no call netting. - Compliance confirms whether we can take assignment on a short put in a designated name before we rely on the spread.

Size, as a share of a standard allocation: - 35 unhedged. - 35 on the 100/80. - 40 on the 100/70. - 45 once the June quarter is read and shows opex turning. - 50 with the list, lawsuit and June quarter all clean. - Back to 35 if the June quarter shows opex still rising. - The list check is a precondition for holding anything, since a Treasury designation means exit. The lawsuit and the June quarter gate everything above 40.

When the hedge comes off: - The policy ceiling governs: 35, or 25 after any non-binding action, with the 99.74 cut. - Rungs above the ceiling need either an adjourned Congress with the list and lawsuit clean, or a fresh post-print spread that covers only the shares above the ceiling, is filled before the step, and fits inside a cumulative premium budget of about 3 percent of an allocation through January.

Triggers: - Exit fully on any binding action. - On a non-binding action, take a hedged core to 35 and sell the surplus spread into the volatility spike. - Cut at 91.99 while hedged and at 99.74 when unhedged, with no exceptions. - Shade the core five points on two closes above 5.31 with real yields through 3 percent.

Rebuild and tactical: - Rebuild in steps of 60, 70 and 80 against a June-quarter gate written down before Oct 23. - Go to full size only with the tail covered, plus either the gate and a weekly close above 130.62, or a second clean quarter. - Flat books run the half-size short and are flat before the print. - The holders' extra slice comes back on a close above 111.40 or a completed weekly 9, with cuts always first. - Park the proceeds in short Treasuries near 4.8 percent.

What's left between the two of you is five points of core, worth roughly a point of an allocation at most in any scenario anyone has named. What actually moves the outcome is pricing the chain today, reading three documents this week, and getting one answer from compliance. That's where the remaining effort should go. Neutral Analyst: I'll skip the weekly close. Tonight tells us whether the TD count holds at 7, and the trim proceeds either way.

Reading both of your last rounds, almost every live disagreement traces back to one leg of the hedge: the short 70 put.

The five versus five-and-a-half fight is about how the 70 band is priced. Conservative, your new table at 50 exists because protection stops at 70. Both compliance questions, assignment and buy-to-close, are about the short put. The risk-reversal label comes from the short put. And Aggressive's own mid-life numbers put the forced buyback of that leg at about seven points in a gap, on a market Conservative rightly says will be wide.

So what does that leg actually earn us? On our own sketches, almost nothing. Conservative priced the 100/80 at about four at 40 vol, and I put the 80 put at about a third of a point. That makes an outright December 100 put a little over four. The 70 put is worth a few cents at 40 vol, maybe a third to half a point with heavy skew. So the 100/70 saves us between a nickel and half a point compared with simply owning the put.

Now look at the call. Aggressive priced a 130 call at roughly a point at 40 vol, and Conservative put it near two at 50 vol. That call finances several times what the 70 put ever did.

So stop selling the tail and sell the upside we've already agreed to give up. Own the December 100 put outright. Sell the highest call at 130 or above that brings the net cost to four and a half or less. On our sketches that lands near four at 40 vol and around four to four and a half at 50. It fits across the very band where Conservative showed the put spread alone fails. And Conservative opened this debate asking for a collar. We moved the call from 120 to 130, drifted into put spreads, and spent three rounds fighting over a leg we picked up along the way.

Here's what the collar does to each of your arguments.

Conservative, start with your 50 scenario. With a long put and no short put, the floor goes all the way down. At a net cost of four, each collared share loses at most 5.7 plus 4, about 9.2 percent of its value, whether BABA gaps to 93, 70 or 50. As a share of a full allocation, a 40 loses about 3.7 percent, a 45 about 4.1 and a 50 about 4.6. Your table had those same tiers at 11.7, 13.1 and 14.6 at 50 on the 100/70.

Mid-life marking doesn't make it worse. An American put is always worth at least its intrinsic value, and in a ban gap the short call collapses to pennies. The harsh-marking problem was the short 70 put's time value ballooning, and that leg is gone.

Your 50 scenario also says something about your own default. An unhedged 35 at 50 loses about 18 percent of an allocation, half again over the trader's 12.2 percent budget. That scenario isn't an argument for holding fewer shares. It's an argument for a floor that doesn't stop at 70.

Your netting objection was that the call rescues the hedge exactly when the market-implied odds of landing below 70 are highest. With a collar there's no region below the floor. You were right about the put spread, and the objection simply doesn't apply here.

Your compliance questions shrink to one. Exercising a long put delivers shares, which is divesting. In a ban the short call is worthless and can be closed for pennies, and being assigned on it would mean selling shares, which is also divesting. What's left is whether exercise and delivery still work if the ADR is suspended. That's your operations point, and it now matters more, not less, because the put carries the whole tail. I'd make it a hard precondition for anything above 35, as you asked.

Aggressive, you can now honestly call this a bounded call option on the print. By put-call parity, stock plus a long 100 put plus a short 130 call is a 100/130 call spread. Your version with the short 70 put wasn't bounded below 70. Your claim that the risk budget no longer decides anything was wrong on that structure, and Conservative's 50 table proved it. On the collar, it's true.

Conservative, this next part should matter most to you. Today a collared position carries roughly half a share of directional exposure per share. The 100 put takes off about a third and the 130 call about another sixth. So a collared 45 is roughly 23 points of stock-equivalent exposure, and a collared 50 about 25. Your unhedged default is 35. A collared 50 is a smaller directional bet against our Sell than the position you've been defending. Its exposure also shrinks as the stock falls and grows on a good print until the cap. All three of us said we wanted that shape.

The collar has a cost. We give up upside above 130 until mid-December. Aggressive already accepted that, and the ladder buys full size above 130.62 with new stock anyway. If a strong print carries the stock toward 125, roll the call up as part of the post-print re-hedge.

What the collar doesn't do is make the shares above 40 a good bet on their own. Conservative's breakeven arithmetic holds here too. After premium and the T-bill yield we give up, ten extra points lose about a point anywhere below 100. The good outcomes have to average roughly 120 at expiry just to break even. Aggressive, your coin flip treats the print as one number. Conservative is right that it comes with December guidance covering Singles' Day subsidies and year two of the AI program. So the tiers stay gated. The collar makes 45 and 50 safe once they're earned. It doesn't earn them.

Here's the hedge rule I'd propose, and it's simpler than what we have now. First choice is the collar at four and a half net or less, with the call at 130 or higher. That supports the agreed tiers: 40 as the base, 45 once the June quarter reads clean, 50 with all three checks clean, and 35 on a bad June quarter.

If the collar can't get under four and a half even with a 130 call, the market is pricing BABA's event risk so richly that both legs together can't bridge it. Then we sit at 35. On that 35 we can carry a 100/70 or 100/80 if one fits. For the 100/70 alone, I'd take Conservative's five-point signal, because we'd only be using it in a high-volatility world, which is exactly when his argument bites. The principle underneath is simple: no short put tail on anything above 35.

On the premium cap, you're each half right. Conservative, crisis payouts can't refill the budget. Otherwise the worse the headline, the more room we'd have to climb the ladder. Aggressive, unused insurance we sell back after a good outcome is a genuine refund. The clean dividing line is the put strike:

Call premium collected when the structure goes on counts as an offset.
Proceeds from closing protection count as recovery only if we close it with the stock above the long put's strike.
Anything sold with the put in the money is a claim. It offsets a stock loss and doesn't buy new insurance.

Measured that way, the cap is three percent of an allocation through January. A December collar on a 45 core at four costs about 1.7 percent. Post-print collars, bought after the volatility drains out, should be cheaper, so the path to the 80 rung still fits. If policy risk keeps volatility high and the cap binds, that's the rule doing its job.

There's one knock-on for the non-binding rule. When we cut a hedged core to 35, close the surplus collars, not just the puts. Sell the put legs into the volatility spike and buy back the matching calls, which will be cheap after a drop. Otherwise we're left with naked short calls on shares we no longer own.

On sequencing, Conservative's order is right. The list designation is a one-page check, and it decides whether resting limits at 109.5 even make sense, so read it Monday. Read the lawsuit and the June quarter by the session before CPI. Aggressive gets what he asked for: the last third sized against a known target. If anything is unread by October 23, the default is 40 collared or 35 otherwise.

Write the definition before anyone opens the filing, with three outcomes rather than two:

Clean, worth 45, requires all three of these: the opex ratio at least two points below FY2026's 34.9; operating cash flow positive for the quarter after stripping out working-capital swings; and quick-commerce losses narrowing from the March quarter.
Bad, back to 35, means either the opex ratio at or above 34.9 or negative operating cash flow.
Anything in between holds 40.

Conservative, I wouldn't set the bar by what it would take to carry the stock through 120.40. The gate measures evidence about the turn. The breakeven is already built into how little size that evidence buys. Using a price target to set the evidence bar counts the same caution twice.

The same structure applies after the print. When the gate passes, buy the post-print collar first thing after the volatility drains out, covering only the shares above the policy ceiling. Then add stock over three sessions. That meets Conservative's rule that the hedge is filled before each step, and Aggressive's point about not losing a session. No post-print put spreads with a short tail leg either. The lame duck and a new Congress are exactly when we don't want to be short a 70 put.

On fundamentals, you've converged on roughly five to six percent pretax on the price. That's a few points over real yields, with an open list question and three straight years of falling operating cash flow. It's why we own some and why we're trimming, and only the June quarter moves it. I don't think there's more to win there.

So I'm still at Sell BABA, executed as a trim:

Trim: Sell a third today. Have two-thirds done by the session before CPI, working limits from 106.5 to 109.5. Size the last third against the target the documents set, scaled through 108.2 to 109.5. Finish the session after any close below 104.75, and be at target by October 23.
Reading: The list on Monday. The lawsuit and the June quarter before CPI, judged against the three-outcome definition written first.
Hedge: Price the December 100 put and the 130-and-higher calls before today's close. Put the collar on if it nets four and a half or less. Otherwise sit at 35 with whatever spread fits under the old rules.
Size: 40, 45 and 50 on the collar as gated. 35 on a bad June quarter or without the collar. Nothing above 35 until operations and compliance confirm that exercise and delivery work in a designation.

Everything else stands as agreed:

Exit on any binding action.
On a non-binding action, resize as agreed and close the surplus collars into the spike.
Cut at 91.99 hedged and 99.74 unhedged, with no exceptions.
Apply the rates shade.
Keep the revert rule, with policy setting the ceiling.
Rebuild on the 60, 70, 80 ladder, with collars filled before each step.
Flat-book shorts at half size, with Aggressive's stand-aside rule.
Holders' slice as agreed, with cuts always first.
Three percent premium budget, measured at the strike.
Proceeds in short Treasuries near 4.8.

The short 70 put was bringing in a nickel to half a point and costing us the tail, a compliance trap and three rounds of argument. Swap it for the call we'd already agreed to sell. Conservative gets a floor that goes all the way down, Aggressive gets size that's genuinely bounded, and what's left is a filing we can read next week.

V. Portfolio Manager Decision¶

Portfolio Manager¶

Rating: Underweight

Executive Summary: Underweight BABA. Cut to a core of 40% of a standard allocation protected by a December 100 put / 130-or-higher call collar costing 4.5 points net or less, or to 35% if no qualifying hedge can be bought. Sell one-third of the reduction now, have two-thirds done by the session before September CPI using limits at 106.5-109.5, and place the rest into 108.2-109.5; finish the session after any close below 104.75 and reach target size by Oct 23, with no buying at 104-106 or into the 99.7-101 gap. Exit fully on any binding Treasury, executive-order or delisting action, and cut on a daily close below 91.99 if hedged or 99.74 if unhedged; the horizon runs through the September-quarter report (mid-to-late November), which together with the June-quarter filing decides whether the core rebuilds or goes to Sell.

Investment Thesis: DECISION AND WHY. The research manager, the trader and all three risk analysts converged on reducing BABA, not exiting it. The trader's and analysts' 'Sell' was always a trim to a hedged core, which is Underweight on this scale. The remaining dispute was only core size and how to protect it. I side with that consensus because the case against BABA rests on price and timing, while the franchise itself is intact. PRICE AND TIMING EVIDENCE. (1) Operating income fell 64%, from RMB 140.9B to RMB 50.2B, as opex jumped from 25.8% to 34.9% of revenue. On the bear bound, core earnings are about $2.40 per ADS, roughly 41x at 105.70. The honest range is about 17-44x. Neutral's middle case (a three-point opex improvement plus recurring interest income) gives a low-to-mid-20s multiple and roughly a 4% earnings yield. That is fair value, not cheap, against a 4.77% 2-year Treasury and a 2.92% real yield. (2) The spike was cash, as the Conservative showed. Operating cash flow fell about RMB 87B while opex rose about RMB 100B. Operating cash flow was RMB 76.2B, down 53%. Free cash flow was likely negative, the current ratio fell from 1.79 to 1.28, and net financing outflow fell from RMB 108B to RMB 21B. (3) The tape is in distribution without capitulation. Every SuperTrend timeframe is down (daily flip 114.44, weekly 131.16) and the moving averages are fully bearish. OBV is at a 60-day low of -10.45M after losing 75M in 12 sessions. Highs keep stepping lower (130.62, 120.40, 111.40). Oct 8 was rejected at the 20-day SMA (109.51) on 11.56M shares, the most since Sep 23, and RSI has never reached 30. (4) Event density is high before the print: an unconfirmed defense-list designation, an unknown lawsuit, September CPI, tax-loss season, the Nov 3 midterms, and a 10-year at 5.28%, three basis points from our 5.31% trigger. WHY NOT SELL. Gross margin held at 39.8% versus 40.0%, on record gross profit of RMB 407.5B, and opex ran 25-26% of revenue for three years before the spike. Each opex point is worth about RMB 10B of operating income. Equity is RMB 1.06T with liabilities at 0.74x equity, and the stock trades at about 1.7x book. The weekly TD count is at 7 of 9 with a nascent RSI/MACD divergence, and this stock ran 44% in six weeks this summer. A cheaply protected core is the right way to keep that optionality. WEIGHING THE DEBATE. The Conservative won the sizing arithmetic. An unhedged 40% gap to 70 costs about 13.5% of a full allocation, which breaches the trader's 12.2% budget, while an unhedged 35% costs about 11.8%. He also won the revert rule: an earnings gate says nothing about Treasury, and unhedged 60-80% rungs into the lame duck would cost 20-27% on a ban gap. The Aggressive won that protection, not share count, is the real risk control. He also won no capitulation exceptions, faster rebuilds, and reading the filings before sizing the last third. Neutral's collar settled the hedge. On the analysts' own sketches, the short 70 put saved only a nickel to half a point. It reopened the tail below 70 (a hedged 45 on the 100/70 loses about 13.1% at 50) and created an assignment problem with compliance. A long December 100 put financed by a call at 130 or higher, at a net cost of 4, caps the loss at 5.7 + 4 = 9.7 points per share, about 9.2%, at any gap depth. A collared 40% therefore loses about 3.7% of a full allocation even at 50, and carries only about half a share of directional exposure per share. EXECUTION. Hedge: price the December 100 put and calls at 130 or higher today, and sell the highest call strike that gets the net to 4.5 or less. If the collar fails, stay at 35% and allow only a 100/70 (5 or less) or a 100/80 (4 or less), never a short put on anything above 35%. Size tiers: 35% unhedged; 40% collared; 45% collared if the June quarter reads clean; 50% if the list, lawsuit and June quarter are all clean; 35% on a bad June quarter. Nothing goes above 35% until compliance and operations confirm that put exercise and delivery work under a designation, including the 9988.HK conversion route if the ADR is suspended. Reading: check the list designation Monday Oct 12, and read the lawsuit and June quarter before CPI. Write the definition before opening the filing. Clean means opex at or below 32.9% of revenue, positive operating cash flow excluding working capital, and narrowing quick-commerce losses. Bad means opex at or above 34.9% or negative operating cash flow. Anything between holds 40%. If the reads are not done by Oct 23, default to 40% collared or 35%. Cumulative premium is capped at 3% of a full allocation through January. Call premium counts as an offset, but proceeds from protection closed in the money cannot refill the budget. Triggers: on a non-binding action naming BABA, take a hedged core to 35% (closing the surplus collars into the volatility spike) or an unhedged core to 25%. Shade the core 5 points on two closes above 5.31% with real yields through 3%. When the hedge lapses, size reverts to the policy ceiling (35%, or 25% after a non-binding action) with the 99.74 cut. The only exceptions are a post-print collar on the shares above the ceiling, filled before the step, or Congress adjourning with the list and lawsuit clean. Tactical: flat books only may short at half size, scaled through 108.2-109.5, with a stop on a daily close above 111.40. Take half off at 100-101 and be flat before the print. Stand aside if price closes above 109.51 with the MACD histogram positive and OBV turning up. Run no short against a core. A holder's extra trimmed slice comes back only on a close above 111.40 or a completed weekly TD 9 at 95-101, and cuts always override buys. Park proceeds in short Treasuries at about 4.8%. WHAT CHANGES THE CALL. The September-quarter gate is written against the June quarter before Oct 23. The research manager's reference test is opex at or below 29% or quantified high-20s guidance, a free-cash outflow no worse than about RMB 3B, and customer management revenue holding its growth. If the gate passes, buy the post-print collar first and then move to 60% over three sessions. Add 70% on a close above 114.44 with OBV making a higher swing high at or above its Oct 5 level, and 80% on a weekly close above 120.40. Go to full size only with the policy tail covered and either a weekly close above 130.62 or a second clean quarter. A price signal without the gate is capped at 50%. Move to Sell on any binding Treasury action, or if opex is above 31% with no quantified guidance. PRICE TARGET. The valuation evidence is conditional. Fair value of $127-141 applies only if opex returns near FY2025 levels, and the middle case is roughly fair at today's price, so it gives no base objective. I therefore use the technical objective. The main bearish scenario's first target is 100-101, at the 78.6% retracement of the 91.99 to 132.57 rally: 132.57 - 0.786 x 40.58 = 100.67, next to the gap bottom at 99.74. Target 100.7, about -4.7% from 105.70. Below 104.75/103.78, the secondary zone is 92-95. If the thesis turns, upside is 114-116 and then 129-133. CONFIDENCE AND GAPS. Confidence is medium. The direction is unanimous and well evidenced, but several inputs are missing or unverified. The June-quarter details are absent, and the Aug 21 drop of 8.6% is only inferred to be that report. The list type, the lawsuit, September consensus and the capex breakdown are unknown. There is no option chain, so all hedge costs are Black-Scholes sketches.

Current Price: 105.7

Price Target: 100.7

Confidence: Medium

Time Horizon: 1-2 months

Trading Analysis Report: BABA¶

I. Analyst Team Reports¶

Market Analyst¶

BABA (Alibaba Group Holding Limited, NYQ): technical report¶

1. Indicators used and why¶

2. The big picture: a long-term downtrend¶

3. Trend: moving averages and SuperTrend¶

4. Momentum: MACD and RSI¶

MACD: a new sell crossover, but a weak one¶

RSI 39.09: weak, but not oversold¶

A possible sign of slowing selling (bullish divergence)¶

5. Volatility: ATR and Bollinger Bands¶

6. Volume: OBV and the Oct 8 session¶

7. Exhaustion: TD Sequential setup counts¶

8. Key price levels¶

9. Scenarios and what to watch¶

Most likely: the downtrend continues (bearish)¶

Alternative: a short-term bounce from exhaustion (counter-trend)¶

Timing to watch¶

10. Overall assessment¶

Summary table¶

Sentiment Analyst¶

BABA Sentiment Report (2026-10-01 to 2026-10-08)¶

1. Source-by-source breakdown¶

News (Yahoo Finance, 19 headlines)¶

StockTwits (8 messages)¶

Reddit¶

2. Cross-source divergences and alignments¶

3. Dominant narrative themes¶

4. Catalysts and risks surfaced by the data¶

5. Summary table of key sentiment signals¶

Bottom line¶

News Analyst¶

BABA (Alibaba Group Holding Limited): News and Macro Report¶

1. Summary¶

2. Company News (BABA)¶

A. Regulatory and political risk: the main negative¶

B. AI and cloud: the main positive¶

C. China AI funding cycle: background and comparisons¶

D. Sentiment and positioning¶

3. Macro Backdrop (FRED data)¶

Rates: a rising-yield shock driven by the Fed and long-term bonds¶

Inflation and jobs¶

Oil and geopolitics¶

Currency and risk appetite¶

Prediction markets¶

4. Trading Takeaways¶

Upcoming catalysts¶

Limitations¶

5. Key Points Summary¶

Fundamentals Analyst¶

BABA (Alibaba Group Holding Limited): Fundamental Research Report¶

1. Summary¶

2. Data coverage and limitations (read first)¶

3. Company profile (general background, not from the tools)¶

4. Income statement analysis¶

Multi-year trend (RMB B)¶

Key observations¶

5. Earnings quality¶

6. Cash flow analysis (RMB B)¶

7. Balance sheet and liquidity (RMB B)¶

8. Returns and per-share metrics¶

9. Insider activity¶

10. Actionable insights for traders¶

11. Key metrics summary¶

II. Research Team Decision¶

Bull Researcher¶

1. The recovery math the market is ignoring¶

2. The growth engine: Alibaba owns the whole AI stack¶

3. The chart: the trend is down, but sellers are losing steam¶

4. Answering the bear's best points in advance¶

5. How I'd own it¶

My call: BUY BABA. Accumulate in tranches, with a defined stop below 91.99.¶

1. What I got wrong¶

2. "One or the other" works in both directions¶

3. Evidence that the higher cost base isn't permanent¶

Alibaba has done this before, and it's in our data¶

Cash fell because profit fell: one decision, not two problems¶

Arms races end, and this one is costly for every player¶

Depreciation is real, but it comes with revenue¶